1116650	T2_T3	NONE	arginine/NN (r_pobj) of/IN (r_prep) combinations/NNS (r_pobj) to/IN (r_prep) response/NN (r_pobj) in/IN (r_prep) measured/VBN (l_appos) glucose/NN
1116650	T2_T4	NONE	arginine/NN (r_pobj) of/IN (r_prep) combinations/NNS (r_pobj) to/IN (r_prep) response/NN (r_pobj) in/IN (r_prep) measured/VBN (l_appos) glucose/NN (l_conj) theophylline/NN
1116650	T6_T7	NONE	Glucose/NN (l_advmod) alone/RB (l_conj) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) theophylline/NN
1116650	T8_T9	NONE	Arginine/NN (r_nsubj) caused/VBD (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) glucose/NN
1116650	T8_T10	NONE	Arginine/NN (r_nsubj) caused/VBD (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) glucose/NN (l_conj) theophylline/NN
1116650	T11_T12	NONE	Arginine/NN (r_nsubj) caused/VBD (l_prep) in/IN (l_pobj) absence/NN (l_prep) of/IN (l_pobj) glucose/NN
1116650	T11_T13	NONE	Arginine/NN (r_nsubj) caused/VBD (l_prep) in/IN (l_pobj) absence/NN (l_prep) of/IN (l_pobj) glucose/NN (l_conj) theophylline/NN
1116650	T17_T18	NONE	theophylline/NN (r_pobj) to/IN (r_prep) respond/VBP (l_conj) are/VBP (l_acomp) insensitive/JJ (l_prep) to/IN (l_pobj) glucose/NN
11154900	T2_T3	NONE	carboxymethylcellulose/NN (l_appos) NaCMC/NNP
11154900	T2_T5	NONE	carboxymethylcellulose/NN (l_conj) cysteine/NN (l_appos) Cys/NNP
11154900	T2_T6	NONE	carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN
11154900	T2_T7	NONE	carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP
11154900	T2_T8	NONE	carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN
11154900	T2_T9	NONE	carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN (l_conj) insulin/NN
11154900	T3_T4	NONE	NaCMC/NNP (r_appos) carboxymethylcellulose/NN (l_conj) cysteine/NN
11154900	T3_T5	NONE	NaCMC/NNP (r_appos) carboxymethylcellulose/NN (l_conj) cysteine/NN (l_appos) Cys/NNP
11154900	T3_T6	NONE	NaCMC/NNP (r_appos) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN
11154900	T3_T7	NONE	NaCMC/NNP (r_appos) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP
11154900	T3_T8	NONE	NaCMC/NNP (r_appos) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN
11154900	T3_T9	NONE	NaCMC/NNP (r_appos) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN (l_conj) insulin/NN
11154900	T4_T5	NONE	cysteine/NN (l_appos) Cys/NNP
11154900	T4_T6	NONE	cysteine/NN (r_conj) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN
11154900	T4_T7	NONE	cysteine/NN (r_conj) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP
11154900	T4_T8	NONE	cysteine/NN (r_conj) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN
11154900	T4_T9	NONE	cysteine/NN (r_conj) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN (l_conj) insulin/NN
11154900	T5_T6	NONE	Cys/NNP (r_appos) cysteine/NN (r_conj) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN
11154900	T5_T7	NONE	Cys/NNP (r_appos) cysteine/NN (r_conj) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP
11154900	T5_T8	NONE	Cys/NNP (r_appos) cysteine/NN (r_conj) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN
11154900	T5_T9	NONE	Cys/NNP (r_appos) cysteine/NN (r_conj) carboxymethylcellulose/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) evaluate/VB (l_conj) fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN (l_conj) insulin/NN
11154900	T6_T7	NONE	fluorescein/NN (l_appos) NaFlu/NNP
11154900	T6_T8	NONE	fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN
11154900	T6_T9	NONE	fluorescein/NN (l_appos) NaFlu/NNP (l_conj) drugs/NNS (l_conj) bacitracin/NN (l_conj) insulin/NN
11154900	T10_T11	NONE	Cysteine/NNP (r_nsubjpass) linked/VBN (l_prep) to/TO (l_pobj) NaCMC/NNP
11154900	T13_T14	NONE	NaCMC/NNP (r_nsubj) improved/VBD (r_ccomp) enhanced/VBD (l_nsubj) control/NN (l_prep) of/IN (l_pobj) NaFlu/NNP
11154900	T13_T16	NONE	NaCMC/NNP (r_nsubj) improved/VBD (r_ccomp) enhanced/VBD (l_nsubj) control/NN (l_prep) to/IN (l_pobj) NaCMC/NN (l_acl) conjugated/VBN (l_prep) with/IN (l_pobj) cysteine/NN
11154900	T14_T15	NONE	NaFlu/NNP (r_pobj) of/IN (r_prep) control/NN (l_prep) to/IN (l_pobj) NaCMC/NN
11154900	T14_T16	NONE	NaFlu/NNP (r_pobj) of/IN (r_prep) control/NN (l_prep) to/IN (l_pobj) NaCMC/NN (l_acl) conjugated/VBN (l_prep) with/IN (l_pobj) cysteine/NN
11154900	T15_T16	NONE	NaCMC/NN (l_acl) conjugated/VBN (l_prep) with/IN (l_pobj) cysteine/NN
11154900	T18_T19	NONE	Cys/NNP (r_pobj) of/IN (r_prep) concentration/NN (r_dobj) Decreasing/VBG (l_dep) exhibiting/VBG (l_dobj) %/NN (l_prep) of/IN (l_pobj) cysteine/NN
11154900	T18_T20	NONE	Cys/NNP (r_pobj) of/IN (r_prep) concentration/NN (r_dobj) Decreasing/VBG (l_dep) decreased/VBD (l_dobj) value/NN (l_prep) of/IN (l_pobj) NaFlu/NNP
11154900	T19_T20	NONE	cysteine/NN (r_pobj) of/IN (r_prep) %/NN (r_dobj) exhibiting/VBG (r_dep) Decreasing/VBG (l_dep) decreased/VBD (l_dobj) value/NN (l_prep) of/IN (l_pobj) NaFlu/NNP
11154900	T21_T22	NONE	NaCMC/NN (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) cysteine/NN
11154900	T21_T23	NONE	NaCMC/NN (r_nsubj) had/VBD (l_dobj) effect/NN (l_prep) on/IN (l_pobj) value/NN (l_prep) of/IN (l_pobj) NaFlu/NNP
11154900	T22_T23	NONE	cysteine/NN (r_pobj) of/IN (r_prep) presence/NN (r_pobj) in/IN (r_prep) NaCMC/NN (r_nsubj) had/VBD (l_dobj) effect/NN (l_prep) on/IN (l_pobj) value/NN (l_prep) of/IN (l_pobj) NaFlu/NNP
11154900	T22_T24	NONE	cysteine/NN (r_pobj) of/IN (r_prep) presence/NN (r_pobj) in/IN (r_prep) NaCMC/NN (r_nsubj) had/VBD (l_prep) compared/VBN (l_prep) to/IN (l_pobj) NaCMC/NNP
11154900	T23_T24	NONE	NaFlu/NNP (r_pobj) of/IN (r_prep) value/NN (r_pobj) on/IN (r_prep) effect/NN (r_dobj) had/VBD (l_prep) compared/VBN (l_prep) to/IN (l_pobj) NaCMC/NNP
11154900	T25_T27	NONE	bacitracin/NN (r_dobj) labelled/VBN (l_prep) in/IN (l_pobj) NaCMC/NNP
11154900	T26_T27	NONE	insulin/NN (r_conj) bacitracin/NN (r_dobj) labelled/VBN (l_prep) in/IN (l_pobj) NaCMC/NNP
11154900	T29_T30	NONE	NaCMC/NNP (r_pobj) at/IN (r_prep) Conjugation/NN (l_prep) with/IN (l_pobj) moieties/NNS (l_compound) cysteine/NN
11154900	T29_T31	NONE	NaCMC/NNP (r_pobj) at/IN (r_prep) Conjugation/NN (r_nsubj) improves/VBZ (l_dobj) permeation/NN (l_prep) of/IN (l_pobj) NaFlu/NNP
11154900	T29_T32	NONE	NaCMC/NNP (r_pobj) at/IN (r_prep) Conjugation/NN (r_nsubj) improves/VBZ (l_dobj) permeation/NN (l_appos) bacitracin/NNS
11154900	T29_T33	NONE	NaCMC/NNP (r_pobj) at/IN (r_prep) Conjugation/NN (r_nsubj) improves/VBZ (l_dobj) permeation/NN (l_appos) bacitracin/NNS (l_conj) insulin/NN
11154900	T30_T31	NONE	cysteine/NN (r_compound) moieties/NNS (r_pobj) with/IN (r_prep) Conjugation/NN (r_nsubj) improves/VBZ (l_dobj) permeation/NN (l_prep) of/IN (l_pobj) NaFlu/NNP
11154900	T30_T32	NONE	cysteine/NN (r_compound) moieties/NNS (r_pobj) with/IN (r_prep) Conjugation/NN (r_nsubj) improves/VBZ (l_dobj) permeation/NN (l_appos) bacitracin/NNS
11154900	T30_T33	NONE	cysteine/NN (r_compound) moieties/NNS (r_pobj) with/IN (r_prep) Conjugation/NN (r_nsubj) improves/VBZ (l_dobj) permeation/NN (l_appos) bacitracin/NNS (l_conj) insulin/NN
11154900	T31_T32	NONE	NaFlu/NNP (r_pobj) of/IN (r_prep) permeation/NN (l_appos) bacitracin/NNS
11154900	T31_T33	NONE	NaFlu/NNP (r_pobj) of/IN (r_prep) permeation/NN (l_appos) bacitracin/NNS (l_conj) insulin/NN
11206047	T3_T4	NONE	Acetaminophen/NNP (l_appos) lidocaine/NN
11206047	T3_T5	NONE	Acetaminophen/NNP (l_appos) lidocaine/NN (l_conj) phenobarbital/JJ
11206047	T3_T6	NONE	Acetaminophen/NNP (l_appos) lidocaine/NN (l_conj) phenobarbital/JJ (l_conj) quinidine/NN
11206047	T3_T7	NONE	Acetaminophen/NNP (l_appos) lidocaine/NN (l_conj) phenobarbital/JJ (l_conj) quinidine/NN (l_conj) theophylline/NN
11206047	T3_T8	NONE	Acetaminophen/NNP (l_appos) lidocaine/NN (l_conj) phenobarbital/JJ (l_conj) quinidine/NN (l_conj) acid/NN
11206047	T9_T10	NONE	acetaminophen/RB (r_advmod) phenobarbital/NN
11206047	T11_T12	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_punct) //SYM (l_preconj) theophylline/NN
11206047	T11_T13	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_nmod) lidocaine/NN
11206047	T11_T14	NONE	acetaminophen/RB (r_nmod) quinidine/NN
11206047	T11_T15	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_conj) phenobarbital/NNP
11206047	T11_T17	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_conj) phenobarbital/NNP (l_conj) phenobarbital/JJ
11206047	T11_T18	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_conj) phenobarbital/NNP (l_conj) phenobarbital/JJ (l_appos) acid/NN
11206047	T11_T19	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_appos) lidocaine/NN (l_nmod) quinidine/NN
11206047	T11_T20	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_appos) lidocaine/NN
11206047	T11_T21	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_nmod) theophylline/NN
11206047	T11_T23	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) acid/NN
11206047	T11_T24	NONE	acetaminophen/RB (r_nmod) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) phenobarbital/NN
11206047	T12_T13	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_nmod) lidocaine/NN
11206047	T12_T14	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN
11206047	T12_T15	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_conj) phenobarbital/NNP
11206047	T12_T16	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_conj) phenobarbital/NNP (l_advmod) acetaminophen/RB
11206047	T12_T17	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_conj) phenobarbital/NNP (l_conj) phenobarbital/JJ
11206047	T12_T18	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_conj) phenobarbital/NNP (l_conj) phenobarbital/JJ (l_appos) acid/NN
11206047	T12_T19	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_appos) lidocaine/NN (l_nmod) quinidine/NN
11206047	T12_T20	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_appos) lidocaine/NN
11206047	T12_T22	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN
11206047	T12_T23	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) acid/NN
11206047	T12_T24	NONE	theophylline/NN (r_preconj) //SYM (r_punct) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) phenobarbital/NN
11206047	T13_T14	NONE	lidocaine/NN (r_nmod) quinidine/NN
11206047	T13_T15	NONE	lidocaine/NN (r_nmod) quinidine/NN (l_conj) phenobarbital/NNP
11206047	T13_T16	NONE	lidocaine/NN (r_nmod) quinidine/NN (l_conj) phenobarbital/NNP (l_advmod) acetaminophen/RB
11206047	T13_T17	NONE	lidocaine/NN (r_nmod) quinidine/NN (l_conj) phenobarbital/NNP (l_conj) phenobarbital/JJ
11206047	T13_T18	NONE	lidocaine/NN (r_nmod) quinidine/NN (l_conj) phenobarbital/NNP (l_conj) phenobarbital/JJ (l_appos) acid/NN
11206047	T13_T19	NONE	lidocaine/NN (r_nmod) quinidine/NN (l_appos) lidocaine/NN (l_nmod) quinidine/NN
11206047	T13_T21	NONE	lidocaine/NN (r_nmod) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_nmod) theophylline/NN
11206047	T13_T22	NONE	lidocaine/NN (r_nmod) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN
11206047	T13_T23	NONE	lidocaine/NN (r_nmod) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) acid/NN
11206047	T13_T24	NONE	lidocaine/NN (r_nmod) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) phenobarbital/NN
11206047	T14_T16	NONE	quinidine/NN (l_conj) phenobarbital/NNP (l_advmod) acetaminophen/RB
11206047	T14_T18	NONE	quinidine/NN (l_conj) phenobarbital/NNP (l_conj) phenobarbital/JJ (l_appos) acid/NN
11206047	T14_T20	NONE	quinidine/NN (l_appos) lidocaine/NN
11206047	T14_T21	NONE	quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_nmod) theophylline/NN
11206047	T14_T22	NONE	quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN
11206047	T14_T23	NONE	quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) acid/NN
11206047	T14_T24	NONE	quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) phenobarbital/NN
11206047	T15_T16	NONE	phenobarbital/NNP (l_advmod) acetaminophen/RB
11206047	T15_T18	NONE	phenobarbital/NNP (l_conj) phenobarbital/JJ (l_appos) acid/NN
11206047	T15_T19	NONE	phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_nmod) quinidine/NN
11206047	T15_T20	NONE	phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN
11206047	T15_T21	NONE	phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_nmod) theophylline/NN
11206047	T15_T22	NONE	phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN
11206047	T15_T23	NONE	phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) acid/NN
11206047	T16_T17	NONE	acetaminophen/RB (r_advmod) phenobarbital/NNP (l_conj) phenobarbital/JJ
11206047	T16_T18	NONE	acetaminophen/RB (r_advmod) phenobarbital/NNP (l_conj) phenobarbital/JJ (l_appos) acid/NN
11206047	T16_T19	NONE	acetaminophen/RB (r_advmod) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_nmod) quinidine/NN
11206047	T16_T20	NONE	acetaminophen/RB (r_advmod) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN
11206047	T16_T21	NONE	acetaminophen/RB (r_advmod) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_nmod) theophylline/NN
11206047	T16_T23	NONE	acetaminophen/RB (r_advmod) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) acid/NN
11206047	T16_T24	NONE	acetaminophen/RB (r_advmod) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) phenobarbital/NN
11206047	T17_T18	NONE	phenobarbital/JJ (l_appos) acid/NN
11206047	T17_T19	NONE	phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_nmod) quinidine/NN
11206047	T17_T20	NONE	phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN
11206047	T17_T21	NONE	phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_nmod) theophylline/NN
11206047	T17_T22	NONE	phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN
11206047	T17_T23	NONE	phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) acid/NN
11206047	T18_T19	NONE	acid/NN (r_appos) phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_nmod) quinidine/NN
11206047	T18_T20	NONE	acid/NN (r_appos) phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN
11206047	T18_T21	NONE	acid/NN (r_appos) phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_nmod) theophylline/NN
11206047	T18_T22	NONE	acid/NN (r_appos) phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN
11206047	T18_T24	NONE	acid/NN (r_appos) phenobarbital/JJ (r_conj) phenobarbital/NNP (r_conj) quinidine/NN (l_appos) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) phenobarbital/NN
11206047	T19_T20	NONE	quinidine/NN (r_nmod) lidocaine/NN
11206047	T19_T21	NONE	quinidine/NN (r_nmod) lidocaine/NN (l_conj) acetaminophen/NN (l_nmod) theophylline/NN
11206047	T19_T22	NONE	quinidine/NN (r_nmod) lidocaine/NN (l_conj) acetaminophen/NN
11206047	T19_T23	NONE	quinidine/NN (r_nmod) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) acid/NN
11206047	T19_T24	NONE	quinidine/NN (r_nmod) lidocaine/NN (l_conj) acetaminophen/NN (l_conj) phenobarbital/NN
11206047	T20_T21	NONE	lidocaine/NN (l_conj) acetaminophen/NN (l_nmod) theophylline/NN
11206047	T21_T22	NONE	theophylline/NN (r_nmod) acetaminophen/NN
11206047	T21_T23	NONE	theophylline/NN (r_nmod) acetaminophen/NN (l_conj) acid/NN
11206047	T21_T24	NONE	theophylline/NN (r_nmod) acetaminophen/NN (l_conj) phenobarbital/NN
11206047	T25_T28	NONE	phenobarbital/JJ (r_acomp) were/VBD (l_advmod) alone/RB (l_prep) at/IN (l_pobj) concentrations/NNS (l_prep) in/IN (l_conj) with/IN (l_pobj) ethanol/NN
11206047	T26_T28	NONE	quinidine/UH (r_conj) phenobarbital/JJ (r_acomp) were/VBD (l_advmod) alone/RB (l_prep) at/IN (l_pobj) concentrations/NNS (l_prep) in/IN (l_conj) with/IN (l_pobj) ethanol/NN
11206047	T27_T28	NONE	theophylline/NN (r_conj) quinidine/UH (r_conj) phenobarbital/JJ (r_acomp) were/VBD (l_advmod) alone/RB (l_prep) at/IN (l_pobj) concentrations/NNS (l_prep) in/IN (l_conj) with/IN (l_pobj) ethanol/NN
11206047	T29_T30	MECHANISM	Acetaminophen/NNP (r_nsubj) diminished/VBD (l_dobj) binding/NN (l_prep) of/IN (l_pobj) theophylline/NN
11206047	T31_T32	MECHANISM	Theophylline/NNP (r_nsubj) decreased/VBD (l_dobj) binding/NN (l_prep) of/IN (l_pobj) acetaminophen/NN
11206047	T33_T34	NONE	phenobarbital/VB (r_nsubj) reduced/VBD (r_ccomp) diminished/VBD (l_nsubj) acid/NN
11206047	T34_T35	MECHANISM	acid/NN (r_nsubj) diminished/VBD (l_dobj) binding/NN (l_prep) of/IN (l_pobj) phenobarbital/NN
11206047	T37_T38	EFFECT	acetaminophen/NN (r_pobj) of/IN (r_prep) Coingestion/NNP (l_prep) with/IN (l_pobj) theophylline/NN
11206047	T37_T39	NONE	acetaminophen/NN (r_pobj) of/IN (r_prep) Coingestion/NNP (l_amod) phenobarbital/JJ
11206047	T37_T41	NONE	acetaminophen/NN (r_pobj) of/IN (r_prep) Coingestion/NNP (l_amod) phenobarbital/JJ (l_prep) with/IN (l_pobj) acetaminophen/NN (l_conj) acid/NN
11206047	T37_T42	NONE	acetaminophen/NN (r_pobj) of/IN (r_prep) Coingestion/NNP (l_amod) phenobarbital/JJ (l_prep) with/IN (l_pobj) acetaminophen/NN (l_conj) acid/NN (l_prep) with/IN (l_pobj) phenobarbital/NN
11206047	T38_T39	NONE	theophylline/NN (r_pobj) with/IN (r_prep) Coingestion/NNP (l_amod) phenobarbital/JJ
11206047	T38_T40	NONE	theophylline/NN (r_pobj) with/IN (r_prep) Coingestion/NNP (l_amod) phenobarbital/JJ (l_prep) with/IN (l_pobj) acetaminophen/NN
11206047	T38_T41	NONE	theophylline/NN (r_pobj) with/IN (r_prep) Coingestion/NNP (l_amod) phenobarbital/JJ (l_prep) with/IN (l_pobj) acetaminophen/NN (l_conj) acid/NN
11206047	T38_T42	NONE	theophylline/NN (r_pobj) with/IN (r_prep) Coingestion/NNP (l_amod) phenobarbital/JJ (l_prep) with/IN (l_pobj) acetaminophen/NN (l_conj) acid/NN (l_prep) with/IN (l_pobj) phenobarbital/NN
11206047	T39_T40	EFFECT	phenobarbital/JJ (l_prep) with/IN (l_pobj) acetaminophen/NN
11206047	T39_T41	NONE	phenobarbital/JJ (l_prep) with/IN (l_pobj) acetaminophen/NN (l_conj) acid/NN
11206047	T40_T42	NONE	acetaminophen/NN (l_conj) acid/NN (l_prep) with/IN (l_pobj) phenobarbital/NN
11206047	T41_T42	EFFECT	acid/NN (l_prep) with/IN (l_pobj) phenobarbital/NN
11085333	T1_T2	NONE	cocaine/NN (r_compound) exposure/NN (r_pobj) to/IN (r_prep) responses/NNS (r_nsubj) bred/VBD (l_prep) for/IN (l_pobj) sensitivity/NN (l_prep) to/IN (l_pobj) pentobarbital/NN
11085333	T3_T4	NONE	pentobarbital/NN (r_npadvmod) induced/VBN (r_amod) sedation/NN (r_compound) times/NNS (r_pobj) to/IN (r_prep) response/NN (r_pobj) for/IN (r_prep) selected/VBN (l_conj) used/VBN (l_xcomp) study/VB (l_dobj) sensitization/NN (l_amod) induced/VBN (l_npadvmod) cocaine/NN
11213561	T4_T5	ADVISE	Sildenafil/NNP (r_nsubjpass) contraindicated/VBN (l_prep) in/IN (l_pobj) patients/NNS (l_acl) using/VBG (l_dobj) nitrates/NNS
11213561	T4_T6	ADVISE	Sildenafil/NNP (r_nsubjpass) contraindicated/VBN (l_conj) need/VB (l_xcomp) use/VB (l_dobj) nitrates/NNS
11213561	T7_T9	NONE	blockers/NNS (l_conj) antagonists/NNS (l_conj) thiazide/NN (l_conj) loop/NN (l_dobj) diuretics/NNS
11213561	T7_T10	NONE	blockers/NNS (l_conj) antagonists/NNS (l_conj) thiazide/NN (l_conj) loop/NN (l_dobj) diuretics/NNS
11213561	T7_T11	NONE	blockers/NNS (l_conj) antagonists/NNS (l_conj) thiazide/NN (l_conj) loop/NN (l_dobj) diuretics/NNS (l_conj) inhibitors/NNS
11213561	T8_T9	NONE	antagonists/NNS (l_conj) thiazide/NN (l_conj) loop/NN (l_dobj) diuretics/NNS
11213561	T8_T10	NONE	antagonists/NNS (l_conj) thiazide/NN (l_conj) loop/NN (l_dobj) diuretics/NNS
11213561	T8_T11	NONE	antagonists/NNS (l_conj) thiazide/NN (l_conj) loop/NN (l_dobj) diuretics/NNS (l_conj) inhibitors/NNS
11213561	T9_T10	NONE	diuretics/NNS
11170315	T1_T2	NONE	gliftor/NN (r_pobj) of/IN (r_prep) action/NN (r_pobj) of/IN (r_prep) mode/NN (l_appos) metabolism/NN (l_prep) of/IN (l_pobj) 1,3-difluoroacetone/CD
11170315	T1_T3	NONE	gliftor/NN (r_pobj) of/IN (r_prep) action/NN (r_pobj) of/IN (r_prep) mode/NN (l_appos) metabolism/NN (l_prep) of/IN (l_pobj) 1,3-difluoroacetone/CD (l_prep) to/IN (l_pobj) fluorocitrate/NN
11170315	T2_T3	NONE	1,3-difluoroacetone/CD (l_prep) to/IN (l_pobj) fluorocitrate/NN
11170315	T4_T5	NONE	1,3-difluoroacetone/CD (r_pobj) of/IN (r_prep) toxicology/NN (l_appos) metabolite/NN (l_prep) of/IN (l_pobj) ingredient/NN (l_prep) of/IN (l_pobj) Gliftor/NNP
11170315	T4_T6	NONE	1,3-difluoroacetone/CD (r_pobj) of/IN (r_prep) toxicology/NN (l_appos) metabolite/NN (l_prep) of/IN (l_pobj) ingredient/NN (l_prep) of/IN (l_pobj) Gliftor/NNP (l_appos) 1,3-difluoro-2-propanol/CD
11170315	T5_T6	NONE	Gliftor/NNP (l_appos) 1,3-difluoro-2-propanol/CD
11170315	T7_T8	NONE	1,3-difluoroacetone/CD (r_dobj) converted/VBD (l_advcl) in/IN (l_punct) fluorocitrate/NN
11170315	T9_T10	NONE	1,3-difluoroacetone/CD (r_nmod) weight/NN (r_pobj) of/IN (r_prep) Administration/NN (r_nsubj) resulted/VBD (l_prep) in/IN (l_pobj) synthesis/NN (l_compound) fluorocitrate/JJ
11170315	T11_T12	NONE	1,3-difluoroacetone/CD (r_pobj) with/IN (r_prep) dosed/VBD (r_acl) Animals/NNS (r_nsubj) display/VB (l_dobj) phase/NN (l_prep) in/IN (l_pobj) synthesis/NN (l_compound) fluorocitrate/JJ
11170315	T11_T13	NONE	1,3-difluoroacetone/CD (r_pobj) with/IN (r_prep) dosed/VBD (r_acl) Animals/NNS (r_nsubj) display/VB (l_dobj) phase/NN (l_prep) in/IN (l_pobj) synthesis/NN (l_conj) in/IN (l_pobj) accumulation/NN (l_amod) characteristic/NN (l_prep) of/IN (l_pobj) animals/NNS (l_acl) dosed/VBN (l_prep) with/IN (l_pobj) 1,3-difluoro-2-propanol/CD
11170315	T12_T13	NONE	fluorocitrate/JJ (r_compound) synthesis/NN (l_conj) in/IN (l_pobj) accumulation/NN (l_amod) characteristic/NN (l_prep) of/IN (l_pobj) animals/NNS (l_acl) dosed/VBN (l_prep) with/IN (l_pobj) 1,3-difluoro-2-propanol/CD
11170315	T14_T15	NONE	1,3-difluoro-2-propanol/CD (r_pobj) of/IN (r_prep) conversion/NN (l_prep) to/IN (l_pobj) 1,3-difluoroacetone/CD
11170315	T14_T16	NONE	1,3-difluoro-2-propanol/CD (r_pobj) of/IN (r_prep) conversion/NN (r_nsubj) is/VBZ (r_ccomp) demonstrate/VBP (l_punct) ./. (l_punct) fluorocitrate/NN
11170315	T15_T16	NONE	1,3-difluoroacetone/CD (r_pobj) to/IN (r_prep) conversion/NN (r_nsubj) is/VBZ (r_ccomp) demonstrate/VBP (l_punct) ./. (l_punct) fluorocitrate/NN
11170315	T15_T17	NONE	1,3-difluoroacetone/CD (r_pobj) to/IN (r_prep) conversion/NN (r_nsubj) is/VBZ (r_ccomp) demonstrate/VBP (l_punct) ./. (l_punct) fluorocitrate/NN (l_prep) from/IN (l_pobj) 1,3-difluoro-2-propanol/CD
11170315	T16_T17	NONE	fluorocitrate/NN (l_prep) from/IN (l_pobj) 1,3-difluoro-2-propanol/CD
11170315	T19_T20	NONE	1,3-difluoro-2-propanol/CD (r_pobj) of/IN (r_prep) conversion/NN (l_prep) to/IN (l_pobj) fluorocitrate/NN
11170315	T20_T21	NONE	fluorocitrate/NN (r_pobj) to/IN (r_prep) conversion/NN (r_dobj) prevent/VB (l_conj) eliminate/VB (l_dobj) elevations/NNS (l_acl) seen/VBN (l_prep) in/IN (l_pobj) animals/NNS (l_amod) intoxicated/VBN (l_npadvmod) 1,3-difluoro-2-propanol/CD
11170315	T23_T24	NONE	1,3-difluoroacetone/CD (r_nmod) weight/NN (r_pobj) to/IN (r_prep) prior/RB (r_advmod) rats/NNS (r_pobj) to/IN (r_prep) weight/NN (r_nsubj) was/VBD (l_prep) in/IN (l_pcomp) preventing/VBG (l_dobj) synthesis/NN (l_compound) fluorocitrate/JJ
11170315	T25_T26	EFFECT	4-methylpyrazole/JJ (r_punct) seen/VBN (l_prep) in/IN (l_pobj) animals/NNS (l_acl) treated/VBN (l_prep) with/IN (l_pobj) 1,3-difluoro-2-propanol/CD
11170315	T25_T27	NONE	4-methylpyrazole/JJ (r_punct) seen/VBN (r_acl) properties/NNS (r_nsubj) derive/JJ (l_prep) from/IN (l_pobj) capacity/NN (l_acl) inhibit/VB (l_dobj) oxidation/NN (l_amod) responsible/JJ (l_prep) for/IN (l_pcomp) converting/VBG (l_dobj) 1,3-difluoro-2-propanol/CD
11170315	T25_T28	NONE	4-methylpyrazole/JJ (r_punct) seen/VBN (r_acl) properties/NNS (r_nsubj) derive/JJ (l_prep) from/IN (l_pobj) capacity/NN (l_acl) inhibit/VB (l_dobj) oxidation/NN (l_amod) responsible/JJ (l_prep) for/IN (l_pcomp) converting/VBG (l_prep) to/IN (l_pobj) 1,3-difluoroacetone/CD
11170315	T26_T28	NONE	1,3-difluoro-2-propanol/CD (r_pobj) with/IN (r_prep) treated/VBN (r_acl) animals/NNS (r_pobj) in/IN (r_prep) seen/VBN (r_acl) properties/NNS (r_nsubj) derive/JJ (l_prep) from/IN (l_pobj) capacity/NN (l_acl) inhibit/VB (l_dobj) oxidation/NN (l_amod) responsible/JJ (l_prep) for/IN (l_pcomp) converting/VBG (l_prep) to/IN (l_pobj) 1,3-difluoroacetone/CD
11170315	T27_T28	NONE	1,3-difluoro-2-propanol/CD (r_dobj) converting/VBG (l_prep) to/IN (l_pobj) 1,3-difluoroacetone/CD
11137320	T1_T2	EFFECT	Cypermethrin/NNP (r_npadvmod) induced/VBN (r_nsubjpass) prevented/VBN (l_agent) by/IN (l_pobj) E/NN
11137320	T1_T3	EFFECT	Cypermethrin/NNP (r_npadvmod) induced/VBN (r_nsubjpass) prevented/VBN (l_agent) by/IN (l_pobj) E/NN (l_conj) allopurinol/NN
11137320	T4_T5	NONE	cypermethrin/NN (r_pobj) by/IN (r_prep) induction/NN (r_pobj) of/IN (r_prep) possibility/NN (r_dobj) investigate/VB (r_xcomp) designed/VBN (l_appos) pyrethroid/NN
11137320	T7_T9	EFFECT	allopurinol/NN (r_pobj) with/IN (r_prep) rats/NNS (r_pobj) of/IN (r_prep) Pretreatment/NN (r_nsubj) provided/VBD (l_advcl) induced/VBN (l_agent) by/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) administration/NN (l_compound) cypermethrin/NN
11137320	T7_T10	NONE	allopurinol/NN (r_pobj) with/IN (r_prep) rats/NNS (r_pobj) of/IN (r_prep) Pretreatment/NN (r_nsubj) provided/VBD (r_ccomp) suggest/VBP (l_ccomp) results/NNS (l_nsubj) exposure/NN (l_compound) cypermethrin/JJ
11137320	T7_T12	NONE	allopurinol/NN (r_pobj) with/IN (r_prep) rats/NNS (r_pobj) of/IN (r_prep) Pretreatment/NN (r_nsubj) provided/VBD (r_ccomp) suggest/VBP (l_ccomp) results/NNS (l_advcl) indicated/VBN (l_agent) by/IN (l_pobj) peroxidation/NN (l_relcl) prevented/VBN (l_agent) by/IN (l_pobj) allopurinol/NN (l_conj) E./NNP
11137320	T8_T9	EFFECT	E/NN (r_conj) allopurinol/NN (r_pobj) with/IN (r_prep) rats/NNS (r_pobj) of/IN (r_prep) Pretreatment/NN (r_nsubj) provided/VBD (l_advcl) induced/VBN (l_agent) by/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) administration/NN (l_compound) cypermethrin/NN
11137320	T8_T10	NONE	E/NN (r_conj) allopurinol/NN (r_pobj) with/IN (r_prep) rats/NNS (r_pobj) of/IN (r_prep) Pretreatment/NN (r_nsubj) provided/VBD (r_ccomp) suggest/VBP (l_ccomp) results/NNS (l_nsubj) exposure/NN (l_compound) cypermethrin/JJ
11137320	T8_T11	NONE	E/NN (r_conj) allopurinol/NN (r_pobj) with/IN (r_prep) rats/NNS (r_pobj) of/IN (r_prep) Pretreatment/NN (r_nsubj) provided/VBD (r_ccomp) suggest/VBP (l_ccomp) results/NNS (l_advcl) indicated/VBN (l_agent) by/IN (l_pobj) peroxidation/NN (l_relcl) prevented/VBN (l_agent) by/IN (l_pobj) allopurinol/NN
11137320	T9_T11	NONE	cypermethrin/NN (r_compound) administration/NN (r_pobj) of/IN (r_prep) dose/NN (r_pobj) by/IN (r_agent) induced/VBN (r_advcl) provided/VBD (r_ccomp) suggest/VBP (l_ccomp) results/NNS (l_advcl) indicated/VBN (l_agent) by/IN (l_pobj) peroxidation/NN (l_relcl) prevented/VBN (l_agent) by/IN (l_pobj) allopurinol/NN
11137320	T9_T12	NONE	cypermethrin/NN (r_compound) administration/NN (r_pobj) of/IN (r_prep) dose/NN (r_pobj) by/IN (r_agent) induced/VBN (r_advcl) provided/VBD (r_ccomp) suggest/VBP (l_ccomp) results/NNS (l_advcl) indicated/VBN (l_agent) by/IN (l_pobj) peroxidation/NN (l_relcl) prevented/VBN (l_agent) by/IN (l_pobj) allopurinol/NN (l_conj) E./NNP
11137320	T10_T11	EFFECT	cypermethrin/JJ (r_compound) exposure/NN (r_nsubj) results/NNS (l_advcl) indicated/VBN (l_agent) by/IN (l_pobj) peroxidation/NN (l_relcl) prevented/VBN (l_agent) by/IN (l_pobj) allopurinol/NN
11137320	T10_T12	EFFECT	cypermethrin/JJ (r_compound) exposure/NN (r_nsubj) results/NNS (l_advcl) indicated/VBN (l_agent) by/IN (l_pobj) peroxidation/NN (l_relcl) prevented/VBN (l_agent) by/IN (l_pobj) allopurinol/NN (l_conj) E./NNP
3966974	T1_T2	EFFECT	Misonidazole/NNP (r_nsubj) protects/VBZ (l_dobj) tumour/NN (l_prep) from/IN (l_pobj) toxicity/NN (l_prep) of/IN (l_pobj) CCNU/NNP
3966974	T3_T4	NONE	nitrosourea/NN (l_appos) CCNU/NNP
3966974	T3_T5	NONE	nitrosourea/NN (r_nsubjpass) given/VBN (r_advcl) carried/VBN (l_dobj) studies/NNS (l_prep) on/IN (l_pobj) activity/NN (l_conj) toxicity/NN (l_prep) of/IN (l_pobj) CCNU/NNP
3966974	T3_T6	NONE	nitrosourea/NN (r_nsubjpass) given/VBN (r_advcl) carried/VBN (l_advmod) alone/RB (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) misonidazole/JJ
3966974	T4_T6	NONE	CCNU/NNP (r_appos) nitrosourea/NN (r_nsubjpass) given/VBN (r_advcl) carried/VBN (l_advmod) alone/RB (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) misonidazole/JJ
3966974	T5_T6	NONE	CCNU/NNP (r_pobj) of/IN (r_prep) toxicity/NN (r_conj) activity/NN (r_pobj) on/IN (r_prep) studies/NNS (r_dobj) carried/VBN (l_advmod) alone/RB (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) misonidazole/JJ
3966974	T9_T10	EFFECT	Misonidazole/NNP (r_nsubj) reduced/VBD (l_dobj) activity/NN (l_prep) of/IN (l_pobj) CCNU/NNP
3966974	T11_T12	MECHANISM	Misonidazole/NNP (r_nsubj) has/VBZ (l_dobj) effect/NN (l_prep) on/IN (l_pobj) pharmacokinetics/NNS (l_compound) CCNU/NNP
3966974	T14_T15	NONE	Misonidazole/NNP (r_nsubj) reduced/VBD (l_dobj) AUC/NNP (l_compound) nitrosourea/NN
3966974	T17_T18	MECHANISM	CCNU/NNP (r_compound) cytotoxicity/NN (r_pobj) of/IN (r_prep) reduction/NN (l_prep) by/IN (l_pobj) misonidazole/NN
7653281	T1_T2	NONE	ethanol/NN (r_pobj) of/IN (r_prep) interaction/NN (l_prep) with/IN (l_pobj) congeners/NNS (l_conj) acetaldehyde/NN
7653281	T3_T8	NONE	ethanol/NN (r_dobj) containing/VBG (r_acl) solutions/NNS (r_pobj) with/IN (r_prep) treatment/NN (r_pobj) to/IN (r_prep) submitted/VBN (r_ccomp) treated/VBN (r_ccomp) served/VBD (l_conj) received/VBD (l_dobj) volume/NN (l_prep) of/IN (l_pobj) solution/NN (l_prep) of/IN (l_pobj) dextrose/NN
7653281	T4_T8	NONE	methanol/NN (r_conj) ethanol/NN (r_dobj) containing/VBG (r_acl) solutions/NNS (r_pobj) with/IN (r_prep) treatment/NN (r_pobj) to/IN (r_prep) submitted/VBN (r_ccomp) treated/VBN (r_ccomp) served/VBD (l_conj) received/VBD (l_dobj) volume/NN (l_prep) of/IN (l_pobj) solution/NN (l_prep) of/IN (l_pobj) dextrose/NN
7653281	T5_T7	NONE	alcohols/NNS (r_conj) methanol/NN (r_conj) ethanol/NN (r_dobj) containing/VBG (r_acl) solutions/NNS (r_pobj) with/IN (r_prep) treatment/NN (r_pobj) to/IN (r_prep) submitted/VBN (r_ccomp) treated/VBN (l_prep) with/IN (l_pobj) solution/NN (l_prep) of/IN (l_pobj) ethanol/NN
7653281	T5_T8	NONE	alcohols/NNS (r_conj) methanol/NN (r_conj) ethanol/NN (r_dobj) containing/VBG (r_acl) solutions/NNS (r_pobj) with/IN (r_prep) treatment/NN (r_pobj) to/IN (r_prep) submitted/VBN (r_ccomp) treated/VBN (r_ccomp) served/VBD (l_conj) received/VBD (l_dobj) volume/NN (l_prep) of/IN (l_pobj) solution/NN (l_prep) of/IN (l_pobj) dextrose/NN
7653281	T6_T7	NONE	acetaldehyde/NN (r_conj) alcohols/NNS (r_conj) methanol/NN (r_conj) ethanol/NN (r_dobj) containing/VBG (r_acl) solutions/NNS (r_pobj) with/IN (r_prep) treatment/NN (r_pobj) to/IN (r_prep) submitted/VBN (r_ccomp) treated/VBN (l_prep) with/IN (l_pobj) solution/NN (l_prep) of/IN (l_pobj) ethanol/NN
7653281	T6_T8	NONE	acetaldehyde/NN (r_conj) alcohols/NNS (r_conj) methanol/NN (r_conj) ethanol/NN (r_dobj) containing/VBG (r_acl) solutions/NNS (r_pobj) with/IN (r_prep) treatment/NN (r_pobj) to/IN (r_prep) submitted/VBN (r_ccomp) treated/VBN (r_ccomp) served/VBD (l_conj) received/VBD (l_dobj) volume/NN (l_prep) of/IN (l_pobj) solution/NN (l_prep) of/IN (l_pobj) dextrose/NN
7653281	T7_T8	NONE	ethanol/NN (r_pobj) of/IN (r_prep) solution/NN (r_pobj) with/IN (r_prep) treated/VBN (r_ccomp) served/VBD (l_conj) received/VBD (l_dobj) volume/NN (l_prep) of/IN (l_pobj) solution/NN (l_prep) of/IN (l_pobj) dextrose/NN
7653281	T9_T10	EFFECT	ethanol/NN (r_pobj) of/IN (r_prep) hepatoxicity/NN (r_nsubjpass) enhanced/VBN (l_agent) by/IN (l_pobj) interaction/NN (l_prep) with/IN (l_pobj) congeners/NNS (l_conj) acetaldehyde/NN
11210404	T1_T2	NONE	azithromycin/`` (r_pobj) of/IN (r_prep) effect/NN (l_prep) on/IN (l_pobj) disposition/NN (l_prep) of/IN (l_pobj) zidovudine/NN
11210404	T1_T3	NONE	azithromycin/`` (r_pobj) of/IN (r_prep) effect/NN (l_prep) on/IN (l_pobj) disposition/NN (l_prep) of/IN (l_pobj) zidovudine/NN (l_conj) dideoxyinosine/NN
11210404	T4_T5	NONE	azithromycin/`` (r_amod) for/IN (r_prep) potential/NN (l_acl) interact/VB (l_prep) with/IN (l_pobj) zidovudine/NNP
11210404	T4_T6	NONE	azithromycin/`` (r_amod) for/IN (r_prep) potential/NN (l_acl) interact/VB (l_prep) with/IN (l_pobj) zidovudine/NNP (l_conj) dideoxyinosine/NN
11210404	T7_T8	NONE	zidovudine/NNP (r_nummod) study/NN (r_nsubj) dosed/VBD (l_dobj) subjects/NNS (l_prep) with/IN (l_pobj) day/NN (l_prep) of/IN (l_pobj) azithromycin/NNP
11210404	T8_T9	NONE	azithromycin/NNP (r_pobj) of/IN (r_prep) day/NN (r_pobj) with/IN (r_prep) subjects/NNS (r_dobj) dosed/VBD (l_parataxis) changed/VBN (l_prep) for/IN (l_pobj) Days/NNS (l_appos) day/NN (l_prep) of/IN (l_pobj) zidovudine/NNP
11210404	T10_T11	NONE	dideoxyinosine/NN (r_pobj) of/IN (r_prep) mg/NN (r_pobj) with/IN (r_prep) treated/VBN (l_advcl) received/VBD (l_dobj) mg/IN (l_prep) of/IN (l_pobj) azithromycin/JJ
11210404	T12_T13	NONE	Antiretroviral/JJ (r_amod) plasma/NN (r_nsubjpass) conducted/VBN (l_prep) on/IN (l_pobj) Days/NNS (l_conj) 21/CD (l_prep) for/IN (l_pobj) zidovudine/NNP
11210404	T12_T14	NONE	Antiretroviral/JJ (r_amod) plasma/NN (r_nsubjpass) conducted/VBN (l_prep) on/IN (l_pobj) Days/NNS (l_conj) 21/CD (l_prep) for/IN (l_conj) on/IN (l_pobj) Days/NNS (l_prep) for/IN (l_pobj) dideoxyinosine/NN
11210404	T13_T14	NONE	zidovudine/NNP (r_pobj) for/IN (l_conj) on/IN (l_pobj) Days/NNS (l_prep) for/IN (l_pobj) dideoxyinosine/NN
11210404	T16_T17	NONE	Azithromycin/NNP (r_nsubj) had/VBD (l_dobj) impact/NN (l_prep) on/IN (l_pobj) Cmax/NNP (l_prep) of/IN (l_pobj) zidovudine/NNP
11210404	T16_T18	MECHANISM	Azithromycin/NNP (r_nsubj) had/VBD (l_advcl) decreased/VBD (l_dobj) tmax/NN (l_compound) zidovudine/NN
11210404	T16_T19	MECHANISM	Azithromycin/NNP (r_nsubj) had/VBD (l_advcl) decreased/VBD (l_conj) increased/VBD (l_advcl) phosphorylated/VBN (l_dobj) zidovudine/NN
11210404	T20_T21	NONE	Azithromycin/NNP (r_nsubj) had/VBD (l_dobj) effect/NN (l_prep) on/IN (l_pobj) pharmacokinetics/NNS (l_amod) dideoxyinosine/NN
11210404	T22_T23	NONE	azithromycin/`` (r_nsubjpass) coadministered/VBN (l_prep) with/IN (l_pobj) zidovudine/NNP
11210404	T22_T24	NONE	azithromycin/`` (r_nsubjpass) coadministered/VBN (l_prep) with/IN (l_pobj) zidovudine/NNP (l_conj) dideoxyinosine/NN
11151029	T2_T3	INT	drugs/NNS (r_pobj) with/IN (r_prep) Treatment/NN (r_nsubj) interfere/VB (l_conj) interact/VB (l_prep) with/IN (l_pobj) agents/NNS
11151029	T6_T7	NONE	Imipramine/NNP (r_pobj) for/IN (r_prep) fasted/VBN (r_ccomp) administered/VBN (l_nsubjpass) moclobemide/NN
11151029	T6_T8	NONE	Imipramine/NNP (r_pobj) for/IN (r_prep) fasted/VBN (r_ccomp) administered/VBN (l_nsubjpass) moclobemide/NN (l_conj) clonazepam/NNP
11151029	T6_T9	NONE	Imipramine/NNP (r_pobj) for/IN (r_prep) fasted/VBN (r_ccomp) administered/VBN (l_nsubjpass) moclobemide/NN (l_appos) sertraline/NNP (l_amod) fluoxetine/NN
11151029	T6_T10	NONE	Imipramine/NNP (r_pobj) for/IN (r_prep) fasted/VBN (r_ccomp) administered/VBN (l_nsubjpass) moclobemide/NN (l_appos) sertraline/NNP
11151029	T7_T9	NONE	moclobemide/NN (l_appos) sertraline/NNP (l_amod) fluoxetine/NN
11151029	T7_T10	NONE	moclobemide/NN (l_appos) sertraline/NNP
11151029	T8_T9	NONE	clonazepam/NNP (r_conj) moclobemide/NN (l_appos) sertraline/NNP (l_amod) fluoxetine/NN
11151029	T8_T10	NONE	clonazepam/NNP (r_conj) moclobemide/NN (l_appos) sertraline/NNP
11151029	T9_T10	NONE	fluoxetine/NN (r_amod) sertraline/NNP
11151029	T15_T17	NONE	Fluoxetine/NNP (r_nsubj) increased/VBD (l_dobj) glucose/NN
11151029	T16_T17	NONE	moclobemide/NNP (r_conj) Fluoxetine/NNP (r_nsubj) increased/VBD (l_dobj) glucose/NN
11151029	T18_T19	NONE	Sertraline/NNP (r_nsubj) neutralized/VBD (l_dobj) increase/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) overload/NN (l_compound) glucose/NN
11151029	T22_T23	NONE	sertraline/NNP (r_nsubj) neutralized/VBD (l_prep) after/IN (l_pobj) overload/NN (l_compound) glucose/NN
11115418	T4_T5	NONE	Resveratrol/NNP (r_nsubj) induced/VBN (l_dobj) relaxation/NN (l_acl) preconstricted/VBN (l_prep) with/IN (l_pobj) noradrenaline/NN
11115418	T4_T6	NONE	Resveratrol/NNP (r_nsubj) induced/VBN (l_dobj) relaxation/NN (l_acl) preconstricted/VBN (l_prep) with/IN (l_pobj) noradrenaline/NN (l_conj) KCl/NNP
11115418	T7_T8	NONE	NAME/NNP (r_nsubj) alter/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) reseveratrol/NN
11115418	T9_T10	NONE	Indomethacin/NNP (r_nsubj) was/VBD (l_acomp) ineffective/JJ (l_prep) in/IN (l_pcomp) altering/VBG (l_dobj) activity/NN (l_compound) resveratrol/NN
11115418	T11_T12	NONE	noradrenaline/NN (r_npadvmod) precontracted/VBN (r_amod) arteries/NNS (r_pobj) In/IN (r_prep) attenuated/VBN (l_nsubjpass) responses/NNS (l_prep) to/IN (l_pobj) resveratrol/NN
11137351	T4_T5	NONE	ginsenosides/NNS (r_pobj) of/IN (r_prep) effect/NN (r_dobj) investigated/VBD (l_advcl) using/VBG (l_dobj) nimodipine/NN (l_compound) blockers/NNS
11137351	T4_T6	NONE	ginsenosides/NNS (r_pobj) of/IN (r_prep) effect/NN (r_dobj) investigated/VBD (l_advcl) using/VBG (l_dobj) nimodipine/NN
11137351	T4_T7	NONE	ginsenosides/NNS (r_pobj) of/IN (r_prep) effect/NN (r_dobj) investigated/VBD (l_conj) GVIA/NNP
11137351	T4_T8	NONE	ginsenosides/NNS (r_pobj) of/IN (r_prep) effect/NN (r_dobj) investigated/VBD (l_conj) GVIA/NNP (l_conj) agatoxin/NN (l_appos) IVA/NNP
11137351	T5_T6	NONE	blockers/NNS (r_compound) nimodipine/NN
11137351	T5_T7	NONE	blockers/NNS (r_compound) nimodipine/NN (r_dobj) using/VBG (r_advcl) investigated/VBD (l_conj) GVIA/NNP
11137351	T5_T8	NONE	blockers/NNS (r_compound) nimodipine/NN (r_dobj) using/VBG (r_advcl) investigated/VBD (l_conj) GVIA/NNP (l_conj) agatoxin/NN (l_appos) IVA/NNP
11137351	T6_T7	NONE	nimodipine/NN (r_dobj) using/VBG (r_advcl) investigated/VBD (l_conj) GVIA/NNP
11137351	T6_T8	NONE	nimodipine/NN (r_dobj) using/VBG (r_advcl) investigated/VBD (l_conj) GVIA/NNP (l_conj) agatoxin/NN (l_appos) IVA/NNP
11137351	T7_T8	NONE	GVIA/NNP (l_conj) agatoxin/NN (l_appos) IVA/NNP
11137351	T10_T11	NONE	Nimodipine/NNP (r_nsubj) had/VBD (l_dobj) effect/NN (l_prep) on/IN (l_pobj) response/NN (l_compound) ginsenosides/NNS
11137351	T12_T13	NONE	ginsenosides/NNS (r_nsubjpass) coupled/VBN (l_prep) to/IN (l_pobj) types/NNS (l_prep) including/VBG (l_pobj) channel/NN (l_amod) sensitive/JJ (l_npadvmod) GVIA/NNP
11137351	T12_T14	NONE	ginsenosides/NNS (r_nsubjpass) coupled/VBN (l_prep) to/IN (l_pobj) types/NNS (l_prep) including/VBG (l_pobj) channel/NN (l_conj) channel/NN (l_amod) sensitive/JJ (l_npadvmod) IVA/NNP
11137351	T12_T15	NONE	ginsenosides/NNS (r_nsubjpass) coupled/VBN (l_prep) to/IN (l_pobj) types/NNS (l_prep) including/VBG (l_pobj) channel/NN (l_conj) channel/NN (l_conj) channel/NN (l_nmod) agatoxin/NN (l_nmod) conotoxin/NN (l_nmod) nimodipine/NN
11137351	T12_T16	NONE	ginsenosides/NNS (r_nsubjpass) coupled/VBN (l_prep) to/IN (l_pobj) types/NNS (l_prep) including/VBG (l_pobj) channel/NN (l_conj) channel/NN (l_conj) channel/NN (l_nmod) agatoxin/NN (l_nmod) GVIA/NNP
11137351	T12_T17	NONE	ginsenosides/NNS (r_nsubjpass) coupled/VBN (l_prep) to/IN (l_pobj) types/NNS (l_prep) including/VBG (l_pobj) channel/NN (l_conj) channel/NN (l_conj) channel/NN (l_amod) resistant/JJ (l_npadvmod) VIA/NNP
11137351	T13_T14	NONE	GVIA/NNP (r_npadvmod) sensitive/JJ (r_amod) channel/NN (l_conj) channel/NN (l_amod) sensitive/JJ (l_npadvmod) IVA/NNP
11137351	T13_T15	NONE	GVIA/NNP (r_npadvmod) sensitive/JJ (r_amod) channel/NN (l_conj) channel/NN (l_conj) channel/NN (l_nmod) agatoxin/NN (l_nmod) conotoxin/NN (l_nmod) nimodipine/NN
11137351	T13_T17	NONE	GVIA/NNP (r_npadvmod) sensitive/JJ (r_amod) channel/NN (l_conj) channel/NN (l_conj) channel/NN (l_amod) resistant/JJ (l_npadvmod) VIA/NNP
11137351	T14_T15	NONE	IVA/NNP (r_npadvmod) sensitive/JJ (r_amod) channel/NN (l_conj) channel/NN (l_nmod) agatoxin/NN (l_nmod) conotoxin/NN (l_nmod) nimodipine/NN
11137351	T14_T16	NONE	IVA/NNP (r_npadvmod) sensitive/JJ (r_amod) channel/NN (l_conj) channel/NN (l_nmod) agatoxin/NN (l_nmod) GVIA/NNP
11137351	T15_T16	NONE	nimodipine/NN (r_nmod) conotoxin/NN (r_nmod) agatoxin/NN (l_nmod) GVIA/NNP
11137351	T15_T17	NONE	nimodipine/NN (r_nmod) conotoxin/NN (r_nmod) agatoxin/NN (r_nmod) channel/NN (l_amod) resistant/JJ (l_npadvmod) VIA/NNP
11137351	T16_T17	NONE	GVIA/NNP (r_nmod) agatoxin/NN (r_nmod) channel/NN (l_amod) resistant/JJ (l_npadvmod) VIA/NNP
11137351	T18_T19	NONE	ginsenosides/NNS (r_pobj) by/IN (r_prep) regulation/NN (r_nsubj) be/VB (l_attr) basis/NN (l_prep) of/IN (l_pobj) effects/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) ginseng/NN
11152438	T1_T2	NONE	II/NNP (r_dobj) buforin/NN (r_pcomp) of/IN (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_prep) in/IN (l_advmod) azithromycin/JJ
11152438	T1_T3	NONE	II/NNP (r_dobj) buforin/NN (r_pcomp) of/IN (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_prep) in/IN (l_advmod) azithromycin/JJ (l_conj) minocycline/NN
11152438	T4_T5	NONE	II/NNP (r_dobj) buforin/NN (r_pcomp) of/IN (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_intj) azithromycin/JJ
11152438	T4_T6	NONE	II/NNP (r_dobj) buforin/NN (r_pcomp) of/IN (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_intj) azithromycin/JJ (l_conj) minocycline/NN
11152438	T10_T11	EFFECT	II/NNP (r_nsubj) be/VB (l_acomp) active/JJ (l_prep) in/IN (l_pcomp) inhibiting/VBG (l_prep) in/IN (l_amod) vitro/FW (l_prep) upon/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) azithromycin/JJ
11152438	T10_T12	EFFECT	II/NNP (r_nsubj) be/VB (l_acomp) active/JJ (l_prep) in/IN (l_pcomp) inhibiting/VBG (l_prep) in/IN (l_amod) vitro/FW (l_prep) upon/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) azithromycin/JJ (l_conj) minocycline/NN
15825399	T3_T4	NONE	drug/NN (l_appos) nitrate/NN
11121884	T4_T5	NONE	opioids/NNS
11121884	T5_T6	NONE	opioids/NNS
11160777	T2_T3	NONE	thiazolidinediones/NNS (l_appos) rosiglitazone/NN
11160777	T2_T4	NONE	thiazolidinediones/NNS (l_appos) rosiglitazone/NN (l_conj) pioglitazone/NN
11160777	T2_T5	NONE	thiazolidinediones/NNS (l_appos) class/NN (l_prep) of/IN (l_pobj) agents/NNS
11160777	T3_T5	NONE	rosiglitazone/NN (r_appos) thiazolidinediones/NNS (l_appos) class/NN (l_prep) of/IN (l_pobj) agents/NNS
11160777	T4_T5	NONE	pioglitazone/NN (r_conj) rosiglitazone/NN (r_appos) thiazolidinediones/NNS (l_appos) class/NN (l_prep) of/IN (l_pobj) agents/NNS
15830476	T1_T2	NONE	probenecid/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) volume/NN (l_prep) of/IN (l_pobj) distribution/NN (l_conj) elimination/NN (l_prep) of/IN (l_pobj) cloxacillin/NN
15830476	T3_T5	MECHANISM	penicillins/NNS (r_pobj) of/IN (r_prep) concentrations/NNS (l_acl) reached/VBN (l_prep) after/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) probenecid/NN
15830476	T4_T5	MECHANISM	cephaloridine/NN (r_conj) penicillins/NNS (r_pobj) of/IN (r_prep) concentrations/NNS (l_acl) reached/VBN (l_prep) after/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) probenecid/NN
15830476	T6_T7	NONE	probenecid/NN (r_nsubj) has/VBZ (l_dobj) effect/NN (l_prep) on/IN (l_pobj) distribution/NN (l_prep) of/IN (l_pobj) cloxacillin/NN
15830476	T6_T8	NONE	probenecid/NN (r_nsubj) has/VBZ (r_ccomp) determine/VB (r_advcl) studied/VBN (l_nsubjpass) elimination/NN (l_prep) of/IN (l_pobj) cloxacillin/NN
15830476	T7_T9	NONE	cloxacillin/NN (r_pobj) of/IN (r_prep) distribution/NN (r_pobj) on/IN (r_prep) effect/NN (r_dobj) has/VBZ (r_ccomp) determine/VB (r_advcl) studied/VBN (l_dobj) function/NN (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) probenecid/NN
15830476	T8_T9	NONE	cloxacillin/NN (r_pobj) of/IN (r_prep) elimination/NN (r_nsubjpass) studied/VBN (l_dobj) function/NN (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) probenecid/NN
15830476	T10_T11	NONE	cloxacillin/NN (r_pobj) of/IN (r_prep) distribution/NN (r_pobj) of/IN (r_prep) volume/NN (l_prep) with/IN (l_conj) without/IN (l_pobj) probenecid/NN
15830476	T14_T15	MECHANISM	probenecid/NN (l_prep) of/IN (l_pobj) elimination/NN (l_prep) of/IN (l_pobj) cloxacillin/NN
11271411	T1_T2	NONE	hydrocortisone/NN (r_compound) administration/NN (r_nsubj) affect/VB (l_dobj) responses/NNS (l_prep) to/IN (l_pobj) amphetamine/NN
11271411	T4_T5	NONE	glucocorticoids/NNS (r_conj) stress/NN (r_pobj) of/IN (r_prep) effects/NNS (l_prep) on/IN (l_pobj) effects/NNS (l_prep) of/IN (l_pobj) psychostimulants/NNS
11271411	T6_T7	NONE	hydrocortisone/NN (r_compound) pretreatment/NN (l_prep) on/IN (l_pobj) effects/NNS (l_prep) of/IN (l_pobj) amphetamine/NN
11271411	T8_T9	NONE	Hydrocortisone/NNP (r_appos) METHODS/NNS (l_acl) administered/VBN (l_nsubjpass) amphetamine/NN
11271411	T12_T13	NONE	hydrocortisone/NN (r_compound) pretreatment/NN (r_nsubj) affect/VB (l_dobj) any/DT (l_prep) of/IN (l_pobj) effects/NNS (l_prep) of/IN (l_pobj) amphetamine/NN
11271411	T14_T15	NONE	glucocorticoids/NNS (r_pobj) of/IN (r_prep) effects/NNS (r_pobj) to/IN (r_prep) contrast/NN (r_pobj) In/IN (r_prep) indicate/VBP (l_ccomp) enhance/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) amphetamine/NN
11213850	T1_T2	NONE	fluoxetine/NN (r_pobj) of/IN (r_prep) coadministration/NN (l_prep) on/IN (l_pobj) pharmacokinetics/NNS (l_amod) cisapride/NN
11213850	T3_T4	NONE	fluoxetine/NN (l_prep) on/IN (l_pobj) safety/NN (l_prep) of/IN (l_pobj) cisapride/NN
11213850	T5_T6	NONE	cisapride/NN (r_appos) phase/NN (l_advmod) fluoxetine/NN
11213850	T5_T8	NONE	cisapride/NN (r_appos) phase/NN (r_nsubj) cisapride/NN (l_conj) fluoxetine/NN
11213850	T6_T7	NONE	fluoxetine/NN (r_advmod) phase/NN (r_nsubj) cisapride/NN
11213850	T10_T11	MECHANISM	fluoxetine/NN (r_pobj) of/IN (r_prep) Coadministration/NN (r_nsubj) decreased/VBD (l_dobj) concentrations/NNS (l_amod) cisapride/NN
11213850	T12_T13	NONE	cisapride/NN (r_pobj) of/IN (r_prep) administration/NN (r_pobj) during/IN (l_conj) with/IN (l_pobj) fluoxetine/NN
11213850	T14_T15	NONE	Cisapride/NNP (r_nsubjpass) tolerated/VBN (l_advcl) administered/VBN (l_conj) with/IN (l_pobj) fluoxetine/NN
11213850	T16_T17	NONE	Cisapride/NNP (r_nsubjpass) administered/VBN (l_prep) to/IN (l_pobj) patients/NNS (l_acl) receiving/VBG (l_dobj) dosages/NNS (l_prep) of/IN (l_pobj) fluoxetine/NN
11180038	T1_T2	NONE	everolimus/NN (r_pobj) of/IN (r_prep) assessment/NN (l_prep) in/IN (l_pobj) recipients/NNS (l_appos) pharmacokinetics/NNS (l_conj) relationships/NNS (l_conj) influence/NN (l_prep) on/IN (l_pobj) cyclosporine/NN
11180038	T3_T5	NONE	everolimus/NN (r_pobj) of/IN (r_prep) pharmacokinetics/NNS (l_appos) INN/NNP (l_appos) ciclosporin/NN
11180038	T6_T7	NONE	everolimus/NN (r_compound) tablets/NNS (r_dobj) receive/VB (l_prep) with/IN (l_pobj) cyclosporine/NN
11180038	T6_T8	NONE	everolimus/NN (r_compound) tablets/NNS (r_dobj) receive/VB (l_prep) with/IN (l_pobj) cyclosporine/NN (l_conj) prednisone/NN
11180038	T13_T14	NONE	cyclosporine/NN (r_compound) dosing/NN (r_pobj) in/IN (r_prep) differences/NNS (l_prep) at/IN (l_pobj) levels/NNS (l_prep) of/IN (l_pobj) exposure/NN (l_compound) everolimus/NN
11180038	T18_T19	NONE	Cyclosporine/NN (r_nsubj) doses/NNS (r_nsubj) exhibited/VBD (l_prep) during/IN (l_pobj) course/NN (l_advmod) regardless/RB (l_prep) of/IN (l_pobj) level/NN (l_nmod) everolimus/NN
11180038	T21_T22	NONE	everolimus/NN (r_compound) doses/NNS (r_pobj) of/IN (r_prep) range/NN (r_pobj) For/IN (r_prep) were/VBD (l_attr) effects/NNS (l_prep) on/IN (l_pobj) dosing/NN (l_compound) cyclosporine/NN
1113260	T1_T2	INT	F2alpha/NN (l_conj) oxytocin/NN
1113260	T5_T6	NONE	norepinephrine/NN (r_pobj) to/IN (r_prep) reactions/NNS (r_pobj) In/IN (r_prep) were/VBD (l_nsubj) oxytocin/NN
1113260	T5_T7	NONE	norepinephrine/NN (r_pobj) to/IN (r_prep) reactions/NNS (r_pobj) In/IN (r_prep) were/VBD (l_attr) PGF2alpha/NN
1113260	T6_T7	NONE	oxytocin/NN (r_nsubj) were/VBD (l_attr) PGF2alpha/NN
1113260	T8_T9	EFFECT	PGF2alpha/NN (l_acl) produced/VBD (l_prep) after/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) oxytocin/NN
1113260	T13_T14	EFFECT	PGF2alpha/NN (r_pobj) of/IN (r_prep) effect/NN (l_prep) upon/IN (l_pobj) reaction/NN (l_prep) to/IN (l_pobj) oxytocin/NN
7756965	T1_T2	NONE	cimetidine/NN (l_prep) on/IN (l_pobj) excretion/NN (l_prep) of/IN (l_pobj) verografin/NN
7756965	T1_T3	NONE	cimetidine/NN (l_prep) on/IN (l_conj) iodamide/NN
7756965	T2_T3	NONE	verografin/NN (r_pobj) of/IN (r_prep) excretion/NN (r_pobj) on/IN (l_conj) iodamide/NN
7756965	T4_T5	MECHANISM	cimetidine/NN (r_pobj) of/IN (r_prep) injection/NN (l_prep) in/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) verografine/NN
7756965	T4_T6	MECHANISM	cimetidine/NN (r_pobj) of/IN (r_prep) injection/NN (l_prep) in/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) verografine/NN (l_conj) excretion/NN (l_amod) iodamide/JJ
7756965	T5_T6	NONE	verografine/NN (l_conj) excretion/NN (l_amod) iodamide/JJ
7756965	T7_T8	NONE	verografine/NN (l_conj) excretion/NN (l_amod) iodamide/JJ
7756965	T9_T10	NONE	cimetidine/NN (r_nsubj) unchanged/JJ (l_dobj) secretion/NN (l_prep) of/IN (l_pobj) cardiotrast/NN
7756965	T11_T12	NONE	cimetidine/NN (l_prep) on/IN (l_pobj) transport/NN (l_nmod) verografine/NN
7756965	T11_T13	NONE	cimetidine/NN (l_prep) on/IN (l_pobj) transport/NN (l_compound) iodamide/JJ
7756965	T12_T13	NONE	verografine/NN (r_nmod) transport/NN (l_compound) iodamide/JJ
11219477	T4_T6	NONE	sildenafil/NN (r_pobj) concerning/VBG (r_prep) commentaries/NNS (r_conj) reports/NNS (r_conj) studies/NNS (r_appos) METHODS/NNS (r_nsubjpass) identified/VBN (l_advcl) using/VBG (l_dobj) sildenafil/NN (l_conj) Viagra/NNP
11219477	T7_T8	NONE	Sildenafil/NNP (r_nsubj) demonstrated/VBN (l_prep) in/IN (l_pobj) men/NNS (l_appos) inhibitors/NNS
11219477	T7_T9	NONE	Sildenafil/NNP (r_nsubj) demonstrated/VBN (l_prep) in/IN (l_pobj) men/NNS (l_appos) inhibitors/NNS (l_appos) SSRIs/NNPS
11219477	T8_T9	NONE	inhibitors/NNS (l_appos) SSRIs/NNPS
11219477	T12_T13	NONE	sildenafil/NN (r_nsubjpass) considered/VBN (r_ccomp) are/VBP (l_nsubj) patients/NNS (l_prep) with/IN (l_amod) moderate/JJ (l_prep) to/TO (l_pobj) disease/NN (l_conj) those/DT (l_acl) taking/VBG (l_dobj) therapy/NN (l_compound) nitrate/NN
11219477	T13_T14	EFFECT	nitrate/NN (r_compound) therapy/NN (r_dobj) taking/VBG (r_acl) those/DT (r_conj) disease/NN (r_pobj) to/TO (r_prep) moderate/JJ (r_amod) with/IN (r_prep) patients/NNS (r_nsubj) are/VBP (l_prep) at/IN (l_pobj) risk/NN (l_prep) for/IN (l_pobj) effects/NNS (l_prep) with/IN (l_pobj) therapy/NN (l_compound) sildenafil/NN
11114408	T3_T4	NONE	Phencyclidine/NNP (l_appos) PCP/NNP
11114408	T6_T7	NONE	antipsychotic/JJ (r_amod) clozapine/NN
11114408	T6_T8	NONE	antipsychotic/JJ (r_amod) clozapine/NN (r_nsubjpass) tested/VBN (l_prep) with/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) PCP/NNP
11114408	T7_T8	NONE	clozapine/NN (r_nsubjpass) tested/VBN (l_prep) with/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) PCP/NNP
11114408	T11_T12	NONE	clozapine/NN (r_pobj) with/IN (r_prep) dosing/VBG (r_acl) Acute/NNP (r_nsubj) failed/VBD (l_xcomp) alter/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) PCP/NNP
11114408	T13_T14	NONE	clozapine/NN (r_pobj) with/IN (r_prep) dosing/NN (r_nsubj) affect/VB (l_dobj) behaviors/NNS (l_acl) associated/VBN (l_prep) with/IN (l_pobj) intoxication/NN (l_compound) PCP/NNP
11114408	T16_T17	NONE	antipsychotics/NNS (r_pobj) of/IN (r_prep) efficacy/NN (r_pobj) for/IN (r_prep) required/VBN (r_advcl) focus/VB (l_prep) on/IN (l_pobj) investigation/NN (l_prep) of/IN (l_pobj) effects/NNS (l_prep) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) PCP/NNP
3871245	T1_T2	NONE	1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine/CD (l_appos) MPTP/NNP
3871245	T1_T3	NONE	1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine/CD (l_appos) MPTP/NNP (l_conj) methamphetamine/NN
3871245	T4_T5	NONE	MPTP/NNP (r_compound) administration/NN (r_pobj) following/VBG (r_prep) consequences/NNS (r_nsubjpass) evaluated/VBN (l_conj) compared/VBN (l_prep) to/IN (l_pobj) effects/NNS (l_prep) following/VBG (l_pobj) administration/NN (l_compound) methamphetamine/NN
3871245	T6_T7	EFFECT	MPTP/NNP (r_nsubj) induced/VBD (l_conj) prevented/VBN (l_agent) by/IN (l_pobj) pretreatment/NN (l_amod) pargyline/NN
3871245	T8_T9	EFFECT	MPTP/NNP (r_npadvmod) induced/VBN (r_amod) damage/NN (r_nsubj) produced/VBD (l_dobj) tolerance/NN (l_prep) to/IN (l_pobj) effects/NNS (l_prep) of/IN (l_pobj) amphetamine/NN
3871245	T8_T10	EFFECT	MPTP/NNP (r_npadvmod) induced/VBN (r_amod) damage/NN (r_nsubj) produced/VBD (l_dobj) tolerance/NN (l_prep) to/IN (l_pobj) effects/NNS (l_conj) supersensitivity/NN (l_prep) to/IN (l_pobj) effects/NNS (l_prep) of/IN (l_pobj) apomorphine/NN
3871245	T9_T10	NONE	amphetamine/NN (r_pobj) of/IN (r_prep) effects/NNS (l_conj) supersensitivity/NN (l_prep) to/IN (l_pobj) effects/NNS (l_prep) of/IN (l_pobj) apomorphine/NN
3871245	T11_T12	NONE	Methamphetamine/NN (r_nsubjpass) potentiated/VBN (l_prep) like/IN (l_pobj) MPTP/NNP
3871245	T11_T13	EFFECT	Methamphetamine/NN (r_nsubjpass) potentiated/VBN (l_agent) by/IN (l_pobj) pretreatment/NN (l_amod) pargyline/NN
3871245	T12_T13	NONE	MPTP/NNP (r_pobj) like/IN (r_prep) potentiated/VBN (l_agent) by/IN (l_pobj) pretreatment/NN (l_amod) pargyline/NN
3881461	T1_T3	EFFECT	Dexamethasone/NN (r_nsubj) inhibit/VBP (l_conj) stimulate/VB (l_dobj) EGF-/NNP
3881461	T1_T4	EFFECT	Dexamethasone/NN (r_nsubj) inhibit/VBP (l_conj) stimulate/VB (l_dobj) proliferation/NN (l_amod) induced/VBN (l_npadvmod) insulin/NN
3881461	T2_T3	EFFECT	acetate/NN (r_conj) Dexamethasone/NN (r_nsubj) inhibit/VBP (l_conj) stimulate/VB (l_dobj) EGF-/NNP
3881461	T2_T4	EFFECT	acetate/NN (r_conj) Dexamethasone/NN (r_nsubj) inhibit/VBP (l_conj) stimulate/VB (l_dobj) proliferation/NN (l_amod) induced/VBN (l_npadvmod) insulin/NN
3881461	T3_T4	NONE	EGF-/NNP (r_dobj) stimulate/VB (l_dobj) proliferation/NN (l_amod) induced/VBN (l_npadvmod) insulin/NN
3881461	T5_T6	NONE	transferrin/NN (r_dobj) containing/VBG (r_acl) RPMI1640/NNP (r_pobj) of/IN (r_prep) consisting/VBG (r_acl) medium/NN (r_pobj) in/IN (r_prep) proliferates/VBZ (l_npadvmod) EGF/NNP
3881461	T5_T7	NONE	transferrin/NN (r_dobj) containing/VBG (r_acl) RPMI1640/NNP (r_pobj) of/IN (r_prep) consisting/VBG (r_acl) medium/NN (r_pobj) in/IN (r_prep) proliferates/VBZ (l_npadvmod) EGF/NNP (l_conj) insulin/NN
3881461	T8_T10	NONE	dexamethasone/NN (r_nsubj) affected/VBD (l_dobj) proliferation/NN (l_prep) of/IN (l_pobj) epithelium/NN (l_prep) in/IN (l_pobj) RPMI1640/NNP (l_acl) containing/VBG (l_dobj) transferrin/NN
3881461	T8_T11	EFFECT	dexamethasone/NN (r_nsubj) affected/VBD (r_advcl) modify/VBP (l_dobj) effect/NN (l_prep) of/IN (l_pobj) EGF/NN
3881461	T8_T12	EFFECT	dexamethasone/NN (r_nsubj) affected/VBD (r_advcl) modify/VBP (l_dobj) effect/NN (l_prep) of/IN (l_pobj) EGF/NN (l_conj) insulin/NN
3881461	T9_T10	NONE	acetate/NN (r_conj) dexamethasone/NN (r_nsubj) affected/VBD (l_dobj) proliferation/NN (l_prep) of/IN (l_pobj) epithelium/NN (l_prep) in/IN (l_pobj) RPMI1640/NNP (l_acl) containing/VBG (l_dobj) transferrin/NN
3881461	T9_T11	EFFECT	acetate/NN (r_conj) dexamethasone/NN (r_nsubj) affected/VBD (r_advcl) modify/VBP (l_dobj) effect/NN (l_prep) of/IN (l_pobj) EGF/NN
3881461	T9_T12	EFFECT	acetate/NN (r_conj) dexamethasone/NN (r_nsubj) affected/VBD (r_advcl) modify/VBP (l_dobj) effect/NN (l_prep) of/IN (l_pobj) EGF/NN (l_conj) insulin/NN
3881461	T10_T11	NONE	transferrin/NN (r_dobj) containing/VBG (r_acl) RPMI1640/NNP (r_pobj) in/IN (r_prep) epithelium/NN (r_pobj) of/IN (r_prep) proliferation/NN (r_dobj) affected/VBD (r_advcl) modify/VBP (l_dobj) effect/NN (l_prep) of/IN (l_pobj) EGF/NN
3881461	T10_T12	NONE	transferrin/NN (r_dobj) containing/VBG (r_acl) RPMI1640/NNP (r_pobj) in/IN (r_prep) epithelium/NN (r_pobj) of/IN (r_prep) proliferation/NN (r_dobj) affected/VBD (r_advcl) modify/VBP (l_dobj) effect/NN (l_prep) of/IN (l_pobj) EGF/NN (l_conj) insulin/NN
3881461	T13_T14	NONE	Dexamethasone/NN (l_prep) at/IN (l_pobj) acetate/NN
3881461	T13_T15	EFFECT	Dexamethasone/NN (r_nsubj) inhibits/VBZ (l_dobj) proliferation/NN (l_acl) stimulated/VBN (l_agent) by/IN (l_pobj) EGF/NNP
3881461	T14_T15	EFFECT	acetate/NN (r_pobj) at/IN (r_prep) Dexamethasone/NN (r_nsubj) inhibits/VBZ (l_dobj) proliferation/NN (l_acl) stimulated/VBN (l_agent) by/IN (l_pobj) EGF/NNP
3881461	T17_T18	EFFECT	acetate/NN (r_conj) M/NNP (r_nsubj) enhance/VB (l_dobj) activity/NN (l_prep) of/IN (l_pobj) EGF/NNP
3881461	T19_T20	NONE	Dexamethasone/NNP (r_nsubj) had/VBD (l_dobj) effect/NN (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) insulin/NN
3881461	T21_T22	EFFECT	acetate/NN (r_nsubj) stimulated/VBN (l_conj) inhibit/VB (l_conj) proliferation/NN (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) insulin/NN
3881461	T23_T27	EFFECT	dexamethasone/NN (r_nsubj) regulate/VB (l_dobj) proliferation/NN (l_prep) by/IN (l_pobj) modification/NN (l_prep) of/IN (l_pobj) activity/NN (l_prep) of/IN (l_pobj) insulin/NN
3881461	T23_T28	EFFECT	dexamethasone/NN (r_nsubj) regulate/VB (l_dobj) proliferation/NN (l_prep) by/IN (l_pobj) modification/NN (l_prep) of/IN (l_pobj) activity/NN (l_prep) of/IN (l_pobj) insulin/NN (l_conj) EGF/NNP
3881461	T24_T27	EFFECT	acetate/NN (r_conj) dexamethasone/NN (r_nsubj) regulate/VB (l_dobj) proliferation/NN (l_prep) by/IN (l_pobj) modification/NN (l_prep) of/IN (l_pobj) activity/NN (l_prep) of/IN (l_pobj) insulin/NN
3881461	T24_T28	EFFECT	acetate/NN (r_conj) dexamethasone/NN (r_nsubj) regulate/VB (l_dobj) proliferation/NN (l_prep) by/IN (l_pobj) modification/NN (l_prep) of/IN (l_pobj) activity/NN (l_prep) of/IN (l_pobj) insulin/NN (l_conj) EGF/NNP
3881461	T25_T27	EFFECT	glucocorticoids/NNS (r_conj) dexamethasone/NN (r_nsubj) regulate/VB (l_dobj) proliferation/NN (l_prep) by/IN (l_pobj) modification/NN (l_prep) of/IN (l_pobj) activity/NN (l_prep) of/IN (l_pobj) insulin/NN
3881461	T25_T28	EFFECT	glucocorticoids/NNS (r_conj) dexamethasone/NN (r_nsubj) regulate/VB (l_dobj) proliferation/NN (l_prep) by/IN (l_pobj) modification/NN (l_prep) of/IN (l_pobj) activity/NN (l_prep) of/IN (l_pobj) insulin/NN (l_conj) EGF/NNP
3881461	T26_T27	EFFECT	retinoids/NNS (r_conj) glucocorticoids/NNS (r_conj) dexamethasone/NN (r_nsubj) regulate/VB (l_dobj) proliferation/NN (l_prep) by/IN (l_pobj) modification/NN (l_prep) of/IN (l_pobj) activity/NN (l_prep) of/IN (l_pobj) insulin/NN
3881461	T26_T28	EFFECT	retinoids/NNS (r_conj) glucocorticoids/NNS (r_conj) dexamethasone/NN (r_nsubj) regulate/VB (l_dobj) proliferation/NN (l_prep) by/IN (l_pobj) modification/NN (l_prep) of/IN (l_pobj) activity/NN (l_prep) of/IN (l_pobj) insulin/NN (l_conj) EGF/NNP
6536282	T4_T5	NONE	lead/NN (l_appos) TML/NNP
6536282	T7_T8	NONE	alcohol/NN (r_pobj) of/IN (r_prep) solution/NN (r_pobj) v/LS (r_prep) %/NN (r_nsubjpass) prepared/VBN (l_prep) from/IN (l_pobj) solution/NN (l_prep) of/IN (l_pobj) ethanol/NN
6536282	T10_T11	EFFECT	lead/NN (r_pobj) to/IN (r_prep) exposure/NN (r_nsubj) alter/VB (l_dobj) responsiveness/NN (l_prep) to/IN (l_pobj) alcohol/NN
10978746	T1_T2	NONE	contortrostatin/NNS (r_pobj) by/IN (r_prep) phosphorylation/NN (r_pobj) of/IN (r_prep) regulation/NN (l_appos) disintegrin/NN (l_conj) disintegrins/NNS (l_amod) echistatin/NN
10978746	T1_T3	NONE	contortrostatin/NNS (r_pobj) by/IN (r_prep) phosphorylation/NN (r_pobj) of/IN (r_prep) regulation/NN (l_appos) disintegrin/NN (l_conj) disintegrins/NNS (l_amod) echistatin/NN (l_conj) flavoridin/NN
10978746	T4_T5	NONE	contortrostatin/NN (r_nsubjpass) compared/VBN (l_advmod) echistatin/NN
10978746	T4_T6	NONE	contortrostatin/NN (r_nsubjpass) compared/VBN (l_advmod) echistatin/NN (l_conj) flavoridin/NN
10978746	T8_T9	EFFECT	Echistatin/NNP (r_nsubj) had/VBD (l_conj) inhibits/VBZ (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) contortrostatin/NN
10978746	T11_T12	EFFECT	Flavoridin/NNP (r_nsubjpass) found/VBN (l_conj) block/VB (l_dobj) phosphorylation/NN (l_amod) induced/VBN (l_npadvmod) contortrostatin/NN
7798493	T7_T8	NONE	isoproterenol/NN (r_pobj) for/IN (r_prep) values/NNS (l_relcl) is/VBZ (l_attr) substrate/NN (l_prep) for/IN (l_pobj) norepinephrine/NN
7798493	T9_T11	EFFECT	cocaine/NN (r_appos) inhibitors/VBZ (r_nsubj) potentiated/VBD (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) norepinephrine/NN
7798493	T10_T11	EFFECT	desipramine/NN (r_conj) cocaine/NN (r_appos) inhibitors/VBZ (r_nsubj) potentiated/VBD (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) norepinephrine/NN
7798493	T12_T13	NONE	mazindol/NN (r_dobj) using/VBG (r_acl) experiments/NNS (r_nsubj) revealed/VBD (l_dobj) decrease/NN (l_prep) by/IN (l_pobj) %/NN (l_prep) in/IN (l_pobj) norepinephrine/NN
1115445	T1_T2	INT	Rifampin/NNP (l_conj) warfarin/NN
1115445	T3_T4	INT	warfarin/NN (r_pobj) between/IN (r_prep) interaction/NN (r_nsubjpass) known/JJ (l_auxpass) is/VBZ (l_advmod) rifampin/NN
1115445	T5_T6	MECHANISM	Rifampin/NNP (r_nsubjpass) reported/VBN (l_xcomp) increase/VB (l_dobj) requirements/NNS (l_compound) warfarin/JJ
1115445	T7_T8	MECHANISM	rifampin/NN (r_pobj) of/IN (r_prep) administration/NN (l_conj) warfarin/NN
1115445	T7_T9	NONE	rifampin/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) resulted/VBD (l_prep) in/IN (l_pobj) need/NN (l_prep) for/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) warfarin/NN
1115445	T10_T11	MECHANISM	rifampin/NN (r_pobj) of/IN (r_prep) Withdrawal/NN (r_nsubj) decreased/VBD (l_dobj) requirement/NN (l_compound) warfarin/JJ
1115445	T12_T13	MECHANISM	rifampin/NN (r_pcomp) of/IN (r_prep) ability/NN (r_pobj) by/IN (r_agent) mediated/VBN (l_conj) catabolism/NN (l_prep) of/IN (l_pobj) warfarin/NN
1115445	T14_T15	EFFECT	rifampin/NN (r_pobj) of/IN (r_prep) effect/NN (l_prep) on/IN (l_pobj) requirement/NN (l_compound) warfarin/JJ
1115445	T15_T16	NONE	warfarin/JJ (r_compound) requirement/NN (r_pobj) on/IN (r_prep) effect/NN (r_nsubj) appeared/VBD (l_xcomp) be/VB (l_attr) days/NNS (l_prep) after/IN (l_pobj) initiation/NN (l_prep) of/IN (l_pobj) rifampin/NN
1115445	T15_T17	NONE	warfarin/JJ (r_compound) requirement/NN (r_pobj) on/IN (r_prep) effect/NN (r_nsubj) appeared/VBD (l_conj) extended/VBD (l_prep) after/IN (l_pobj) withdrawal/NN (l_amod) rifampin/JJ
11210678	T1_T3	NONE	diazepam/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN
11210678	T1_T4	NONE	diazepam/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN (l_conj) metamizol/NN
11210678	T1_T5	NONE	diazepam/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN (l_conj) metamizol/NN (l_conj) indomethacin/NN
11210678	T2_T3	NONE	midazolam/NN (r_conj) diazepam/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN
11210678	T2_T4	NONE	midazolam/NN (r_conj) diazepam/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN (l_conj) metamizol/NN
11210678	T2_T5	NONE	midazolam/NN (r_conj) diazepam/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN (l_conj) metamizol/NN (l_conj) indomethacin/NN
11210678	T6_T8	NONE	midazolam/NN (r_pobj) of/IN (r_prep) influence/NN (l_prep) on/IN (l_pobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN
11210678	T6_T9	NONE	midazolam/NN (r_pobj) of/IN (r_prep) influence/NN (l_appos) metamizol/NN
11210678	T6_T10	NONE	midazolam/NN (r_pobj) of/IN (r_prep) influence/NN (l_appos) metamizol/NN (l_conj) indomethacin/NN
11210678	T7_T8	NONE	diazepam/NN (r_conj) midazolam/NN (r_pobj) of/IN (r_prep) influence/NN (l_prep) on/IN (l_pobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN
11210678	T7_T9	NONE	diazepam/NN (r_conj) midazolam/NN (r_pobj) of/IN (r_prep) influence/NN (l_appos) metamizol/NN
11210678	T7_T10	NONE	diazepam/NN (r_conj) midazolam/NN (r_pobj) of/IN (r_prep) influence/NN (l_appos) metamizol/NN (l_conj) indomethacin/NN
11210678	T8_T9	NONE	morphine/NN (r_pobj) of/IN (r_prep) effect/NN (r_pobj) on/IN (r_prep) influence/NN (l_appos) metamizol/NN
11210678	T8_T10	NONE	morphine/NN (r_pobj) of/IN (r_prep) effect/NN (r_pobj) on/IN (r_prep) influence/NN (l_appos) metamizol/NN (l_conj) indomethacin/NN
11210678	T11_T12	NONE	Benzodiazepines/NNS (r_nsubjpass) administered/VBN (l_advcl) mice/NNS (l_prep) before/IN (l_pcomp) applying/VBG (l_dobj) drugs/NNS
11210678	T14_T15	EFFECT	Diazepam/NNP (l_prep) at/IN (l_pobj) doses/NNS (l_acl) injected/VBD (l_prep) with/IN (l_pobj) morphine/NN
11210678	T14_T16	NONE	Diazepam/NNP (r_nsubjpass) found/VBN (l_xcomp) decrease/VB (l_dobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN
11210678	T17_T18	EFFECT	diazepam/NN (r_nsubj) decreased/VBD (l_dobj) effect/NN (l_prep) of/IN (l_pobj) metamizol/NN
11210678	T17_T19	EFFECT	diazepam/NN (r_nsubj) decreased/VBD (l_prep) in/IN (l_conj) indomethacin/NN
11210678	T18_T19	NONE	metamizol/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) decreased/VBD (l_prep) in/IN (l_conj) indomethacin/NN
11210678	T20_T21	EFFECT	Midazolam/NNP (r_nsubj) used/VBN (l_xcomp) decreased/VBD (l_dobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN
11210678	T20_T22	EFFECT	Midazolam/NNP (r_nsubj) used/VBN (l_xcomp) decreased/VBD (l_npadvmod) metamizol/NN
11210678	T20_T23	EFFECT	Midazolam/NNP (r_nsubj) used/VBN (l_xcomp) decreased/VBD (l_npadvmod) metamizol/NN (l_prep) in/IN (l_conj) indomethacin/NN
11210678	T21_T22	NONE	morphine/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) decreased/VBD (l_npadvmod) metamizol/NN
11210678	T21_T23	NONE	morphine/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) decreased/VBD (l_npadvmod) metamizol/NN (l_prep) in/IN (l_conj) indomethacin/NN
11210678	T22_T23	NONE	metamizol/NN (l_prep) in/IN (l_conj) indomethacin/NN
11217868	T1_T2	NONE	inhibitors/NNS (r_pobj) of/IN (r_prep) roles/NNS (l_prep) in/IN (l_pobj) therapy/NN (l_amod) antiretroviral/JJ
11217868	T3_T4	NONE	inhibitor/NN (l_appos) regimens/NNS (l_amod) NNRTI)-based/JJ
11217868	T3_T5	NONE	inhibitor/NN (l_appos) regimens/NNS (l_prep) for/IN (l_pobj) therapy/NN (l_amod) antiretroviral/JJ
11217868	T3_T6	NONE	inhibitor/NN (l_appos) regimens/NNS (l_prep) for/IN (l_pobj) therapy/NN (l_conj) concerns/NNS (l_prep) regarding/VBG (l_pobj) inhibitor/NN
11217868	T3_T7	NONE	inhibitor/NN (r_pobj) of/IN (r_prep) availability/NN (r_nsubj) led/VBN (l_nsubj) disturbances/NNS (l_amod) PI)-related/VBN
11217868	T4_T5	NONE	NNRTI)-based/JJ (r_amod) regimens/NNS (l_prep) for/IN (l_pobj) therapy/NN (l_amod) antiretroviral/JJ
11217868	T4_T6	NONE	NNRTI)-based/JJ (r_amod) regimens/NNS (l_prep) for/IN (l_pobj) therapy/NN (l_conj) concerns/NNS (l_prep) regarding/VBG (l_pobj) inhibitor/NN
11217868	T4_T7	NONE	NNRTI)-based/JJ (r_amod) regimens/NNS (r_appos) inhibitor/NN (r_pobj) of/IN (r_prep) availability/NN (r_nsubj) led/VBN (l_nsubj) disturbances/NNS (l_amod) PI)-related/VBN
11217868	T5_T6	NONE	antiretroviral/JJ (r_amod) therapy/NN (l_conj) concerns/NNS (l_prep) regarding/VBG (l_pobj) inhibitor/NN
11217868	T5_T7	NONE	antiretroviral/JJ (r_amod) therapy/NN (r_pobj) for/IN (r_prep) regimens/NNS (r_appos) inhibitor/NN (r_pobj) of/IN (r_prep) availability/NN (r_nsubj) led/VBN (l_nsubj) disturbances/NNS (l_amod) PI)-related/VBN
11217868	T6_T7	NONE	inhibitor/NN (r_pobj) regarding/VBG (r_prep) concerns/NNS (r_conj) therapy/NN (r_pobj) for/IN (r_prep) regimens/NNS (r_appos) inhibitor/NN (r_pobj) of/IN (r_prep) availability/NN (r_nsubj) led/VBN (l_nsubj) disturbances/NNS (l_amod) PI)-related/VBN
11217868	T8_T9	NONE	NNRTI/NNP (r_npadvmod) based/VBN (r_amod) regimens/NNS (r_nsubj) have/VB (l_dobj) advantages/NNS (l_prep) over/IN (l_pobj) therapy/NN (l_amod) based/VBN (l_npadvmod) PI/NNP
11217868	T13_T15	NONE	efavirenz/NN (r_nsubjpass) compared/VBN (l_prep) to/IN (l_pobj) therapy/NN (l_prep) with/IN (l_pobj) PI/NNP
11217868	T13_T16	NONE	efavirenz/NN (r_nsubjpass) compared/VBN (l_prep) to/IN (l_pobj) therapy/NN (l_appos) indinavir/NNS
11217868	T13_T17	NONE	efavirenz/NN (r_nsubjpass) compared/VBN (l_prep) with/IN (l_pcomp) observed/VBN (l_prep) with/IN (l_pobj) regimens/NNS (l_amod) nevirapine/JJ
11217868	T14_T15	NONE	nevirapine/NN (r_conj) efavirenz/NN (r_nsubjpass) compared/VBN (l_prep) to/IN (l_pobj) therapy/NN (l_prep) with/IN (l_pobj) PI/NNP
11217868	T14_T16	NONE	nevirapine/NN (r_conj) efavirenz/NN (r_nsubjpass) compared/VBN (l_prep) to/IN (l_pobj) therapy/NN (l_appos) indinavir/NNS
11217868	T14_T18	NONE	nevirapine/NN (r_conj) efavirenz/NN (r_nsubjpass) compared/VBN (l_prep) with/IN (l_pcomp) observed/VBN (l_prep) with/IN (l_pobj) regimens/NNS (l_acl) observed/VBN (l_prep) with/IN (l_pobj) efavirenz/NN
11217868	T15_T16	NONE	PI/NNP (r_pobj) with/IN (r_prep) therapy/NN (l_appos) indinavir/NNS
11217868	T15_T17	NONE	PI/NNP (r_pobj) with/IN (r_prep) therapy/NN (r_pobj) to/IN (r_prep) compared/VBN (l_prep) with/IN (l_pcomp) observed/VBN (l_prep) with/IN (l_pobj) regimens/NNS (l_amod) nevirapine/JJ
11217868	T15_T18	NONE	PI/NNP (r_pobj) with/IN (r_prep) therapy/NN (r_pobj) to/IN (r_prep) compared/VBN (l_prep) with/IN (l_pcomp) observed/VBN (l_prep) with/IN (l_pobj) regimens/NNS (l_acl) observed/VBN (l_prep) with/IN (l_pobj) efavirenz/NN
11217868	T16_T17	NONE	indinavir/NNS (r_appos) therapy/NN (r_pobj) to/IN (r_prep) compared/VBN (l_prep) with/IN (l_pcomp) observed/VBN (l_prep) with/IN (l_pobj) regimens/NNS (l_amod) nevirapine/JJ
11217868	T16_T18	NONE	indinavir/NNS (r_appos) therapy/NN (r_pobj) to/IN (r_prep) compared/VBN (l_prep) with/IN (l_pcomp) observed/VBN (l_prep) with/IN (l_pobj) regimens/NNS (l_acl) observed/VBN (l_prep) with/IN (l_pobj) efavirenz/NN
11217868	T17_T18	NONE	nevirapine/JJ (r_amod) regimens/NNS (l_acl) observed/VBN (l_prep) with/IN (l_pobj) efavirenz/NN
11217868	T19_T20	NONE	nevirapine/NN (r_nsubj) be/VB (l_acomp) superior/JJ (l_prep) to/IN (l_pobj) nelfinavir/NNS (l_compound) PI/NNP
11217868	T19_T21	NONE	nevirapine/NN (r_nsubj) be/VB (l_acomp) superior/JJ (l_prep) to/IN (l_pobj) nelfinavir/NNS
11217868	T20_T21	NONE	PI/NNP (r_compound) nelfinavir/NNS
11217868	T22_T23	NONE	nevirapine-/NN (r_npadvmod) based/VBN (l_npadvmod) delavirdine/NN
11217868	T25_T26	NONE	efavirenz/NN (r_pobj) of/IN (r_prep) superiority/NN (l_prep) over/IN (l_pobj) regimens/NNS (l_amod) based/VBN (l_npadvmod) indinavir/NNS
11217868	T28_T29	NONE	Efavirenz/NNP (r_nsubj) demonstrated/VBN (l_dobj) superiority/NN (l_prep) over/IN (l_pobj) nelfinavir/NNS
7794883	T1_T2	EFFECT	glycine/NN (l_conj) glutamate/NN
7794883	T6_T7	EFFECT	glycine/NN (l_conj) glutamate/NN
7794883	T6_T8	NONE	glycine/NN (r_pobj) of/IN (r_prep) application/NN (r_nsubj) increased/VBD (l_prep) in/IN (l_pobj) comparison/NN (l_prep) with/IN (l_pobj) effect/NN (l_prep) of/IN (l_pobj) glutamate/NN
46730	T1_T3	NONE	coumaphos/NN (r_pobj) of/IN (r_prep) administration/NN (l_appos) interactions/NNS (l_prep) of/IN (l_pobj) coumaphos/NN (l_prep) with/IN (l_pobj) bishydroxycoumarin/NN
46730	T1_T4	NONE	coumaphos/NN (r_pobj) of/IN (r_prep) administration/NN (l_appos) interactions/NNS (l_prep) of/IN (l_pobj) coumaphos/NN (l_prep) with/IN (l_pobj) bishydroxycoumarin/NN (l_conj) trichlorfon/NN
46730	T1_T5	NONE	coumaphos/NN (r_pobj) of/IN (r_prep) administration/NN (l_appos) interactions/NNS (l_prep) of/IN (l_pobj) coumaphos/NN (l_prep) with/IN (l_pobj) bishydroxycoumarin/NN (l_conj) trichlorfon/NN (l_conj) sodium/NN
46730	T2_T3	NONE	coumaphos/NN (l_prep) with/IN (l_pobj) bishydroxycoumarin/NN
46730	T2_T4	NONE	coumaphos/NN (l_prep) with/IN (l_pobj) bishydroxycoumarin/NN (l_conj) trichlorfon/NN
46730	T2_T5	NONE	coumaphos/NN (l_prep) with/IN (l_pobj) bishydroxycoumarin/NN (l_conj) trichlorfon/NN (l_conj) sodium/NN
46730	T6_T7	NONE	coumaphos/NN (l_appos) bishydroxycoumarin/NN
46730	T6_T8	NONE	coumaphos/NN (l_appos) bishydroxycoumarin/NN (l_appos) anticoagulant/NN
46730	T6_T9	NONE	coumaphos/NN (r_pobj) with/IN (r_prep) treatments/NNS (r_pobj) between/IN (r_prep) Interactions/NNS (r_nsubjpass) investigated/VBN (l_nsubjpass) trichlorfon/NN
46730	T6_T10	NONE	coumaphos/NN (r_pobj) with/IN (r_prep) treatments/NNS (r_pobj) between/IN (r_prep) Interactions/NNS (r_nsubjpass) investigated/VBN (l_nsubjpass) trichlorfon/NN (l_parataxis) compound/NN
46730	T6_T11	NONE	coumaphos/NN (r_pobj) with/IN (r_prep) treatments/NNS (r_pobj) between/IN (r_prep) Interactions/NNS (r_nsubjpass) investigated/VBN (l_nsubjpass) trichlorfon/NN (l_conj) sodium/NN
46730	T7_T8	NONE	bishydroxycoumarin/NN (l_appos) anticoagulant/NN
46730	T7_T9	NONE	bishydroxycoumarin/NN (r_appos) coumaphos/NN (r_pobj) with/IN (r_prep) treatments/NNS (r_pobj) between/IN (r_prep) Interactions/NNS (r_nsubjpass) investigated/VBN (l_nsubjpass) trichlorfon/NN
46730	T7_T10	NONE	bishydroxycoumarin/NN (r_appos) coumaphos/NN (r_pobj) with/IN (r_prep) treatments/NNS (r_pobj) between/IN (r_prep) Interactions/NNS (r_nsubjpass) investigated/VBN (l_nsubjpass) trichlorfon/NN (l_parataxis) compound/NN
46730	T7_T11	NONE	bishydroxycoumarin/NN (r_appos) coumaphos/NN (r_pobj) with/IN (r_prep) treatments/NNS (r_pobj) between/IN (r_prep) Interactions/NNS (r_nsubjpass) investigated/VBN (l_nsubjpass) trichlorfon/NN (l_conj) sodium/NN
46730	T8_T9	NONE	anticoagulant/NN (r_appos) bishydroxycoumarin/NN (r_appos) coumaphos/NN (r_pobj) with/IN (r_prep) treatments/NNS (r_pobj) between/IN (r_prep) Interactions/NNS (r_nsubjpass) investigated/VBN (l_nsubjpass) trichlorfon/NN
46730	T8_T10	NONE	anticoagulant/NN (r_appos) bishydroxycoumarin/NN (r_appos) coumaphos/NN (r_pobj) with/IN (r_prep) treatments/NNS (r_pobj) between/IN (r_prep) Interactions/NNS (r_nsubjpass) investigated/VBN (l_nsubjpass) trichlorfon/NN (l_parataxis) compound/NN
46730	T8_T11	NONE	anticoagulant/NN (r_appos) bishydroxycoumarin/NN (r_appos) coumaphos/NN (r_pobj) with/IN (r_prep) treatments/NNS (r_pobj) between/IN (r_prep) Interactions/NNS (r_nsubjpass) investigated/VBN (l_nsubjpass) trichlorfon/NN (l_conj) sodium/NN
46730	T9_T10	NONE	trichlorfon/NN (l_parataxis) compound/NN
46730	T10_T11	NONE	compound/NN (r_parataxis) trichlorfon/NN (l_conj) sodium/NN
46730	T12_T13	NONE	coumaphos/NN (r_pobj) of/IN (r_prep) mg/NN (r_pobj) of/IN (r_prep) dose/NN (r_nsubj) affect/VB (l_dobj) enzymes/NNS (l_conj) effect/NN (l_prep) of/IN (l_pobj) coumarin/NN
46730	T14_T15	EFFECT	trichlorfon/NN (r_pobj) of/IN (r_prep) injection/NN (r_pobj) with/IN (r_prep) treatment/NN (r_nsubj) appeared/VBD (l_xcomp) produce/VB (l_dobj) effects/NNS (l_prep) with/IN (l_pobj) those/DT (l_acl) produced/VBN (l_agent) by/IN (l_pobj) treatment/NN (l_prep) with/IN (l_pobj) mg/NN (l_prep) of/IN (l_pobj) coumaphos/NN
46730	T16_T17	EFFECT	sodium/NN (r_pobj) of/IN (r_prep) mg/NN (r_dobj) given/VBN (r_ccomp) reduced/VBN (l_nsubjpass) effect/NN (l_prep) of/IN (l_pobj) mg/NN (l_prep) of/IN (l_pobj) kg/NNS (l_nmod) coumaphos/NN
11180040	T1_T2	EFFECT	2698/CD (r_prep) 8/CD (r_nummod) ADL/NNP (r_nsubj) prevents/VBZ (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
11180040	T4_T5	NONE	antagonist/NN (l_relcl) prevent/VB (l_dobj) effects/NNS (l_amod) induced/VBN (l_npadvmod) opioid/NN
11180040	T6_T7	NONE	morphine/NN (r_conj) placebo/NN (r_conj) placebo/NN (r_pobj) with/IN (r_prep) volunteers/NNS (r_pobj) in/IN (r_prep) measured/VBN (l_conj) ADL/NNP (l_npadvmod) 8/CD (l_prep) 2698/CD
11180040	T7_T8	NONE	2698/CD (r_prep) 8/CD (r_npadvmod) ADL/NNP (l_conj) morphine/NN
11180040	T9_T11	NONE	Morphine/NNP (r_nsubj) prolonged/VBD (r_amod) time/NN (l_parataxis) prevented/VBN (l_agent) by/IN (l_pobj) ADL/NNP (l_nummod) 8/CD (l_prep) 2698/CD
11180040	T10_T11	EFFECT	Morphine/NNP (r_nsubj) prolonged/VBD (r_amod) time/NN (r_npadvmod) time/NN (l_parataxis) prevented/VBN (l_agent) by/IN (l_pobj) ADL/NNP (l_nummod) 8/CD (l_prep) 2698/CD
11180040	T12_T13	NONE	2698/CD (r_prep) 8/CD (r_nummod) ADL/NNP (l_conj) placebo/NN (l_conj) morphine/NN
11180040	T14_T15	NONE	Morphine/NNP (r_nmod) constriction/NN (r_nsubj) were/VBD (l_acomp) unaffected/JJ (l_prep) by/IN (l_pobj) ADL/NNP (l_nummod) 8/CD (l_prep) 2698/CD
11180040	T16_T17	EFFECT	2698/CD (r_prep) 8/CD (r_nummod) ADL/NNP (r_nsubj) prevents/VBZ (l_dobj) increases/NNS (l_amod) induced/VBN (l_npadvmod) morphine/NN
2981680	T3_T2	NONE	)/-RRB- (r_punct) absorption/NN (l_prep) of/IN (l_pobj) arsenate(As(V/NN
2981680	T4_T5	NONE	arsenate/NN (r_nsubj) is/VBZ (l_conj) concentrations/NNS (l_punct) )/-RRB-
2981680	T4_T6	NONE	arsenate/NN (r_nsubj) is/VBZ (l_conj) is/VBZ (l_csubj) declining/VBG (l_prep) to/IN (l_pobj) absorption/NN (l_prep) at/IN (l_pobj) Transfer/NN (l_prep) to/IN (l_pobj) cells/NNS (l_prep) at/IN (l_pobj) concentration/NN (l_nmod) As(V/NN (l_punct) )/-RRB-
2981680	T14_T15	MECHANISM	D3/NNP (r_compound) administration/NN (r_nsubj) was/VBD (l_acomp) effective/JJ (l_prep) in/IN (l_pcomp) elevating/VBG (l_dobj) absorption/NN (l_compound) arsenate/NN
11125235	T1_T2	EFFECT	verapamil/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_amod) enhanced/VBN (l_npadvmod) bombesin/NN
11125235	T1_T3	NONE	verapamil/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN
11125235	T2_T3	NONE	bombesin/NN (r_npadvmod) enhanced/VBN (r_amod) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN
11125235	T4_T6	NONE	bombesin/NN (r_pobj) of/IN (r_prep) administration/NN (l_appos) verapamil/NNP
11125235	T4_T7	NONE	bombesin/NN (r_pobj) of/IN (r_prep) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (l_appos) blocker/NN
11125235	T4_T8	NONE	bombesin/NN (r_pobj) of/IN (r_prep) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) investigated/VBN (l_prep) on/IN (l_pobj) incidence/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN
11125235	T4_T9	NONE	bombesin/NN (r_pobj) of/IN (r_prep) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) investigated/VBN (l_prep) on/IN (l_pobj) incidence/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN (l_appos) AOM/NNP
11125235	T5_T6	NONE	hydrochloride/NN (r_conj) bombesin/NN (r_pobj) of/IN (r_prep) administration/NN (l_appos) verapamil/NNP
11125235	T5_T7	NONE	hydrochloride/NN (r_conj) bombesin/NN (r_pobj) of/IN (r_prep) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (l_appos) blocker/NN
11125235	T5_T8	NONE	hydrochloride/NN (r_conj) bombesin/NN (r_pobj) of/IN (r_prep) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) investigated/VBN (l_prep) on/IN (l_pobj) incidence/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN
11125235	T5_T9	NONE	hydrochloride/NN (r_conj) bombesin/NN (r_pobj) of/IN (r_prep) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) investigated/VBN (l_prep) on/IN (l_pobj) incidence/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN (l_appos) AOM/NNP
11125235	T6_T7	NONE	verapamil/NNP (r_appos) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (l_appos) blocker/NN
11125235	T6_T8	NONE	verapamil/NNP (r_appos) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) investigated/VBN (l_prep) on/IN (l_pobj) incidence/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN
11125235	T6_T9	NONE	verapamil/NNP (r_appos) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) investigated/VBN (l_prep) on/IN (l_pobj) incidence/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN (l_appos) AOM/NNP
11125235	T7_T8	NONE	blocker/NN (r_appos) effects/NNS (r_nsubjpass) investigated/VBN (l_prep) on/IN (l_pobj) incidence/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN
11125235	T7_T9	NONE	blocker/NN (r_appos) effects/NNS (r_nsubjpass) investigated/VBN (l_prep) on/IN (l_pobj) incidence/NN (l_prep) of/IN (l_pobj) metastasis/NN (l_prep) of/IN (l_pobj) adenocarcinomas/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) azoxymethane/NN (l_appos) AOM/NNP
11125235	T8_T9	NONE	azoxymethane/NN (l_appos) AOM/NNP
11125235	T10_T11	NONE	AOM/NNP (r_pobj) of/IN (r_prep) injections/NNS (l_conj) injections/NNS (l_prep) of/IN (l_pobj) bombesin/NN
11125235	T10_T12	NONE	AOM/NNP (r_pobj) of/IN (r_prep) injections/NNS (r_dobj) given/VBN (l_conj) from/IN (l_punct) ,/, (l_preconj) injections/NNS (l_prep) of/IN (l_pobj) verapamil/NN
11125235	T11_T12	NONE	bombesin/NN (r_pobj) of/IN (r_prep) injections/NNS (r_conj) injections/NNS (r_dobj) given/VBN (l_conj) from/IN (l_punct) ,/, (l_preconj) injections/NNS (l_prep) of/IN (l_pobj) verapamil/NN
11125235	T14_T15	NONE	verapamil/NN (r_nsubj) had/VBD (l_dobj) effect/NN (l_prep) on/IN (l_pobj) enhancement/NN (l_prep) of/IN (l_pobj) carcinogenesis/NN (l_prep) by/IN (l_pobj) bombesin/NN
11125235	T16_T17	EFFECT	Verapamil/NNP (r_nsubj) decreased/VBD (l_dobj) incidence/NN (l_prep) of/IN (l_pobj) invasion/NN (l_relcl) enhanced/VBN (l_agent) by/IN (l_pobj) bombesin/NN
11206417	T9_T11	NONE	glucose/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubj) were/VBD (l_prep) under/IN (l_cc) but/CC (l_punct) administered/VBN (l_punct) -/HYPH (l_punct) co/NNP (l_punct) was/VBD (l_nsubj) somatostatin/NN
11206417	T10_T11	NONE	insulin/NN (r_conj) glucose/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubj) were/VBD (l_prep) under/IN (l_cc) but/CC (l_punct) administered/VBN (l_punct) -/HYPH (l_punct) co/NNP (l_punct) was/VBD (l_nsubj) somatostatin/NN
11152855	T1_T2	NONE	dofetillide/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) pharmacokinetics/NNS (l_prep) of/IN (l_pobj) digoxin/NN
11152855	T3_T4	NONE	dofetilide/NN (r_pobj) of/IN (r_prep) effect/NN (l_prep) on/IN (l_pobj) pharmacokinetics/NNS (l_prep) of/IN (l_pobj) digoxin/NN
11152855	T5_T6	NONE	dofetilide/NN (r_compound) treatment/NN (r_pobj) of/IN (r_prep) days/NNS (r_nsubj) affect/VB (l_dobj) variables/NNS (l_prep) of/IN (l_pobj) digoxin/NN
11152855	T5_T8	NONE	dofetilide/NN (r_compound) treatment/NN (r_pobj) of/IN (r_prep) days/NNS (r_nsubj) affect/VB (r_ccomp) necessitate/VB (l_dobj) adjustment/NN (l_prep) in/IN (l_pobj) dose/NN (l_compound) digoxin/JJ
11152855	T6_T7	NONE	digoxin/NN (r_pobj) of/IN (r_prep) variables/NNS (r_dobj) affect/VB (r_ccomp) necessitate/VB (l_nsubj) use/NN (l_prep) of/IN (l_pobj) dofetilide/NN
11152855	T7_T8	NONE	dofetilide/NN (r_pobj) of/IN (r_prep) use/NN (r_nsubj) necessitate/VB (l_dobj) adjustment/NN (l_prep) in/IN (l_pobj) dose/NN (l_compound) digoxin/JJ
11144988	T1_T2	NONE	rofecoxib/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) pharmacokinetics/NNS (l_prep) of/IN (l_pobj) digoxin/NN
11144988	T3_T4	NONE	rofecoxib/JJ (r_pobj) of/IN (r_prep) effect/NN (r_dobj) examined/VBD (l_prep) at/IN (l_pobj) state/NN (l_prep) on/IN (l_pobj) pharmacokinetics/NNS (l_prep) of/IN (l_pobj) digoxin/NN
11144988	T10_T11	NONE	digoxin/NNP (r_compound) AUC(0-infinity/NN (r_pobj) For/IN (r_prep) were/VBD (l_nsubj) 24/CD (l_conj) Cmax/NNP (l_appos) ratios/NNS (l_parataxis) interval/NN (l_prep) for/IN (l_pobj) rofecoxib/JJ
11144988	T11_T12	NONE	rofecoxib/JJ (l_conj) placebo/NN (l_nmod) digoxin/NN
11144988	T15_T17	NONE	rofecoxib/NN (l_conj) treatments/NNS (l_compound) digoxin/NN
11144988	T19_T20	NONE	digoxin/NN (r_pobj) of/IN (r_prep) excretion/NN (l_prep) after/IN (l_pobj) treatment/NN (l_prep) with/IN (l_pobj) rofecoxib/NN
11144988	T22_T23	NONE	Rofecoxib/NNP (r_nsubj) influence/VB (l_dobj) plasma/NN (l_conj) elimination/NN (l_prep) of/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) digoxin/NN
17894105	T4_T5	NONE	benzodiazepine/NN (l_appos) chlordiazepoxide/NN
11085328	T1_T2	NONE	IV/NNP (r_pobj) of/IN (r_prep) effects/NNS (l_appos) locomotion/NN (l_compound) phencyclidine/NN (l_punct) upon/IN (l_punct) CCG-1/NNP
11085328	T1_T3	NONE	IV/NNP (r_pobj) of/IN (r_prep) effects/NNS (l_appos) locomotion/NN (l_compound) phencyclidine/NN
11085328	T1_T4	NONE	IV/NNP (r_pobj) of/IN (r_prep) effects/NNS (l_appos) locomotion/NN (l_amod) PCP)-induced/VBN
11085328	T2_T3	NONE	CCG-1/NNP (r_punct) upon/IN (r_punct) phencyclidine/NN
11085328	T2_T4	NONE	CCG-1/NNP (r_punct) upon/IN (r_punct) phencyclidine/NN (r_compound) locomotion/NN (l_amod) PCP)-induced/VBN
11085328	T3_T4	NONE	phencyclidine/NN (r_compound) locomotion/NN (l_amod) PCP)-induced/VBN
11085328	T7_T8	NONE	IV/NNP (r_nsubjpass) found/VBN (l_prep) on/IN (l_punct) ,/, (l_punct) CCG-1/NNP
11085328	T7_T9	NONE	IV/NNP (r_nsubjpass) found/VBN (l_prep) on/IN (l_pobj) changes/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) PCP/NNP
11085328	T8_T9	NONE	CCG-1/NNP (r_punct) ,/, (r_punct) on/IN (l_pobj) changes/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) PCP/NNP
11085328	T10_T11	EFFECT	IV/NNP (r_pobj) of/IN (r_prep) effects/NNS (r_nsubj) were/VBD (l_acomp) strong/JJ (l_conj) depressed/JJ (l_dobj) hyperlocomotion/NN (l_amod) induced/VBN (l_npadvmod) PCP/NNP
11085328	T14_T16	NONE	PCP/NNP (r_npadvmod) induced/VBN (r_amod) changes/NNS (r_pobj) of/IN (r_prep) mechanisms/NNS (r_dobj) examine/VB (r_acl) order/NN (r_pobj) In/IN (r_prep) carried/VBN (l_nsubjpass) analysis/NN (l_acl) treated/VBN (l_prep) with/IN (l_pobj) PCP/NNP (l_conj) IV/NNP
11085328	T14_T17	NONE	PCP/NNP (r_npadvmod) induced/VBN (r_amod) changes/NNS (r_pobj) of/IN (r_prep) mechanisms/NNS (r_dobj) examine/VB (r_acl) order/NN (r_pobj) In/IN (r_prep) carried/VBN (l_nsubjpass) analysis/NN (l_acl) treated/VBN (l_prep) with/IN (l_pobj) PCP/NNP (l_conj) IV/NNP (l_conj) CCG-1/NNP
11180037	T1_T2	MECHANISM	Fluvoxamine/NNP (r_nsubj) inhibits/VBZ (l_dobj) biotransformation/NN (l_prep) of/IN (l_pobj) tolbutamide/NN
11180037	T4_T5	NONE	tolbutamide/VB (r_conj) fluvoxamine/NN (r_pobj) between/IN (r_prep) interaction/NN (r_dobj) examine/VB (l_advcl) confirm/VB (l_ccomp) inhibits/VBZ (l_nsubj) fluvoxamine/NN
11180037	T9_T11	NONE	tolbutamide/NN (r_pobj) for/IN (r_prep) analyzed/VBN (l_conj) analyzed/VBN (l_prep) for/IN (l_pobj) tolbutamide/NN (l_conj) metabolites/NNS (l_appos) 4-hydroxytolbutamide/RB
11180037	T9_T12	NONE	tolbutamide/NN (r_pobj) for/IN (r_prep) analyzed/VBN (l_conj) analyzed/VBN (l_prep) for/IN (l_pobj) tolbutamide/NN (l_conj) metabolites/NNS (l_appos) 4-hydroxytolbutamide/RB (l_conj) carboxytolbutamide/VB
11180037	T10_T11	NONE	tolbutamide/NN (l_conj) metabolites/NNS (l_appos) 4-hydroxytolbutamide/RB
11180037	T10_T12	NONE	tolbutamide/NN (l_conj) metabolites/NNS (l_appos) 4-hydroxytolbutamide/RB (l_conj) carboxytolbutamide/VB
11180037	T13_T14	MECHANISM	fluvoxamine/NN (r_pobj) with/IN (r_prep) treatment/NN (r_pobj) During/IN (r_prep) was/VBD (l_attr) decrease/NN (l_prep) in/IN (l_pobj) median/NN (l_prep) of/IN (l_pobj) clearance/NN (l_prep) of/IN (l_pobj) tolbutamide/NN
11180037	T16_T18	NONE	4-hydroxytolbutamide/JJ (r_pobj) of/IN (r_prep) means/NNS (r_pobj) by/IN (r_prep) clearance/NN (r_nsubjpass) reduced/VBN (l_prep) in/IN (l_pobj) groups/NNS (l_appos) h/NN (l_prep) in/IN (l_pobj) group/NN (l_relcl) received/VBD (l_dobj) mg/NN (l_prep) of/IN (l_pobj) tolbutamide/NN
11180037	T16_T19	NONE	4-hydroxytolbutamide/JJ (r_pobj) of/IN (r_prep) means/NNS (r_pobj) by/IN (r_prep) clearance/NN (r_nsubjpass) reduced/VBN (l_dep) h/NN (l_prep) in/IN (l_pobj) group/NN (l_relcl) received/VBD (l_dobj) mg/NN (l_prep) of/IN (l_pobj) tolbutamide/NN
11180037	T17_T18	NONE	carboxytolbutamide/NN (r_conj) 4-hydroxytolbutamide/JJ (r_pobj) of/IN (r_prep) means/NNS (r_pobj) by/IN (r_prep) clearance/NN (r_nsubjpass) reduced/VBN (l_prep) in/IN (l_pobj) groups/NNS (l_appos) h/NN (l_prep) in/IN (l_pobj) group/NN (l_relcl) received/VBD (l_dobj) mg/NN (l_prep) of/IN (l_pobj) tolbutamide/NN
11180037	T17_T19	NONE	carboxytolbutamide/NN (r_conj) 4-hydroxytolbutamide/JJ (r_pobj) of/IN (r_prep) means/NNS (r_pobj) by/IN (r_prep) clearance/NN (r_nsubjpass) reduced/VBN (l_dep) h/NN (l_prep) in/IN (l_pobj) group/NN (l_relcl) received/VBD (l_dobj) mg/NN (l_prep) of/IN (l_pobj) tolbutamide/NN
11158747	T4_T5	NONE	amprenavir/NNS (r_nsubjpass) given/VBN (l_prep) with/IN (l_pobj) rifabutin/NN
11158747	T4_T6	NONE	amprenavir/NNS (r_nsubjpass) given/VBN (l_prep) with/IN (l_pobj) rifabutin/NN (l_conj) rifampin/NN
11158747	T7_T8	NONE	amprenavir/NNS (r_dobj) received/VBD (l_advcl) followed/VBN (l_agent) by/IN (l_pobj) rifabutin/NN
11158747	T7_T9	NONE	amprenavir/NNS (r_dobj) received/VBD (l_advcl) followed/VBN (l_dobj) cohort/NN (l_conj) rifampin/NN
11158747	T8_T9	NONE	rifabutin/NN (r_pobj) by/IN (r_agent) followed/VBN (l_dobj) cohort/NN (l_conj) rifampin/NN
11158747	T10_T13	NONE	amprenavir/NNS (r_dobj) received/VBD (l_conj) received/VBD (l_advmod) rifampin/NN
11158747	T11_T12	NONE	rifabutin/NN (r_conj) amprenavir/NNS (r_dobj) received/VBD (l_conj) received/VBD (l_dobj) amprenavir/NNS
11158747	T11_T13	NONE	rifabutin/NN (r_conj) amprenavir/NNS (r_dobj) received/VBD (l_conj) received/VBD (l_advmod) rifampin/NN
11158747	T12_T13	NONE	amprenavir/NNS (r_dobj) received/VBD (l_advmod) rifampin/NN
11158747	T18_T19	NONE	Rifabutin/NNP (r_nsubj) affect/VB (l_dobj) pharmacokinetics/NNS (l_poss) amprenavir/NNS
11158747	T20_T21	MECHANISM	Amprenavir/NNP (r_nsubj) increased/VBD (l_prep) of/IN (l_pcomp) rifabutin/NN
11158747	T20_T22	MECHANISM	Amprenavir/NNP (r_nsubj) increased/VBD (l_prep) of/IN (l_pcomp) rifabutin/NN (l_prep) by/IN (l_pobj) 2.93-fold/CD (l_conj) AUC(ss/NNP (l_prep) of/IN (l_pobj) desacetylrifabutin/NN
11158747	T21_T22	NONE	rifabutin/NN (l_prep) by/IN (l_pobj) 2.93-fold/CD (l_conj) AUC(ss/NNP (l_prep) of/IN (l_pobj) desacetylrifabutin/NN
11158747	T23_T24	MECHANISM	Rifampin/NNP (r_nsubj) decreased/VBD (l_dobj) AUC(ss/NNP (l_prep) of/IN (l_pobj) amprenavir/NNS
11158747	T23_T25	NONE	Rifampin/NNP (r_nsubj) decreased/VBD (l_conj) had/VBD (l_nsubj) amprenavir/NNS
11158747	T24_T26	NONE	amprenavir/NNS (r_pobj) of/IN (r_prep) AUC(ss/NNP (r_dobj) decreased/VBD (l_conj) had/VBD (l_dobj) effect/NN (l_prep) on/IN (l_pcomp) rifampin/JJ
11158747	T25_T26	NONE	amprenavir/NNS (r_nsubj) had/VBD (l_dobj) effect/NN (l_prep) on/IN (l_pcomp) rifampin/JJ
11158747	T28_T29	NONE	rifabutin/NN (r_pobj) of/IN (r_prep) weeks/NNS (r_pobj) after/IN (r_prep) results/NNS (l_conj) increased/VBN (l_advmod) rifampin/NN
11158747	T32_T33	EFFECT	Amprenavir/NNP (l_conj) rifabutin/NN
11158747	T34_T35	MECHANISM	Rifampin/NNP (r_nsubj) increases/VBZ (l_dobj) clearance/NN (l_prep) of/IN (l_pobj) amprenavir/NNS
11158747	T36_T37	MECHANISM	Amprenavir/NNP (r_nsubj) decreases/VBZ (l_dobj) clearance/NN (l_prep) of/IN (l_pobj) rifabutin/NN
11158747	T36_T38	MECHANISM	Amprenavir/NNP (r_nsubj) decreases/VBZ (l_dobj) clearance/NN (l_prep) of/IN (l_pobj) rifabutin/NN (l_conj) desacetylrifabutin/NN
11158747	T39_T40	NONE	Amprenavir/NNP (r_nsubj) inhibits/VBZ (l_conj) are/VBP (l_advmod) rifampin/NN
11158747	T39_T41	NONE	Amprenavir/NNP (r_nsubj) inhibits/VBZ (l_conj) are/VBP (l_advmod) rifampin/NN (l_conj) rifabutin/NN
2982252	T2_T3	NONE	blockers/NNS (l_prep) as/IN (l_pobj) verapamil/NN
2982252	T2_T4	NONE	blockers/NNS (l_prep) as/IN (l_pobj) verapamil/NN (l_conj) diltiazem/NN
2982252	T2_T5	NONE	blockers/NNS (l_prep) as/IN (l_pobj) verapamil/NN (l_conj) diltiazem/NN (l_conj) nifedipine/NN
15825309	T1_T2	INT	clindamycin/NN (r_pobj) of/IN (r_prep) Interaction/NN (l_conj) gentamicin/NN
15825309	T3_T4	NONE	clindamycin/NN (r_pobj) of/IN (r_prep) concentrations/NNS (l_conj) gentamicin/NN
15825309	T5_T6	NONE	clindamycin/NN (l_prep) per/IN (l_pobj) Gentamicin/NNP
15825309	T6_T7	NONE	Gentamicin/NNP (r_pobj) per/IN (r_prep) clindamycin/NN (r_pobj) of/IN (r_prep) less/JJR (r_nummod) mug/NN (r_pobj) by/IN (r_prep) inhibited/VBN (l_conj) interfere/VB (l_prep) with/IN (l_pobj) activity/NN (l_prep) of/IN (l_pobj) clindamycin/NN
15825309	T8_T9	NONE	gentamicin/NN (r_pobj) of/IN (r_prep) less/JJR (r_nummod) mug/NN (l_prep) per/IN (l_pobj) Combinations/NNS (l_prep) of/IN (l_pobj) clindamycin/NN
15825309	T9_T10	EFFECT	clindamycin/NN (r_pobj) of/IN (r_prep) Combinations/NNS (r_pobj) per/IN (r_prep) mug/NN (r_pobj) by/IN (r_prep) inhibited/VBN (l_conj) were/VBD (l_nsubj) gentamicin/NN
15825309	T11_T12	NONE	clindamycin/NN (r_pobj) to/IN (r_prep) resistant/JJ (r_acomp) were/VBD (l_attr) concentration/NN (l_conj) gentamicin/NN
15825309	T13_T14	EFFECT	clindamycin/NN (l_conj) gentamicin/NN
11120981	T1_T2	NONE	indinavir/NNS (l_appos) IDV/NNP
11120981	T1_T3	NONE	indinavir/NNS (r_pobj) before/IN (r_prep) taken/VBN (r_advcl) affect/VB (l_nsubj) didanosine/NN
11120981	T1_T4	NONE	indinavir/NNS (r_pobj) before/IN (r_prep) taken/VBN (r_advcl) affect/VB (l_dobj) exposure/NN (l_compound) IDV/NNP
11120981	T2_T3	NONE	IDV/NNP (r_appos) indinavir/NNS (r_pobj) before/IN (r_prep) taken/VBN (r_advcl) affect/VB (l_nsubj) didanosine/NN
11120981	T3_T4	NONE	didanosine/NN (r_nsubj) affect/VB (l_dobj) exposure/NN (l_compound) IDV/NNP
11120981	T5_T6	MECHANISM	indinavir/NNS (l_conj) didanosine/NN
11120981	T5_T8	NONE	indinavir/NNS (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) reduces/VBZ (l_conj) is/VBZ (l_ccomp) given/VBN (l_nsubjpass) indinavir/NNS (l_compound) administration/NN (l_compound) didanosine/NN
11120981	T6_T7	NONE	didanosine/NN (r_conj) indinavir/NNS (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) reduces/VBZ (l_dobj) level/NN (l_prep) of/IN (l_pobj) exposure/NN (l_prep) to/IN (l_pobj) indinavir/NNS
11120981	T6_T9	NONE	didanosine/NN (r_conj) indinavir/NNS (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) reduces/VBZ (l_conj) is/VBZ (l_ccomp) given/VBN (l_nsubjpass) indinavir/NNS
11120981	T7_T8	NONE	indinavir/NNS (r_pobj) to/IN (r_prep) exposure/NN (r_pobj) of/IN (r_prep) level/NN (r_dobj) reduces/VBZ (l_conj) is/VBZ (l_ccomp) given/VBN (l_nsubjpass) indinavir/NNS (l_compound) administration/NN (l_compound) didanosine/NN
11120981	T8_T9	NONE	didanosine/NN (r_compound) administration/NN (r_compound) indinavir/NNS
11120981	T14_T15	MECHANISM	indinavir/NNS (r_nsubjpass) taken/VBN (l_prep) after/IN (l_pobj) administration/NN (l_compound) didanosine/NN
11120981	T16_T17	ADVISE	Indinavir/NNS (r_nsubjpass) taken/VBN (l_prep) following/VBG (l_pobj) administration/NN (l_prep) of/IN (l_pobj) mg/IN (l_prep) of/IN (l_pobj) didanosine/NN
10978751	T4_T5	NONE	pyrocarbonate/NN (r_nsubjpass) used/VBN (l_xcomp) modify/VB (l_dobj) residues/NNS (l_prep) on/IN (l_pobj) Modification/NN (l_compound) A./NN
10978751	T4_T6	NONE	pyrocarbonate/NN (r_nsubjpass) used/VBN (l_xcomp) modify/VB (l_dobj) residues/NNS (l_prep) on/IN (l_pobj) Modification/NN (l_prep) of/IN (l_pobj) toxin/NN
10978751	T8_T9	NONE	A/NN (r_pobj) of/IN (r_prep) Treatment/NN (r_nsubj) revealed/VBN (l_nsubj) pyrocarbonate/NN
10978751	T10_T11	NONE	pyrocarbonate/NN (r_appos) effects/NNS (r_nsubjpass) reversed/VBN (l_agent) by/IN (l_pobj) treatment/NN (l_compound) hydroxylamine/NN
10978751	T14_T16	NONE	A./NN (r_npadvmod) Exposed/VBD (r_amod) histidines/NNS (r_pobj) of/IN (r_prep) activity/NN (r_pobj) to/IN (r_prep) crucial/JJ (r_acomp) be/VB (r_ccomp) suggest/VBP (l_ccomp) are/VBP (l_acomp) available/JJ (l_prep) for/IN (l_pobj) chelation/NN (l_compound) zinc/NN
10978751	T14_T18	NONE	A./NN (r_npadvmod) Exposed/VBD (r_amod) histidines/NNS (r_pobj) of/IN (r_prep) activity/NN (r_pobj) to/IN (r_prep) crucial/JJ (r_acomp) be/VB (r_ccomp) suggest/VBP (l_conj) exploited/VBN (l_prep) in/IN (l_pobj) development/NN (l_prep) of/IN (l_pobj) protocol/NN (l_prep) for/IN (l_pobj) A/DT (l_acl) using/VBG (l_dobj) chromatography/NN (l_compound) chelating/VBG (l_compound) zinc/NN
10978751	T15_T16	NONE	A/DT (r_pobj) on/IN (r_prep) histidines/NNS (r_pobj) of/IN (r_prep) activity/NN (r_pobj) to/IN (r_prep) crucial/JJ (r_acomp) be/VB (r_ccomp) suggest/VBP (l_ccomp) are/VBP (l_acomp) available/JJ (l_prep) for/IN (l_pobj) chelation/NN (l_compound) zinc/NN
10978751	T15_T18	NONE	A/DT (r_pobj) on/IN (r_prep) histidines/NNS (r_pobj) of/IN (r_prep) activity/NN (r_pobj) to/IN (r_prep) crucial/JJ (r_acomp) be/VB (r_ccomp) suggest/VBP (l_conj) exploited/VBN (l_prep) in/IN (l_pobj) development/NN (l_prep) of/IN (l_pobj) protocol/NN (l_prep) for/IN (l_pobj) A/DT (l_acl) using/VBG (l_dobj) chromatography/NN (l_compound) chelating/VBG (l_compound) zinc/NN
10978751	T16_T17	NONE	zinc/NN (r_compound) chelation/NN (r_pobj) for/IN (r_prep) available/JJ (r_acomp) are/VBP (r_ccomp) suggest/VBP (l_conj) exploited/VBN (l_prep) in/IN (l_pobj) development/NN (l_prep) of/IN (l_pobj) protocol/NN (l_prep) for/IN (l_pobj) A/DT
10978751	T17_T18	NONE	A/DT (l_acl) using/VBG (l_dobj) chromatography/NN (l_compound) chelating/VBG (l_compound) zinc/NN
15825391	T1_T2	NONE	B/NN (r_pobj) of/IN (r_prep) toxicity/NN (l_conj) filipin/NN
15825391	T3_T4	NONE	antibiotics/NNS (r_pobj) Among/IN (r_prep) used/VBN (l_prep) like/IN (l_pobj) filipin/NN
15825391	T3_T5	NONE	antibiotics/NNS (r_pobj) Among/IN (r_prep) used/VBN (r_ccomp) is/VBZ (l_nsubj) B/NN
15825391	T4_T5	NONE	filipin/NN (r_pobj) like/IN (r_prep) used/VBN (r_ccomp) is/VBZ (l_nsubj) B/NN
15825391	T6_T7	NONE	filipin/NN (r_pobj) of/IN (r_prep) toxicity/NN (l_conj) value/NN (l_prep) of/IN (l_pobj) B/NN
15825391	T6_T8	NONE	filipin/NN (r_pobj) of/IN (r_prep) toxicity/NN (r_nsubjpass) rationalized/VBN (l_conj) showed/VBD (l_nsubj) antibiotics/NNS
15825391	T6_T10	NONE	filipin/NN (r_pobj) of/IN (r_prep) toxicity/NN (r_nsubjpass) rationalized/VBN (r_ccomp) was/VBD (l_advcl) was/VBD (l_nsubj) B/NNP
15825391	T6_T12	NONE	filipin/NN (r_pobj) of/IN (r_prep) toxicity/NN (r_nsubjpass) rationalized/VBN (r_ccomp) was/VBD (l_advcl) was/VBD (l_conj) inhibited/VBN (l_advcl) inhibited/VBN (l_nsubjpass) effects/NNS (l_prep) of/IN (l_pobj) B/NNP
15825391	T7_T8	NONE	B/NN (r_pobj) of/IN (r_prep) value/NN (r_conj) toxicity/NN (r_nsubjpass) rationalized/VBN (l_conj) showed/VBD (l_nsubj) antibiotics/NNS
15825391	T7_T9	NONE	B/NN (r_pobj) of/IN (r_prep) value/NN (r_conj) toxicity/NN (r_nsubjpass) rationalized/VBN (r_ccomp) was/VBD (l_nsubj) filipin/NN
15825391	T7_T11	NONE	B/NN (r_pobj) of/IN (r_prep) value/NN (r_conj) toxicity/NN (r_nsubjpass) rationalized/VBN (r_ccomp) was/VBD (l_advcl) was/VBD (l_conj) inhibited/VBN (l_nsubjpass) effects/NNS (l_prep) of/IN (l_pobj) filipin/NN
15825391	T8_T9	NONE	antibiotics/NNS (r_nsubj) showed/VBD (r_conj) rationalized/VBN (r_ccomp) was/VBD (l_nsubj) filipin/NN
15825391	T8_T10	NONE	antibiotics/NNS (r_nsubj) showed/VBD (r_conj) rationalized/VBN (r_ccomp) was/VBD (l_advcl) was/VBD (l_nsubj) B/NNP
15825391	T8_T11	NONE	antibiotics/NNS (r_nsubj) showed/VBD (r_conj) rationalized/VBN (r_ccomp) was/VBD (l_advcl) was/VBD (l_conj) inhibited/VBN (l_nsubjpass) effects/NNS (l_prep) of/IN (l_pobj) filipin/NN
15825391	T8_T12	NONE	antibiotics/NNS (r_nsubj) showed/VBD (r_conj) rationalized/VBN (r_ccomp) was/VBD (l_advcl) was/VBD (l_conj) inhibited/VBN (l_advcl) inhibited/VBN (l_nsubjpass) effects/NNS (l_prep) of/IN (l_pobj) B/NNP
15825391	T9_T10	NONE	filipin/NN (r_nsubj) was/VBD (l_advcl) was/VBD (l_nsubj) B/NNP
15825391	T9_T12	NONE	filipin/NN (r_nsubj) was/VBD (l_advcl) was/VBD (l_conj) inhibited/VBN (l_advcl) inhibited/VBN (l_nsubjpass) effects/NNS (l_prep) of/IN (l_pobj) B/NNP
15825391	T10_T11	NONE	B/NNP (r_nsubj) was/VBD (l_conj) inhibited/VBN (l_nsubjpass) effects/NNS (l_prep) of/IN (l_pobj) filipin/NN
15825391	T11_T12	NONE	filipin/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) inhibited/VBN (l_advcl) inhibited/VBN (l_nsubjpass) effects/NNS (l_prep) of/IN (l_pobj) B/NNP
3967572	T1_T2	MECHANISM	theophylline/JJ (r_amod) clearance/NN (l_amod) secondary/JJ (l_prep) to/IN (l_pobj) therapy/NN (l_compound) phenytoin/NN
3967572	T3_T4	MECHANISM	theophylline/NN (r_amod) clearance/NN (r_nsubj) accelerated/VBD (l_prep) with/IN (l_pobj) administration/NN (l_compound) phenytoin/JJ
3967572	T6_T7	EFFECT	phenytoin/NN (r_nsubjpass) added/VBN (l_prep) due/IN (l_pcomp) lowered/VBN (l_dobj) concentrations/NNS (l_amod) theophylline/JJ
2857198	T1_T2	NONE	ouabain/NN (l_prep) on/IN (l_pobj) contraction/NN (l_amod) induced/VBN (l_npadvmod) palytoxin/NN
2857198	T3_T4	NONE	Palytoxin/NNP (l_appos) PTX/NNP
2857198	T5_T6	EFFECT	ouabain/NN (r_pobj) of/IN (r_prep) presence/NN (r_pobj) In/IN (r_prep) failed/VBD (l_nsubj) M/NNP (l_nmod) PTX/NNP
2857198	T8_T9	EFFECT	ouabain/NN (r_nsubjpass) applied/VBN (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) phentolamine/NN
2857198	T8_T10	NONE	ouabain/NN (r_nsubjpass) applied/VBN (r_advcl) abolished/VBN (l_nsubjpass) responses/NNS (l_prep) to/IN (l_pobj) PTX/NNP
2857198	T9_T10	NONE	phentolamine/NN (r_pobj) of/IN (r_prep) presence/NN (r_pobj) in/IN (r_prep) applied/VBN (r_advcl) abolished/VBN (l_nsubjpass) responses/NNS (l_prep) to/IN (l_pobj) PTX/NNP
2857198	T13_T14	EFFECT	ouabain/VB (r_relcl) muscle/NN (r_pobj) of/IN (r_prep) Exposure/NN (r_nsubj) increased/VBD (l_dobj) release/NN (l_amod) induced/VBN (l_npadvmod) PTX/NNP
11137650	T1_T2	NONE	KRM-1648/NNP (r_pobj) of/IN (r_prep) activity/NN (r_pobj) In/IN (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) ofloxacin/DT
11137650	T3_T4	NONE	benzoxazinorifamycin/NNS (r_pobj) of/IN (r_prep) effect/NN (l_appos) KRM-1648/NNP
11137650	T3_T5	NONE	benzoxazinorifamycin/NNS (r_pobj) of/IN (r_prep) effect/NN (l_appos) KRM-1648/NNP (l_advmod) alone/RB (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) ofloxacin/DT
11137650	T4_T5	NONE	KRM-1648/NNP (l_advmod) alone/RB (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) ofloxacin/DT
11137650	T6_T7	NONE	KRM-1648/NNP (r_pobj) of/IN (r_prep) concentration/NN (r_conj) concentration/NN (r_nsubj) was/VBD (l_advcl) corresponding/VBG (l_ccomp) were/VBD (l_nsubj) values/NNS (l_prep) for/IN (l_pobj) rifampicin/NNS
11137650	T6_T8	NONE	KRM-1648/NNP (r_pobj) of/IN (r_prep) concentration/NN (r_conj) concentration/NN (r_nsubj) was/VBD (l_advcl) corresponding/VBG (l_ccomp) were/VBD (l_nsubj) values/NNS (l_prep) for/IN (l_pobj) rifampicin/NNS (l_conj) rifabutin/NN
11137650	T9_T10	EFFECT	ofloxacin/DT (r_pobj) with/IN (r_prep) combined/VBN (r_advcl) exhibited/VBD (l_nsubj) KRM-1648/NNP
11137650	T9_T11	NONE	ofloxacin/DT (r_pobj) with/IN (r_prep) combined/VBN (r_advcl) exhibited/VBD (l_advcl) observed/VBN (l_prep) with/IN (l_pobj) combination/NN (l_prep) of/IN (l_pobj) rifampicin/NNS
11137650	T9_T12	NONE	ofloxacin/DT (r_pobj) with/IN (r_prep) combined/VBN (r_advcl) exhibited/VBD (l_advcl) observed/VBN (l_prep) with/IN (l_pobj) combination/NN (l_prep) of/IN (l_pobj) rifampicin/NNS (l_conj) rifabutin/NN
11137650	T10_T11	NONE	KRM-1648/NNP (r_nsubj) exhibited/VBD (l_advcl) observed/VBN (l_prep) with/IN (l_pobj) combination/NN (l_prep) of/IN (l_pobj) rifampicin/NNS
11137650	T10_T12	NONE	KRM-1648/NNP (r_nsubj) exhibited/VBD (l_advcl) observed/VBN (l_prep) with/IN (l_pobj) combination/NN (l_prep) of/IN (l_pobj) rifampicin/NNS (l_conj) rifabutin/NN
11137650	T10_T13	NONE	KRM-1648/NNP (r_nsubj) exhibited/VBD (l_advcl) observed/VBN (l_prep) with/IN (l_pobj) combination/NN (l_prep) of/IN (l_pobj) rifampicin/NNS (l_conj) rifabutin/NN (l_conj) ofloxacin/DT
11137650	T11_T13	EFFECT	rifampicin/NNS (l_conj) rifabutin/NN (l_conj) ofloxacin/DT
11137650	T12_T13	EFFECT	rifabutin/NN (l_conj) ofloxacin/DT
11085305	T2_T3	NONE	methamphetamine/NN (l_appos) METH/NN
11085305	T5_T6	EFFECT	METH/NNP (r_nsubj) caused/VBD (l_dobj) increase/NN (l_relcl) abolished/VBN (l_agent) by/IN (l_pobj) pretreatment/NN (l_prep) with/IN (l_pobj) antagonist/NN (l_appos) SCH-23390/NNP
11085305	T5_T7	NONE	METH/NNP (r_nsubj) caused/VBD (l_dobj) increase/NN (l_relcl) abolished/VBN (l_agent) by/IN (l_pobj) clozapine/NN (l_amod) neuroleptic/JJ
11085305	T5_T8	NONE	METH/NNP (r_nsubj) caused/VBD (l_dobj) increase/NN (l_relcl) abolished/VBN (l_agent) by/IN (l_pobj) clozapine/NN
11085305	T6_T7	NONE	SCH-23390/NNP (r_appos) antagonist/NN (r_pobj) with/IN (r_prep) pretreatment/NN (r_pobj) by/IN (r_agent) abolished/VBN (l_agent) by/IN (l_pobj) clozapine/NN (l_amod) neuroleptic/JJ
11085305	T6_T8	NONE	SCH-23390/NNP (r_appos) antagonist/NN (r_pobj) with/IN (r_prep) pretreatment/NN (r_pobj) by/IN (r_agent) abolished/VBN (l_agent) by/IN (l_pobj) clozapine/NN
11085305	T7_T8	NONE	neuroleptic/JJ (r_amod) clozapine/NN
11166779	T5_T6	EFFECT	Etofibrate/NNP (r_nsubj) elicited/VBD (l_dobj) enhancement/NN (l_prep) of/IN (l_pobj) activity/NN (l_nmod) heparin/VBN
1089034	T4_T5	NONE	amphetamine/NN (r_pobj) of/IN (r_prep) users/NNS (r_pobj) of/IN (r_prep) number/NN (r_pobj) of/IN (r_prep) basis/NN (r_pobj) On/IN (r_prep) is/VBZ (l_conj) is/VBZ (l_acomp) comparable/JJ (l_prep) to/IN (l_pobj) that/DT (l_prep) in/IN (l_pobj) alcoholics/NNS (l_conj) addicts/NNS (l_compound) heroin/NN
1089034	T6_T7	NONE	alcohol/NN (r_npadvmod) related/VBN (r_amod) deaths/NNS (r_pobj) of/IN (r_prep) number/NN (r_nsubj) is/VBZ (l_acomp) greater/JJR (l_prep) than/IN (l_pobj) number/NN (l_prep) of/IN (l_pobj) deaths/NNS (l_prep) in/IN (l_pobj) amphetamine/NN
1089034	T6_T8	NONE	alcohol/NN (r_npadvmod) related/VBN (r_amod) deaths/NNS (r_pobj) of/IN (r_prep) number/NN (r_nsubj) is/VBZ (l_acomp) greater/JJR (l_prep) than/IN (l_pobj) number/NN (l_prep) of/IN (l_pobj) deaths/NNS (l_prep) in/IN (l_pobj) amphetamine/NN (l_conj) users/NNS (l_compound) heroin/NN
1089034	T7_T8	NONE	amphetamine/NN (l_conj) users/NNS (l_compound) heroin/NN
11213358	T1_T3	NONE	estradiol/NN (l_conj) progesterone/NN (l_prep) on/IN (l_pobj) sensitivity/NN (l_prep) to/IN (l_pobj) noradrenaline/NN
11213358	T2_T3	NONE	progesterone/NN (l_prep) on/IN (l_pobj) sensitivity/NN (l_prep) to/IN (l_pobj) noradrenaline/NN
11213358	T4_T5	NONE	estradiol/NN (r_pobj) of/IN (r_prep) doses/NNS (r_pobj) of/IN (r_prep) effects/NNS (r_dobj) investigate/VB (l_prep) of/IN (l_pobj) progesterone/NN
11213358	T4_T6	NONE	estradiol/NN (r_pobj) of/IN (r_prep) doses/NNS (r_pobj) of/IN (r_prep) effects/NNS (r_dobj) investigate/VB (l_prep) of/IN (l_pobj) progesterone/NN (l_prep) on/IN (l_pobj) response/NN (l_prep) to/IN (l_pobj) noradrenaline/NN
11213358	T5_T6	NONE	progesterone/NN (l_prep) on/IN (l_pobj) response/NN (l_prep) to/IN (l_pobj) noradrenaline/NN
11213358	T10_T11	EFFECT	estradiol/NN (r_compound) group/NN (r_nsubj) were/VBD (l_acomp) supersensitive/JJ (l_prep) to/IN (l_pobj) noradrenaline/NN
11213358	T12_T13	EFFECT	estradiol/NN (r_compound) rats/NNS (r_pobj) from/IN (r_prep) rings/NNS (r_nsubj) were/VBD (l_acomp) supersensitive/JJ (l_prep) to/IN (l_pobj) noradrenaline/NN
11213358	T12_T14	NONE	estradiol/NN (r_compound) rats/NNS (r_pobj) from/IN (r_prep) rings/NNS (r_nsubj) were/VBD (l_advcl) compared/VBN (l_prep) to/TO (l_pobj) vehicle-/VB (l_conj) progesterone-/FW
11213358	T12_T15	NONE	estradiol/NN (r_compound) rats/NNS (r_pobj) from/IN (r_prep) rings/NNS (r_nsubj) were/VBD (l_advcl) compared/VBN (l_prep) to/TO (l_pobj) vehicle-/VB (l_conj) progesterone-/FW (l_conj) progesterone/NN
11213358	T13_T14	NONE	noradrenaline/NN (r_pobj) to/IN (r_prep) supersensitive/JJ (r_acomp) were/VBD (l_advcl) compared/VBN (l_prep) to/TO (l_pobj) vehicle-/VB (l_conj) progesterone-/FW
11213358	T13_T15	NONE	noradrenaline/NN (r_pobj) to/IN (r_prep) supersensitive/JJ (r_acomp) were/VBD (l_advcl) compared/VBN (l_prep) to/TO (l_pobj) vehicle-/VB (l_conj) progesterone-/FW (l_conj) progesterone/NN
11213358	T13_T16	NONE	noradrenaline/NN (r_pobj) to/IN (r_prep) supersensitive/JJ (r_acomp) were/VBD (l_advcl) compared/VBN (l_prep) to/TO (l_pobj) vehicle-/VB (l_conj) rats/NNS (l_amod) treated/VBN (l_npadvmod) estradiol/NN
11213358	T14_T16	NONE	progesterone-/FW (r_conj) vehicle-/VB (l_conj) rats/NNS (l_amod) treated/VBN (l_npadvmod) estradiol/NN
11213358	T15_T16	NONE	progesterone/NN (r_conj) progesterone-/FW (r_conj) vehicle-/VB (l_conj) rats/NNS (l_amod) treated/VBN (l_npadvmod) estradiol/NN
1167743	T1_T2	NONE	ketamine/NN (r_pobj) of/IN (l_conj) of/IN (l_pobj) anesthesia/NN (l_compound) Innovar/NNP
1167743	T1_T3	NONE	ketamine/NN (r_pobj) of/IN (l_conj) of/IN (l_pobj) anesthesia/NN (l_prep) on/IN (l_pobj) tolerance/NN (l_compound) digitalis/NN
1167743	T2_T3	NONE	Innovar/NNP (r_compound) anesthesia/NN (l_prep) on/IN (l_pobj) tolerance/NN (l_compound) digitalis/NN
1167743	T4_T5	NONE	digitalis/NN (r_compound) tolerance/NN (l_prep) in/IN (l_pobj) dogs/NNS (l_acl) anesthetized/VBN (l_prep) with/IN (l_pobj) ketamine/NN
1167743	T4_T6	NONE	digitalis/NN (r_compound) tolerance/NN (l_appos) Vet/NNP
1167743	T4_T7	NONE	digitalis/NN (r_compound) tolerance/NN (l_appos) Vet/NNP (l_conj) pentobarbital/NN
1167743	T4_T8	NONE	digitalis/NN (r_compound) tolerance/NN (l_appos) Vet/NNP (l_appos) dosage/NN (l_prep) of/IN (l_pobj) ouabain/NN
1167743	T4_T9	NONE	digitalis/NN (r_compound) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) of/IN (l_pobj) ouabain/NN
1167743	T4_T10	NONE	digitalis/NN (r_compound) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN
1167743	T4_T11	NONE	digitalis/NN (r_compound) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN (l_conj) Innovar/NNP
1167743	T4_T12	NONE	digitalis/NN (r_compound) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_prep) than/IN (l_prep) with/IN (l_pobj) pentobarbital/NN
1167743	T5_T6	NONE	ketamine/NN (r_pobj) with/IN (r_prep) anesthetized/VBN (r_acl) dogs/NNS (r_pobj) in/IN (r_prep) tolerance/NN (l_appos) Vet/NNP
1167743	T5_T7	NONE	ketamine/NN (r_pobj) with/IN (r_prep) anesthetized/VBN (r_acl) dogs/NNS (r_pobj) in/IN (r_prep) tolerance/NN (l_appos) Vet/NNP (l_conj) pentobarbital/NN
1167743	T5_T8	EFFECT	ketamine/NN (r_pobj) with/IN (r_prep) anesthetized/VBN (r_acl) dogs/NNS (r_pobj) in/IN (r_prep) tolerance/NN (l_appos) Vet/NNP (l_appos) dosage/NN (l_prep) of/IN (l_pobj) ouabain/NN
1167743	T5_T9	NONE	ketamine/NN (r_pobj) with/IN (r_prep) anesthetized/VBN (r_acl) dogs/NNS (r_pobj) in/IN (r_prep) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) of/IN (l_pobj) ouabain/NN
1167743	T5_T11	NONE	ketamine/NN (r_pobj) with/IN (r_prep) anesthetized/VBN (r_acl) dogs/NNS (r_pobj) in/IN (r_prep) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN (l_conj) Innovar/NNP
1167743	T5_T12	NONE	ketamine/NN (r_pobj) with/IN (r_prep) anesthetized/VBN (r_acl) dogs/NNS (r_pobj) in/IN (r_prep) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_prep) than/IN (l_prep) with/IN (l_pobj) pentobarbital/NN
1167743	T6_T8	EFFECT	Vet/NNP (l_appos) dosage/NN (l_prep) of/IN (l_pobj) ouabain/NN
1167743	T6_T9	NONE	Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) of/IN (l_pobj) ouabain/NN
1167743	T6_T10	NONE	Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN
1167743	T6_T11	NONE	Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN (l_conj) Innovar/NNP
1167743	T6_T12	NONE	Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_prep) than/IN (l_prep) with/IN (l_pobj) pentobarbital/NN
1167743	T7_T8	EFFECT	pentobarbital/NN (r_conj) Vet/NNP (l_appos) dosage/NN (l_prep) of/IN (l_pobj) ouabain/NN
1167743	T7_T9	NONE	pentobarbital/NN (r_conj) Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) of/IN (l_pobj) ouabain/NN
1167743	T7_T10	NONE	pentobarbital/NN (r_conj) Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN
1167743	T7_T11	NONE	pentobarbital/NN (r_conj) Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN (l_conj) Innovar/NNP
1167743	T8_T10	NONE	ouabain/NN (r_pobj) of/IN (r_prep) dosage/NN (r_appos) Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN
1167743	T8_T11	NONE	ouabain/NN (r_pobj) of/IN (r_prep) dosage/NN (r_appos) Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN (l_conj) Innovar/NNP
1167743	T8_T12	NONE	ouabain/NN (r_pobj) of/IN (r_prep) dosage/NN (r_appos) Vet/NNP (r_appos) tolerance/NN (r_pobj) of/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) was/VBD (l_advcl) was/VBD (l_nsubj) LD50/NNP (l_prep) with/IN (l_prep) than/IN (l_prep) with/IN (l_pobj) pentobarbital/NN
1167743	T9_T10	NONE	ouabain/NN (r_pobj) of/IN (r_prep) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN
1167743	T9_T11	NONE	ouabain/NN (r_pobj) of/IN (r_prep) LD50/NNP (l_prep) with/IN (l_pobj) ketamine/NN (l_conj) Innovar/NNP
1167743	T9_T12	NONE	ouabain/NN (r_pobj) of/IN (r_prep) LD50/NNP (l_prep) with/IN (l_prep) than/IN (l_prep) with/IN (l_pobj) pentobarbital/NN
1167743	T10_T12	NONE	ketamine/NN (r_pobj) with/IN (l_prep) than/IN (l_prep) with/IN (l_pobj) pentobarbital/NN
1167743	T11_T12	NONE	Innovar/NNP (r_conj) ketamine/NN (r_pobj) with/IN (l_prep) than/IN (l_prep) with/IN (l_pobj) pentobarbital/NN
1167743	T13_T14	EFFECT	ouabain/NN (r_pobj) by/IN (r_agent) induced/VBN (r_acl) tachycardia/NNS (r_nsubjpass) converted/VBN (l_prep) following/VBG (l_pobj) administration/NN (l_prep) of/IN (l_pobj) Innovar/NNP
1167743	T13_T15	EFFECT	ouabain/NN (r_pobj) by/IN (r_agent) induced/VBN (r_acl) tachycardia/NNS (r_nsubjpass) converted/VBN (l_prep) following/VBG (l_pobj) administration/NN (l_prep) of/IN (l_pobj) Innovar/NNP (l_conj) ketamine/NN
1167743	T13_T16	EFFECT	ouabain/NN (r_pobj) by/IN (r_agent) induced/VBN (r_acl) tachycardia/NNS (r_nsubjpass) converted/VBN (l_prep) following/VBG (l_pobj) administration/NN (l_prep) of/IN (l_pobj) Innovar/NNP (l_conj) ketamine/NN (l_conj) droperidol/NN
1167743	T13_T17	NONE	ouabain/NN (r_pobj) by/IN (r_agent) induced/VBN (r_acl) tachycardia/NNS (r_nsubjpass) converted/VBN (l_conj) after/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) fentayl/JJ
1167743	T13_T18	NONE	ouabain/NN (r_pobj) by/IN (r_agent) induced/VBN (r_acl) tachycardia/NNS (r_nsubjpass) converted/VBN (l_conj) after/IN (l_pobj) administration/NN (l_advmod) alone/RB (l_conj) after/IN (l_pobj) pentobarbital/NN
1167743	T14_T17	NONE	Innovar/NNP (r_pobj) of/IN (r_prep) administration/NN (r_pobj) following/VBG (r_prep) converted/VBN (l_conj) after/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) fentayl/JJ
1167743	T14_T18	NONE	Innovar/NNP (r_pobj) of/IN (r_prep) administration/NN (r_pobj) following/VBG (r_prep) converted/VBN (l_conj) after/IN (l_pobj) administration/NN (l_advmod) alone/RB (l_conj) after/IN (l_pobj) pentobarbital/NN
1167743	T15_T17	NONE	ketamine/NN (r_conj) Innovar/NNP (r_pobj) of/IN (r_prep) administration/NN (r_pobj) following/VBG (r_prep) converted/VBN (l_conj) after/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) fentayl/JJ
1167743	T15_T18	NONE	ketamine/NN (r_conj) Innovar/NNP (r_pobj) of/IN (r_prep) administration/NN (r_pobj) following/VBG (r_prep) converted/VBN (l_conj) after/IN (l_pobj) administration/NN (l_advmod) alone/RB (l_conj) after/IN (l_pobj) pentobarbital/NN
1167743	T16_T17	NONE	droperidol/NN (r_conj) ketamine/NN (r_conj) Innovar/NNP (r_pobj) of/IN (r_prep) administration/NN (r_pobj) following/VBG (r_prep) converted/VBN (l_conj) after/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) fentayl/JJ
1167743	T16_T18	NONE	droperidol/NN (r_conj) ketamine/NN (r_conj) Innovar/NNP (r_pobj) of/IN (r_prep) administration/NN (r_pobj) following/VBG (r_prep) converted/VBN (l_conj) after/IN (l_pobj) administration/NN (l_advmod) alone/RB (l_conj) after/IN (l_pobj) pentobarbital/NN
1167743	T17_T18	NONE	fentayl/JJ (r_pobj) of/IN (r_prep) administration/NN (l_advmod) alone/RB (l_conj) after/IN (l_pobj) pentobarbital/NN
2857099	T1_T2	EFFECT	picrotoxin/NN (r_nsubj) removes/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) diazepam/NN
2857099	T1_T3	EFFECT	picrotoxin/NN (r_nsubj) removes/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) diazepam/NN (l_conj) phenazepam/NN
2857099	T1_T4	EFFECT	picrotoxin/NN (r_nsubj) removes/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) diazepam/NN (l_conj) phenazepam/NN (l_conj) phenibut/NN
2857099	T1_T5	EFFECT	picrotoxin/NN (r_nsubj) removes/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) diazepam/NN (l_conj) phenazepam/NN (l_conj) phenibut/NN (l_conj) amizyl/NNS
2857099	T1_T6	EFFECT	picrotoxin/NN (r_nsubj) removes/VBZ (l_conj) reduces/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) phentolamine/NN
2857099	T2_T6	NONE	diazepam/NN (r_pobj) of/IN (r_prep) action/NN (r_dobj) removes/VBZ (l_conj) reduces/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) phentolamine/NN
2857099	T3_T6	NONE	phenazepam/NN (r_conj) diazepam/NN (r_pobj) of/IN (r_prep) action/NN (r_dobj) removes/VBZ (l_conj) reduces/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) phentolamine/NN
2857099	T4_T6	NONE	phenibut/NN (r_conj) phenazepam/NN (r_conj) diazepam/NN (r_pobj) of/IN (r_prep) action/NN (r_dobj) removes/VBZ (l_conj) reduces/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) phentolamine/NN
2857099	T5_T6	NONE	amizyl/NNS (r_conj) phenibut/NN (r_conj) phenazepam/NN (r_conj) diazepam/NN (r_pobj) of/IN (r_prep) action/NN (r_dobj) removes/VBZ (l_conj) reduces/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) phentolamine/NN
3881917	T2_T3	NONE	agents/NNS (l_amod) available/JJ (l_prep) in/IN (l_pobj) States/NNP (l_appos) verapamil/NN
3881917	T2_T4	NONE	agents/NNS (l_amod) available/JJ (l_prep) in/IN (l_pobj) States/NNP (l_appos) verapamil/NN (l_conj) nifedipine/NN
3881917	T2_T5	NONE	agents/NNS (l_amod) available/JJ (l_prep) in/IN (l_pobj) States/NNP (l_appos) verapamil/NN (l_conj) nifedipine/NN (l_conj) diltiazem/NNP
3881917	T6_T8	NONE	verapamil/NN (r_pobj) for/IN (r_prep) characteristics/NNS (r_pobj) by/IN (l_conj) for/IN (l_pobj) nifedipine/NN
3881917	T7_T8	NONE	diltiazem/NN (r_conj) verapamil/NN (r_pobj) for/IN (r_prep) characteristics/NNS (r_pobj) by/IN (l_conj) for/IN (l_pobj) nifedipine/NN
1109248	T1_T2	INT	warfarin/JJ (r_compound) interactions/NNS (l_prep) with/IN (l_pobj) sedatives/NNS
1109248	T3_T4	NONE	anticoagulant/JJ (r_amod) interference/NN (l_prep) by/IN (l_pobj) phenobarbital/JJ
1109248	T3_T5	NONE	anticoagulant/JJ (r_amod) interference/NN (l_prep) by/IN (l_pobj) phenobarbital/JJ (l_conj) secobarbital/JJ
1109248	T3_T6	NONE	anticoagulant/JJ (r_amod) interference/NN (l_prep) by/IN (l_pobj) phenobarbital/JJ (l_conj) secobarbital/JJ (l_conj) glutethimide/NN
1109248	T3_T7	NONE	anticoagulant/JJ (r_amod) interference/NN (l_prep) by/IN (l_pobj) phenobarbital/JJ (l_conj) secobarbital/JJ (l_conj) glutethimide/NN (l_conj) hydrate/NN
1109248	T3_T8	NONE	anticoagulant/JJ (r_amod) interference/NN (l_prep) by/IN (l_pobj) phenobarbital/JJ (l_conj) secobarbital/JJ (l_conj) glutethimide/NN (l_conj) hydrate/NN (l_conj) methaqualone/NN
1109248	T3_T9	NONE	anticoagulant/JJ (r_amod) interference/NN (r_pobj) of/IN (r_prep) intensity/NN (r_nsubjpass) investigated/VBN (l_prep) in/IN (l_pobj) patients/NNS (l_acl) receiving/VBG (l_dobj) therapy/NN (l_compound) coumarin/NN
1109248	T4_T9	NONE	phenobarbital/JJ (r_pobj) by/IN (r_prep) interference/NN (r_pobj) of/IN (r_prep) intensity/NN (r_nsubjpass) investigated/VBN (l_prep) in/IN (l_pobj) patients/NNS (l_acl) receiving/VBG (l_dobj) therapy/NN (l_compound) coumarin/NN
1109248	T5_T9	NONE	secobarbital/JJ (r_conj) phenobarbital/JJ (r_pobj) by/IN (r_prep) interference/NN (r_pobj) of/IN (r_prep) intensity/NN (r_nsubjpass) investigated/VBN (l_prep) in/IN (l_pobj) patients/NNS (l_acl) receiving/VBG (l_dobj) therapy/NN (l_compound) coumarin/NN
1109248	T6_T9	NONE	glutethimide/NN (r_conj) secobarbital/JJ (r_conj) phenobarbital/JJ (r_pobj) by/IN (r_prep) interference/NN (r_pobj) of/IN (r_prep) intensity/NN (r_nsubjpass) investigated/VBN (l_prep) in/IN (l_pobj) patients/NNS (l_acl) receiving/VBG (l_dobj) therapy/NN (l_compound) coumarin/NN
1109248	T7_T9	NONE	hydrate/NN (r_conj) glutethimide/NN (r_conj) secobarbital/JJ (r_conj) phenobarbital/JJ (r_pobj) by/IN (r_prep) interference/NN (r_pobj) of/IN (r_prep) intensity/NN (r_nsubjpass) investigated/VBN (l_prep) in/IN (l_pobj) patients/NNS (l_acl) receiving/VBG (l_dobj) therapy/NN (l_compound) coumarin/NN
1109248	T8_T9	NONE	methaqualone/NN (r_conj) hydrate/NN (r_conj) glutethimide/NN (r_conj) secobarbital/JJ (r_conj) phenobarbital/JJ (r_pobj) by/IN (r_prep) interference/NN (r_pobj) of/IN (r_prep) intensity/NN (r_nsubjpass) investigated/VBN (l_prep) in/IN (l_pobj) patients/NNS (l_acl) receiving/VBG (l_dobj) therapy/NN (l_compound) coumarin/NN
1109248	T11_T14	NONE	phenobarbital/JJ (r_pobj) of/IN (r_prep) administration/NN (r_pobj) during/IN (r_prep) observed/VBN (r_ccomp) was/VBD (l_attr) change/NN (l_prep) during/IN (l_pobj) trials/NNS (l_prep) of/IN (l_pobj) hydrate/NN
1109248	T11_T15	NONE	phenobarbital/JJ (r_pobj) of/IN (r_prep) administration/NN (r_pobj) during/IN (r_prep) observed/VBN (r_ccomp) was/VBD (l_attr) change/NN (l_prep) during/IN (l_pobj) trials/NNS (l_prep) of/IN (l_pobj) hydrate/NN (l_conj) methaqualone/NN
1109248	T12_T14	NONE	secobarbital/JJ (r_conj) phenobarbital/JJ (r_pobj) of/IN (r_prep) administration/NN (r_pobj) during/IN (r_prep) observed/VBN (r_ccomp) was/VBD (l_attr) change/NN (l_prep) during/IN (l_pobj) trials/NNS (l_prep) of/IN (l_pobj) hydrate/NN
1109248	T12_T15	NONE	secobarbital/JJ (r_conj) phenobarbital/JJ (r_pobj) of/IN (r_prep) administration/NN (r_pobj) during/IN (r_prep) observed/VBN (r_ccomp) was/VBD (l_attr) change/NN (l_prep) during/IN (l_pobj) trials/NNS (l_prep) of/IN (l_pobj) hydrate/NN (l_conj) methaqualone/NN
1109248	T13_T14	NONE	glutethimide/NN (r_conj) secobarbital/JJ (r_conj) phenobarbital/JJ (r_pobj) of/IN (r_prep) administration/NN (r_pobj) during/IN (r_prep) observed/VBN (r_ccomp) was/VBD (l_attr) change/NN (l_prep) during/IN (l_pobj) trials/NNS (l_prep) of/IN (l_pobj) hydrate/NN
1109248	T13_T15	NONE	glutethimide/NN (r_conj) secobarbital/JJ (r_conj) phenobarbital/JJ (r_pobj) of/IN (r_prep) administration/NN (r_pobj) during/IN (r_prep) observed/VBN (r_ccomp) was/VBD (l_attr) change/NN (l_prep) during/IN (l_pobj) trials/NNS (l_prep) of/IN (l_pobj) hydrate/NN (l_conj) methaqualone/NN
1109248	T16_T18	ADVISE	Barbiturates/NNS (r_nsubjpass) administered/VBN (l_prep) to/IN (l_pobj) patients/NNS (l_acl) receiving/VBG (l_dobj) drugs/NNS
1109248	T17_T18	ADVISE	glutethimide/NN (r_conj) Barbiturates/NNS (r_nsubjpass) administered/VBN (l_prep) to/IN (l_pobj) patients/NNS (l_acl) receiving/VBG (l_dobj) drugs/NNS
1109248	T19_T21	INT	hydrate/NN (l_conj) interact/VBP (l_prep) with/IN (l_pobj) agents/NNS
1109248	T20_T21	INT	methaqualone/NN (r_conj) hydrate/NN (l_conj) interact/VBP (l_prep) with/IN (l_pobj) agents/NNS
1109248	T22_T24	NONE	hydrate/NN (r_nsubjpass) administered/VBN (l_prep) without/IN (l_pobj) caution/NN (l_prep) in/IN (l_pobj) monitoring/NN (l_prep) during/IN (l_pobj) therapy/NN (l_amod) anticoagulant/NN
1109248	T23_T24	NONE	methaqualone/NN (r_conj) hydrate/NN (r_nsubjpass) administered/VBN (l_prep) without/IN (l_pobj) caution/NN (l_prep) in/IN (l_pobj) monitoring/NN (l_prep) during/IN (l_pobj) therapy/NN (l_amod) anticoagulant/NN
7625885	T2_T3	NONE	E2/NNP (l_appos) diarrhea/NN (l_amod) dmPGE2)-induced/VBN
7625885	T14_T16	EFFECT	Loperamide/NNP (r_nsubj) inhibited/VBD (l_dobj) dmPGE2/NN
7625885	T15_T16	EFFECT	morphine/NN (r_conj) Loperamide/NNP (r_nsubj) inhibited/VBD (l_dobj) dmPGE2/NN
7625885	T18_T19	EFFECT	methyllevallorphan/NNP (r_nsubj) antagonized/VBD (l_dobj) effect/NN (l_prep) of/IN (l_pobj) loperamide/NN
7625885	T18_T20	EFFECT	methyllevallorphan/NNP (r_nsubj) antagonized/VBD (l_conj) antagonized/VBD (l_dobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN
7625885	T19_T20	NONE	loperamide/NN (r_pobj) of/IN (r_prep) effect/NN (r_dobj) antagonized/VBD (l_conj) antagonized/VBD (l_dobj) effect/NN (l_prep) of/IN (l_pobj) morphine/NN
10150268	T2_T3	NONE	fluoroquinolones/NNS (r_nsubj) are/VBP (l_attr) class/NN (l_prep) of/IN (l_pobj) antibiotics/NNS
11148572	T1_T4	NONE	cyclophosphamide/NN (l_conj) doxorubicin/NN (l_conj) vincristine/NN (l_conj) chemotherapy/NN (l_compound) prednisone/JJ
11148572	T1_T5	NONE	cyclophosphamide/NN (l_conj) doxorubicin/NN (l_conj) vincristine/NN (l_conj) chemotherapy/NN (l_conj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T2_T4	NONE	doxorubicin/NN (l_conj) vincristine/NN (l_conj) chemotherapy/NN (l_compound) prednisone/JJ
11148572	T2_T5	NONE	doxorubicin/NN (l_conj) vincristine/NN (l_conj) chemotherapy/NN (l_conj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T3_T4	NONE	vincristine/NN (l_conj) chemotherapy/NN (l_compound) prednisone/JJ
11148572	T3_T5	NONE	vincristine/NN (l_conj) chemotherapy/NN (l_conj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T4_T5	NONE	prednisone/JJ (r_compound) chemotherapy/NN (l_conj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T11_T15	NONE	cyclophosphamide/FW (l_conj) doxorubicin/NN (l_conj) teniposide/NN (l_conj) prednisone/NN (l_prep) with/IN (l_pobj) vincristine/NN
11148572	T11_T16	NONE	cyclophosphamide/FW (l_conj) doxorubicin/NN (l_conj) teniposide/NN (l_conj) prednisone/NN (l_prep) with/IN (l_pobj) vincristine/NN (l_conj) bleomycin/NNS
11148572	T11_T17	NONE	cyclophosphamide/FW (r_appos) regimen/NN (l_prep) without/IN (l_pcomp) receiving/VBG (l_dobj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T12_T15	NONE	doxorubicin/NN (l_conj) teniposide/NN (l_conj) prednisone/NN (l_prep) with/IN (l_pobj) vincristine/NN
11148572	T12_T16	NONE	doxorubicin/NN (l_conj) teniposide/NN (l_conj) prednisone/NN (l_prep) with/IN (l_pobj) vincristine/NN (l_conj) bleomycin/NNS
11148572	T12_T17	NONE	doxorubicin/NN (r_conj) cyclophosphamide/FW (r_appos) regimen/NN (l_prep) without/IN (l_pcomp) receiving/VBG (l_dobj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T13_T15	NONE	teniposide/NN (l_conj) prednisone/NN (l_prep) with/IN (l_pobj) vincristine/NN
11148572	T13_T16	NONE	teniposide/NN (l_conj) prednisone/NN (l_prep) with/IN (l_pobj) vincristine/NN (l_conj) bleomycin/NNS
11148572	T13_T17	NONE	teniposide/NN (r_conj) doxorubicin/NN (r_conj) cyclophosphamide/FW (r_appos) regimen/NN (l_prep) without/IN (l_pcomp) receiving/VBG (l_dobj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T14_T15	NONE	prednisone/NN (l_prep) with/IN (l_pobj) vincristine/NN
11148572	T14_T16	NONE	prednisone/NN (l_prep) with/IN (l_pobj) vincristine/NN (l_conj) bleomycin/NNS
11148572	T14_T17	NONE	prednisone/NN (r_conj) teniposide/NN (r_conj) doxorubicin/NN (r_conj) cyclophosphamide/FW (r_appos) regimen/NN (l_prep) without/IN (l_pcomp) receiving/VBG (l_dobj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T15_T17	NONE	vincristine/NN (r_pobj) with/IN (r_prep) prednisone/NN (r_conj) teniposide/NN (r_conj) doxorubicin/NN (r_conj) cyclophosphamide/FW (r_appos) regimen/NN (l_prep) without/IN (l_pcomp) receiving/VBG (l_dobj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T16_T17	NONE	bleomycin/NNS (r_conj) vincristine/NN (r_pobj) with/IN (r_prep) prednisone/NN (r_conj) teniposide/NN (r_conj) doxorubicin/NN (r_conj) cyclophosphamide/FW (r_appos) regimen/NN (l_prep) without/IN (l_pcomp) receiving/VBG (l_dobj) therapy/NN (l_amod) antiretroviral/JJ
11148572	T18_T19	NONE	Antiretroviral/JJ (r_amod) regimens/NNS (r_nsubj) consisted/VBD (l_prep) of/IN (l_pobj) inhibitors/NNS
11148572	T18_T20	NONE	Antiretroviral/JJ (r_amod) regimens/NNS (r_nsubj) consisted/VBD (l_prep) of/IN (l_pobj) inhibitors/NNS (l_conj) inhibitor/NN
11148572	T21_T22	ADVISE	drugs/NNS
11121387	T5_T6	EFFECT	D/NN (r_nsubj) blocked/VBD (l_dobj) effect/NN (l_prep) of/IN (l_pobj) carbachol/NN
11121387	T7_T8	EFFECT	D/NNP (r_nsubj) inhibited/VBD (l_dobj) concentration/NN (l_amod) stimulated/VBN (l_npadvmod) carbachol/NN
7654327	T3_T4	NONE	D3/NNP (l_appos) 1,25(OH)2D3/CD
7654327	T3_T5	NONE	D3/NNP (l_appos) metabolite/NN (l_prep) of/IN (l_pobj) D/NN
7654327	T4_T5	NONE	1,25(OH)2D3/CD (r_appos) D3/NNP (l_appos) metabolite/NN (l_prep) of/IN (l_pobj) D/NN
7654327	T7_T8	NONE	1,25(OH)2D3/CD (l_conj) TAM/NNP (l_nmod) antiestrogen/NN
7654327	T7_T9	NONE	1,25(OH)2D3/CD (l_conj) TAM/NNP (l_nmod) 4-hydroxytamoxifen/CD
7654327	T8_T9	NONE	antiestrogen/NN (r_nmod) TAM/NNP (l_nmod) 4-hydroxytamoxifen/CD
7654327	T8_T10	NONE	antiestrogen/NN (r_nmod) TAM/NNP
7654327	T9_T10	NONE	4-hydroxytamoxifen/CD (r_nmod) TAM/NNP
7654327	T11_T12	EFFECT	TAM/NNP (r_nsubj) potentiates/VBZ (l_dobj) reduction/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) 1,25(OH)2D3/CD
7654327	T13_T14	EFFECT	1,25(OH)2D3/CD (r_pobj) with/IN (r_prep) treatment/NN (r_nsubj) enhances/VBZ (l_nsubj) TAM/NNP
7654327	T18_T19	NONE	D/NN (r_npadvmod) mediated/VBN (r_amod) signalling/NN (l_conj) disruption/NN (l_prep) of/IN (l_pobj) signalling/NN (l_amod) dependent/JJ (l_npadvmod) estrogen/NN
16649344	T1_T2	NONE	Sirolimus/NN (l_appos) target/NN (l_prep) of/IN (l_pobj) inhibitor/NN (l_compound) rapamycin/NNS
16649344	T3_T4	NONE	Sirolimus/NNP (r_nsubj) works/VBZ (l_prep) from/IN (l_pobj) immunosuppressants/NNS
16649344	T3_T6	NONE	Sirolimus/NNP (r_nsubj) works/VBZ (l_conj) appear/VB (l_xcomp) overlap/VB (l_prep) to/IN (l_pobj) extent/NN (l_prep) with/IN (l_pobj) that/DT (l_acl) associated/VBN (l_prep) with/IN (l_pobj) cyclosporine/NN
16649344	T3_T7	NONE	Sirolimus/NNP (r_nsubj) works/VBZ (l_conj) appear/VB (l_xcomp) overlap/VB (l_prep) to/IN (l_pobj) extent/NN (l_prep) with/IN (l_pobj) that/DT (l_acl) associated/VBN (l_prep) with/IN (l_pobj) cyclosporine/NN (l_conj) tacrolimus/NN
16649344	T4_T5	NONE	immunosuppressants/NNS (r_pobj) from/IN (r_prep) works/VBZ (l_conj) appear/VB (l_nsubj) profile/NN (l_prep) of/IN (l_pobj) sirolimus/NN
16649344	T4_T6	NONE	immunosuppressants/NNS (r_pobj) from/IN (r_prep) works/VBZ (l_conj) appear/VB (l_xcomp) overlap/VB (l_prep) to/IN (l_pobj) extent/NN (l_prep) with/IN (l_pobj) that/DT (l_acl) associated/VBN (l_prep) with/IN (l_pobj) cyclosporine/NN
16649344	T4_T7	NONE	immunosuppressants/NNS (r_pobj) from/IN (r_prep) works/VBZ (l_conj) appear/VB (l_xcomp) overlap/VB (l_prep) to/IN (l_pobj) extent/NN (l_prep) with/IN (l_pobj) that/DT (l_acl) associated/VBN (l_prep) with/IN (l_pobj) cyclosporine/NN (l_conj) tacrolimus/NN
16649344	T5_T6	NONE	sirolimus/NN (r_pobj) of/IN (r_prep) profile/NN (r_nsubj) appear/VB (l_xcomp) overlap/VB (l_prep) to/IN (l_pobj) extent/NN (l_prep) with/IN (l_pobj) that/DT (l_acl) associated/VBN (l_prep) with/IN (l_pobj) cyclosporine/NN
16649344	T5_T7	NONE	sirolimus/NN (r_pobj) of/IN (r_prep) profile/NN (r_nsubj) appear/VB (l_xcomp) overlap/VB (l_prep) to/IN (l_pobj) extent/NN (l_prep) with/IN (l_pobj) that/DT (l_acl) associated/VBN (l_prep) with/IN (l_pobj) cyclosporine/NN (l_conj) tacrolimus/NN
16649344	T8_T9	NONE	sirolimus/NN (r_nsubj) have/VB (l_prep) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) cyclosporine/NN
16649344	T8_T10	NONE	sirolimus/NN (r_nsubj) have/VB (l_prep) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) cyclosporine/NN (l_conj) tacrolimus/NN
16649344	T8_T11	NONE	sirolimus/NN (r_nsubj) have/VB (l_conj) reductions/NNS (l_prep) in/IN (l_pobj) cyclosporine/NN
16649344	T8_T12	NONE	sirolimus/NN (r_nsubj) have/VB (l_conj) reductions/NNS (l_prep) in/IN (l_pobj) cyclosporine/NN (l_conj) dosage/NN (l_compound) tacrolimus/NN
16649344	T9_T12	NONE	cyclosporine/NN (r_pobj) with/IN (r_prep) combination/NN (r_pobj) in/IN (r_prep) have/VB (l_conj) reductions/NNS (l_prep) in/IN (l_pobj) cyclosporine/NN (l_conj) dosage/NN (l_compound) tacrolimus/NN
16649344	T10_T11	NONE	tacrolimus/NN (r_conj) cyclosporine/NN (r_pobj) with/IN (r_prep) combination/NN (r_pobj) in/IN (r_prep) have/VB (l_conj) reductions/NNS (l_prep) in/IN (l_pobj) cyclosporine/NN
16649344	T11_T12	NONE	cyclosporine/NN (l_conj) dosage/NN (l_compound) tacrolimus/NN
163470	T1_T2	NONE	radiopertechnetate/NN (r_pobj) of/IN (r_prep) displacement/NN (l_prep) by/IN (l_pobj) perchlorate/NN
163470	T3_T4	NONE	perchlorate/NN (r_pobj) of/IN (r_prep) doses/NNS (l_conj) scale/NN (l_prep) of/IN (l_pobj) displacement/NN (l_prep) of/IN (l_pobj) radiopertechnetate/NN
163470	T5_T6	NONE	perchlorate/NN (r_pobj) of/IN (r_prep) dose/NN (r_nsubj) was/VBD (l_advcl) concentrating/VBG (l_dobj) pertechnetate/JJ
163470	T5_T7	NONE	perchlorate/NN (r_pobj) of/IN (r_prep) dose/NN (r_nsubj) was/VBD (l_advcl) concentrating/VBG (l_advcl) effective/JJ (l_prep) as/IN (l_pobj) ClO-4-/NNPS (l_conj) min/NN (l_prep) before/IN (l_pobj) injection/NN (l_prep) of/IN (l_pobj) radiopertechnetate/NN
163470	T6_T7	NONE	pertechnetate/JJ (r_dobj) concentrating/VBG (l_advcl) effective/JJ (l_prep) as/IN (l_pobj) ClO-4-/NNPS (l_conj) min/NN (l_prep) before/IN (l_pobj) injection/NN (l_prep) of/IN (l_pobj) radiopertechnetate/NN
163470	T8_T9	MECHANISM	perchlorate/NN (r_pobj) of/IN (r_prep) injection/NN (r_nsubj) produces/VBZ (l_dobj) depletion/NN (l_prep) of/IN (l_pobj) pertechnetate/NN
2857100	T1_T2	NONE	cerulein/NN (r_pobj) by/IN (r_prep) Stimulation/NN (l_appos) analog/NN (l_prep) of/IN (l_pobj) cholecystokinin/NN (l_prep) of/IN (l_pobj) binding/NN (l_compound) spiroperidol/NN
2857100	T1_T3	NONE	cerulein/NN (r_pobj) by/IN (r_prep) Stimulation/NN (l_appos) analog/NN (l_prep) after/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) neuroleptics/NNS
2857100	T2_T3	NONE	spiroperidol/NN (r_compound) binding/NN (r_pobj) of/IN (r_prep) cholecystokinin/NN (r_pobj) of/IN (r_prep) analog/NN (l_prep) after/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) neuroleptics/NNS
2857100	T4_T6	NONE	haloperidol/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) resulted/VBD (l_prep) in/IN (l_pobj) interaction/NN (l_prep) between/IN (l_pobj) sites/NNS (l_nmod) spiroperidol/NNS
2857100	T4_T7	NONE	haloperidol/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) resulted/VBD (l_prep) in/IN (l_pobj) interaction/NN (l_prep) between/IN (l_pobj) sites/NNS (l_prep) for/IN (l_pobj) apomorphine/NN
2857100	T4_T8	NONE	haloperidol/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) resulted/VBD (l_advcl) increased/VBD (l_nsubj) binding/VBG (l_compound) spiroperidol/NN
2857100	T4_T9	NONE	haloperidol/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) resulted/VBD (l_advcl) increased/VBD (l_nsubj) binding/VBG (l_prep) with/IN (l_pobj) sites/NNS (l_prep) for/IN (l_pobj) apomorphine/NN
2857100	T5_T6	NONE	pyreneperone/NN (r_conj) haloperidol/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) resulted/VBD (l_prep) in/IN (l_pobj) interaction/NN (l_prep) between/IN (l_pobj) sites/NNS (l_nmod) spiroperidol/NNS
2857100	T5_T7	NONE	pyreneperone/NN (r_conj) haloperidol/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) resulted/VBD (l_prep) in/IN (l_pobj) interaction/NN (l_prep) between/IN (l_pobj) sites/NNS (l_prep) for/IN (l_pobj) apomorphine/NN
2857100	T5_T8	NONE	pyreneperone/NN (r_conj) haloperidol/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) resulted/VBD (l_advcl) increased/VBD (l_nsubj) binding/VBG (l_compound) spiroperidol/NN
2857100	T5_T9	NONE	pyreneperone/NN (r_conj) haloperidol/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) resulted/VBD (l_advcl) increased/VBD (l_nsubj) binding/VBG (l_prep) with/IN (l_pobj) sites/NNS (l_prep) for/IN (l_pobj) apomorphine/NN
2857100	T6_T7	NONE	spiroperidol/NNS (r_nmod) sites/NNS (l_prep) for/IN (l_pobj) apomorphine/NN
2857100	T6_T9	NONE	spiroperidol/NNS (r_nmod) sites/NNS (r_pobj) between/IN (r_prep) interaction/NN (r_pobj) in/IN (r_prep) resulted/VBD (l_advcl) increased/VBD (l_nsubj) binding/VBG (l_prep) with/IN (l_pobj) sites/NNS (l_prep) for/IN (l_pobj) apomorphine/NN
2857100	T7_T8	NONE	apomorphine/NN (r_pobj) for/IN (r_prep) sites/NNS (r_pobj) between/IN (r_prep) interaction/NN (r_pobj) in/IN (r_prep) resulted/VBD (l_advcl) increased/VBD (l_nsubj) binding/VBG (l_compound) spiroperidol/NN
2857100	T8_T9	NONE	spiroperidol/NN (r_compound) binding/VBG (l_prep) with/IN (l_pobj) sites/NNS (l_prep) for/IN (l_pobj) apomorphine/NN
2857100	T10_T11	NONE	neuroleptics/NNS (r_pobj) of/IN (r_prep) administration/NN (l_conj) effect/NN (l_prep) of/IN (l_pobj) cerulein/NN
2857100	T10_T12	NONE	neuroleptics/NNS (r_pobj) of/IN (r_prep) administration/NN (r_pobj) After/IN (r_prep) replaced/VBN (l_agent) by/IN (l_pobj) action/NN (l_prep) on/IN (l_pobj) binding/NN (l_compound) spiroperidol/NN
2857100	T11_T12	NONE	cerulein/NN (r_pobj) of/IN (r_prep) effect/NN (r_conj) administration/NN (r_pobj) After/IN (r_prep) replaced/VBN (l_agent) by/IN (l_pobj) action/NN (l_prep) on/IN (l_pobj) binding/NN (l_compound) spiroperidol/NN
2857100	T13_T14	NONE	spiroperidol/NNS (r_nmod) sites/NNS (l_prep) for/IN (l_pobj) apomorphine/NN
2857100	T13_T15	NONE	spiroperidol/NNS (r_nmod) sites/NNS (r_pobj) between/IN (r_prep) interaction/NN (r_nsubj) underlies/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) neuroleptics/NNS
2857100	T14_T15	NONE	apomorphine/NN (r_pobj) for/IN (r_prep) sites/NNS (r_pobj) between/IN (r_prep) interaction/NN (r_nsubj) underlies/VBZ (l_dobj) action/NN (l_prep) of/IN (l_pobj) neuroleptics/NNS
7600639	T1_T2	NONE	estradiol/NN (r_pobj) of/IN (r_prep) Effect/NN (l_prep) on/IN (l_pobj) changes/NNS (l_amod) induced/VBN (l_npadvmod) endotoxin/NN
7600639	T3_T4	NONE	estradiol/NN (r_pobj) of/IN (r_prep) effect/NN (l_prep) on/IN (l_pobj) changes/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) endotoxin/NN
7600639	T3_T5	NONE	estradiol/NN (r_pobj) of/IN (r_prep) effect/NN (l_prep) on/IN (l_pobj) changes/NNS (l_acl) induced/VBN (l_agent) by/IN (l_pobj) dose/NN (l_prep) of/IN (l_pobj) endotoxin/NN (l_conj) deaths/NNS (l_amod) due/IN (l_pobj) doses/NNS (l_prep) of/IN (l_pobj) endotoxin/NN
7600639	T6_T7	EFFECT	estradiol/NN (r_pobj) of/IN (r_prep) Injection/NN (r_nsubj) min/NN (l_advcl) changed/VBD (l_nsubj) dose/NN (l_prep) of/IN (l_pobj) endotoxin/NN
7600639	T6_T8	NONE	estradiol/NN (r_pobj) of/IN (r_prep) Injection/NN (r_nsubj) min/NN (l_advcl) changed/VBD (l_dobj) response/NN (l_prep) to/IN (l_pobj) endotoxin/NN
7600639	T9_T10	MECHANISM	estradiol/NN (r_pobj) of/IN (r_prep) concentrations/NNS (l_conj) rats/NNS (l_amod) treated/VBN (l_npadvmod) endotoxin/NN
7600639	T9_T11	NONE	estradiol/NN (r_pobj) of/IN (r_prep) concentrations/NNS (r_nsubj) decreased/VBD (l_advcl) increased/VBD (l_nsubj) those/DT (l_prep) of/IN (l_pobj) rats/NNS (l_amod) treated/VBN (l_npadvmod) endotoxin/NN
7600639	T12_T13	NONE	estradiol/NN (r_pobj) of/IN (r_prep) concentrations/NNS (l_conj) rats/NNS (l_amod) treated/VBN (l_npadvmod) endotoxin/NN
7600639	T12_T14	NONE	estradiol/NN (r_pobj) of/IN (r_prep) concentrations/NNS (r_nsubj) change/VB (l_advcl) dropped/VBD (l_nsubj) those/DT (l_prep) of/IN (l_pobj) rats/NNS (l_amod) treated/VBN (l_npadvmod) endotoxin/NN
7600639	T15_T16	EFFECT	estradiol/NN (r_nsubj) appeared/VBD (l_xcomp) influence/VB (l_dobj) percentage/NN (l_prep) of/IN (l_pobj) deaths/NNS (l_amod) induced/VBN (l_npadvmod) endotoxin/NN
11210403	T3_T5	MECHANISM	trovafloxacin/NN (r_pobj) of/IN (r_prep) bioavailability/NN (r_pobj) in/IN (r_prep) reduction/NN (r_dobj) demonstrated/VBN (l_advcl) administered/VBN (l_prep) with/IN (l_pobj) opiate/NN
11210403	T3_T6	MECHANISM	trovafloxacin/NN (r_pobj) of/IN (r_prep) bioavailability/NN (r_pobj) in/IN (r_prep) reduction/NN (r_dobj) demonstrated/VBN (l_advcl) administered/VBN (l_prep) with/IN (l_pobj) opiate/NN (l_prep) as/IN (l_pobj) morphine/NN
11210403	T4_T5	MECHANISM	ciprofloxacin/NNS (r_conj) trovafloxacin/NN (r_pobj) of/IN (r_prep) bioavailability/NN (r_pobj) in/IN (r_prep) reduction/NN (r_dobj) demonstrated/VBN (l_advcl) administered/VBN (l_prep) with/IN (l_pobj) opiate/NN
11210403	T4_T6	MECHANISM	ciprofloxacin/NNS (r_conj) trovafloxacin/NN (r_pobj) of/IN (r_prep) bioavailability/NN (r_pobj) in/IN (r_prep) reduction/NN (r_dobj) demonstrated/VBN (l_advcl) administered/VBN (l_prep) with/IN (l_pobj) opiate/NN (l_prep) as/IN (l_pobj) morphine/NN
11210403	T5_T6	NONE	opiate/NN (l_prep) as/IN (l_pobj) morphine/NN
11210403	T11_T12	NONE	oxycodone/NN (r_dobj) receive/VB (l_dobj) Q4H/NNP (l_conj) levofloxacin/VBZ
11210403	T11_T14	NONE	oxycodone/NN (r_dobj) receive/VB (r_relcl) study/NN (r_pobj) in/IN (r_prep) randomized/VBN (l_prep) after/IN (l_pcomp) starting/VBG (l_conj) levofloxacin/VBZ
11210403	T12_T13	NONE	levofloxacin/VBZ (r_conj) Q4H/NNP (r_dobj) receive/VB (r_relcl) study/NN (r_pobj) in/IN (r_prep) randomized/VBN (l_prep) after/IN (l_pcomp) starting/VBG (l_dobj) oxycodone/NN
11210403	T13_T14	NONE	oxycodone/NN (r_dobj) starting/VBG (l_conj) levofloxacin/VBZ
11210403	T15_T17	NONE	levofloxacin/JJ (l_prep) versus/FW (l_pobj) regimens/NNS (l_compound) oxycodone/NN
11210403	T16_T17	NONE	levofloxacin/JJ (r_amod) regimens/NNS (l_compound) oxycodone/NN
11206048	T3_T4	NONE	phenytoin/NNP (r_pobj) of/IN (r_prep) concentration/NN (r_nsubj) increased/VBD (l_advcl) coadministered/VBN (l_nsubjpass) fluvoxamine/NNP
11206048	T3_T6	NONE	phenytoin/NNP (r_pobj) of/IN (r_prep) concentration/NN (r_nsubj) increased/VBD (l_advcl) changed/VBN (l_nsubj) dosage/NN (l_prep) of/IN (l_pobj) phenytoin/JJ (l_conj) drugs/NNS
11206048	T4_T5	NONE	fluvoxamine/NNP (r_nsubjpass) coadministered/VBN (r_advcl) increased/VBD (l_advcl) changed/VBN (l_nsubj) dosage/NN (l_prep) of/IN (l_pobj) phenytoin/JJ
11206048	T4_T6	NONE	fluvoxamine/NNP (r_nsubjpass) coadministered/VBN (r_advcl) increased/VBD (l_advcl) changed/VBN (l_nsubj) dosage/NN (l_prep) of/IN (l_pobj) phenytoin/JJ (l_conj) drugs/NNS
11206048	T11_T12	NONE	CYP2C9/NNS (r_pobj) of/IN (r_prep) inhibition/NN (l_prep) by/IN (l_pobj) fluvoxamine/NN
10226677	T1_T2	NONE	contraceptives/NNS (l_appos) POC/NNP
10226677	T1_T3	NONE	contraceptives/NNS (r_pobj) of/IN (r_prep) labeling/NN (r_pobj) for/IN (r_prep) information/NN (r_dobj) provide/VB (r_acl) order/NN (r_pobj) In/IN (r_prep) made/VBN (l_prep) of/IN (l_pobj) norgestrel/NN
10226677	T1_T4	NONE	contraceptives/NNS (r_pobj) of/IN (r_prep) labeling/NN (r_pobj) for/IN (r_prep) information/NN (r_dobj) provide/VB (r_acl) order/NN (r_pobj) In/IN (r_prep) made/VBN (l_prep) of/IN (l_pobj) norgestrel/NN (l_conj) norethindrone/NN
10226677	T2_T3	NONE	POC/NNP (r_appos) contraceptives/NNS (r_pobj) of/IN (r_prep) labeling/NN (r_pobj) for/IN (r_prep) information/NN (r_dobj) provide/VB (r_acl) order/NN (r_pobj) In/IN (r_prep) made/VBN (l_prep) of/IN (l_pobj) norgestrel/NN
10226677	T2_T4	NONE	POC/NNP (r_appos) contraceptives/NNS (r_pobj) of/IN (r_prep) labeling/NN (r_pobj) for/IN (r_prep) information/NN (r_dobj) provide/VB (r_acl) order/NN (r_pobj) In/IN (r_prep) made/VBN (l_prep) of/IN (l_pobj) norgestrel/NN (l_conj) norethindrone/NN
7746025	T2_T4	NONE	caffeine/NN (l_conj) theophylline/NN (l_punct) ,/, (l_punct) 8-phenyltheophylline/NN
7746025	T2_T6	NONE	caffeine/NN (l_conj) theophylline/NN (l_conj) 8-cyclopentyl-1,3-dipropylxanthine/NNP (l_appos) DPCPX/NNP
7746025	T3_T4	NONE	theophylline/NN (l_punct) ,/, (l_punct) 8-phenyltheophylline/NN
7746025	T3_T6	NONE	theophylline/NN (l_conj) 8-cyclopentyl-1,3-dipropylxanthine/NNP (l_appos) DPCPX/NNP
7746025	T4_T5	NONE	8-phenyltheophylline/NN (r_punct) ,/, (r_punct) theophylline/NN (l_conj) 8-cyclopentyl-1,3-dipropylxanthine/NNP
7746025	T4_T6	NONE	8-phenyltheophylline/NN (r_punct) ,/, (r_punct) theophylline/NN (l_conj) 8-cyclopentyl-1,3-dipropylxanthine/NNP (l_appos) DPCPX/NNP
7746025	T5_T6	NONE	8-cyclopentyl-1,3-dipropylxanthine/NNP (l_appos) DPCPX/NNP
7746025	T7_T8	EFFECT	theophylline/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) reduced/VBN (l_agent) by/IN (l_pobj) pretreatment/NN (l_prep) with/IN (l_pobj) CGS/NNP (l_nummod) 21680/CD
7746025	T7_T9	NONE	theophylline/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) reduced/VBN (l_agent) by/IN (l_pobj) pretreatment/NN (l_prep) with/IN (l_pobj) CGS/NNP (l_appos) agonist/NN (l_conj) by/IN (l_pobj) N6-cyclopentyladenosine/NNP
7746025	T7_T10	NONE	theophylline/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) reduced/VBN (l_agent) by/IN (l_pobj) pretreatment/NN (l_prep) with/IN (l_pobj) CGS/NNP (l_appos) agonist/NN (l_conj) by/IN (l_pobj) N6-cyclopentyladenosine/NNP (l_appos) CPA/NNP
7746025	T8_T9	NONE	21680/CD (r_nummod) CGS/NNP (l_appos) agonist/NN (l_conj) by/IN (l_pobj) N6-cyclopentyladenosine/NNP
7746025	T8_T10	NONE	21680/CD (r_nummod) CGS/NNP (l_appos) agonist/NN (l_conj) by/IN (l_pobj) N6-cyclopentyladenosine/NNP (l_appos) CPA/NNP
7746025	T9_T10	NONE	N6-cyclopentyladenosine/NNP (l_appos) CPA/NNP
7746025	T11_T12	EFFECT	theophylline/RB (r_advmod) induced/VBN (r_amod) effects/NNS (l_prep) by/IN (l_pobj) CGS21680/NNP
7746025	T11_T13	NONE	theophylline/RB (r_advmod) induced/VBN (r_amod) effects/NNS (r_pobj) of/IN (r_prep) antagonism/NN (r_nsubjpass) observed/VBN (l_conj) reversed/VBN (l_nsubjpass) effects/NNS (l_amod) induced/VBN (l_npadvmod) DPCPX/NNP
7746025	T11_T14	NONE	theophylline/RB (r_advmod) induced/VBN (r_amod) effects/NNS (r_pobj) of/IN (r_prep) antagonism/NN (r_nsubjpass) observed/VBN (l_conj) reversed/VBN (l_agent) by/IN (l_pobj) CGS/NNP (l_nummod) 21680/CD
7746025	T11_T15	NONE	theophylline/RB (r_advmod) induced/VBN (r_amod) effects/NNS (r_pobj) of/IN (r_prep) antagonism/NN (r_nsubjpass) observed/VBN (l_conj) reversed/VBN (l_agent) by/IN (l_pobj) CGS/NNP (l_conj) by/IN (l_pobj) CPA/NN
7746025	T12_T13	NONE	CGS21680/NNP (r_pobj) by/IN (r_prep) effects/NNS (r_pobj) of/IN (r_prep) antagonism/NN (r_nsubjpass) observed/VBN (l_conj) reversed/VBN (l_nsubjpass) effects/NNS (l_amod) induced/VBN (l_npadvmod) DPCPX/NNP
7746025	T12_T14	NONE	CGS21680/NNP (r_pobj) by/IN (r_prep) effects/NNS (r_pobj) of/IN (r_prep) antagonism/NN (r_nsubjpass) observed/VBN (l_conj) reversed/VBN (l_agent) by/IN (l_pobj) CGS/NNP (l_nummod) 21680/CD
7746025	T12_T15	NONE	CGS21680/NNP (r_pobj) by/IN (r_prep) effects/NNS (r_pobj) of/IN (r_prep) antagonism/NN (r_nsubjpass) observed/VBN (l_conj) reversed/VBN (l_agent) by/IN (l_pobj) CGS/NNP (l_conj) by/IN (l_pobj) CPA/NN
7746025	T13_T14	NONE	DPCPX/NNP (r_npadvmod) induced/VBN (r_amod) effects/NNS (r_nsubjpass) reversed/VBN (l_agent) by/IN (l_pobj) CGS/NNP (l_nummod) 21680/CD
7746025	T13_T15	NONE	DPCPX/NNP (r_npadvmod) induced/VBN (r_amod) effects/NNS (r_nsubjpass) reversed/VBN (l_agent) by/IN (l_pobj) CGS/NNP (l_conj) by/IN (l_pobj) CPA/NN
7746025	T14_T15	NONE	21680/CD (r_nummod) CGS/NNP (l_conj) by/IN (l_pobj) CPA/NN
11180036	T1_T2	MECHANISM	diltiazem/NN (l_conj) sirolimus/NN
11180036	T3_T4	NONE	sirolimus/NN (r_pobj) between/IN (r_prep) interaction/NN (r_nsubjpass) studied/VBN (l_nsubjpass) immunosuppressant/NN
11180036	T3_T5	NONE	sirolimus/NN (r_pobj) between/IN (r_prep) interaction/NN (r_nsubjpass) studied/VBN (l_nsubjpass) immunosuppressant/NN (l_conj) channel/NN (l_appos) diltiazem/NNP (l_compound) blocker/NN
11180036	T3_T6	NONE	sirolimus/NN (r_pobj) between/IN (r_prep) interaction/NN (r_nsubjpass) studied/VBN (l_nsubjpass) immunosuppressant/NN (l_conj) channel/NN (l_appos) diltiazem/NNP
11180036	T4_T5	NONE	immunosuppressant/NN (l_conj) channel/NN (l_appos) diltiazem/NNP (l_compound) blocker/NN
11180036	T4_T6	NONE	immunosuppressant/NN (l_conj) channel/NN (l_appos) diltiazem/NNP
11180036	T5_T6	NONE	blocker/NN (r_compound) diltiazem/NNP
11180036	T7_T8	NONE	drugs/NNS (l_relcl) metabolized/VBN (l_agent) by/IN (l_conj) for/IN (l_pobj) antagonists/NNS
11180036	T9_T10	NONE	sirolimus/NN (r_pobj) of/IN (r_prep) dose/NN (r_pobj) of/IN (r_prep) pharmacokinetics/NNS (r_pobj) of/IN (r_prep) study/NN (r_pobj) in/IN (r_prep) participated/VBD (l_appos) dose/NN (l_prep) of/IN (l_pobj) diltiazem/NN
11180036	T11_T12	MECHANISM	sirolimus/NN (r_compound) area/NN (r_nsubj) increased/VBD (l_conj) increased/VBD (l_prep) with/IN (l_pobj) coadministration/NN (l_compound) diltiazem/NN
11180036	T12_T13	NONE	diltiazem/NN (r_compound) coadministration/NN (r_pobj) with/IN (r_prep) increased/VBD (l_advcl) decreased/VBD (l_nsubj) life/NN (l_prep) of/IN (l_pobj) sirolimus/NN
11180036	T14_T16	NONE	sirolimus/NN (r_pobj) of/IN (r_prep) distribution/NN (r_pobj) of/IN (r_prep) volume/NN (r_conj) clearance/NN (r_nsubj) decreased/VBD (l_prep) with/IN (l_pobj) %/NN (l_relcl) given/VBN (l_prep) with/IN (l_pobj) diltiazem/NN
11180036	T15_T16	MECHANISM	sirolimus/NN (r_nsubjpass) given/VBN (l_prep) with/IN (l_pobj) diltiazem/NN
11180036	T17_T20	NONE	diltiazem/NN (r_pobj) of/IN (r_prep) curve/NN (r_pobj) under/IN (r_prep) concentration/NN (r_nsubj) were/VBD (l_prep) after/IN (l_pobj) coadministration/NN (l_prep) of/IN (l_pobj) sirolimus/NN
11180036	T18_T20	NONE	desacetyldiltiazem/JJ (r_conj) diltiazem/NN (r_pobj) of/IN (r_prep) curve/NN (r_pobj) under/IN (r_prep) concentration/NN (r_nsubj) were/VBD (l_prep) after/IN (l_pobj) coadministration/NN (l_prep) of/IN (l_pobj) sirolimus/NN
11180036	T18_T21	NONE	desacetyldiltiazem/JJ (r_conj) diltiazem/NN (r_pobj) of/IN (r_prep) curve/NN (r_pobj) under/IN (r_prep) concentration/NN (r_nsubj) were/VBD (l_conj) seen/VBN (l_nsubjpass) potentiation/NN (l_prep) of/IN (l_pobj) effects/NNS (l_prep) of/IN (l_pobj) diltiazem/NN
11180036	T19_T20	NONE	desmethyldiltiazem/NN (r_conj) desacetyldiltiazem/JJ (r_conj) diltiazem/NN (r_pobj) of/IN (r_prep) curve/NN (r_pobj) under/IN (r_prep) concentration/NN (r_nsubj) were/VBD (l_prep) after/IN (l_pobj) coadministration/NN (l_prep) of/IN (l_pobj) sirolimus/NN
11180036	T19_T21	NONE	desmethyldiltiazem/NN (r_conj) desacetyldiltiazem/JJ (r_conj) diltiazem/NN (r_pobj) of/IN (r_prep) curve/NN (r_pobj) under/IN (r_prep) concentration/NN (r_nsubj) were/VBD (l_conj) seen/VBN (l_nsubjpass) potentiation/NN (l_prep) of/IN (l_pobj) effects/NNS (l_prep) of/IN (l_pobj) diltiazem/NN
11180036	T20_T21	NONE	sirolimus/NN (r_pobj) of/IN (r_prep) coadministration/NN (r_pobj) after/IN (r_prep) were/VBD (l_conj) seen/VBN (l_nsubjpass) potentiation/NN (l_prep) of/IN (l_pobj) effects/NNS (l_prep) of/IN (l_pobj) diltiazem/NN
11180036	T22_T23	MECHANISM	diltiazem/NN (r_compound) coadministration/NN (r_nsubj) leads/VBZ (l_prep) to/IN (l_pobj) exposure/NN (l_compound) sirolimus/NN
11180036	T22_T24	NONE	diltiazem/NN (r_compound) coadministration/NN (r_nsubj) leads/VBZ (l_prep) by/IN (l_pobj) inhibition/NN (l_prep) of/IN (l_pobj) metabolism/NN (l_prep) of/IN (l_pobj) sirolimus/NN
11180036	T25_T26	ADVISE	sirolimus/NN (r_compound) diltiazem/NN
11180036	T26_T27	NONE	diltiazem/NN (r_compound) interaction/NN (r_pobj) of/IN (r_prep) extent/NN (r_pobj) in/IN (r_prep) variability/NN (r_pobj) Because/IN (r_prep) monitored/VBN (l_nsubjpass) concentrations/NNS (l_compound) sirolimus/NN
6536292	T4_T5	NONE	ethanol/NN (r_appos) saline/NN (r_pobj) of/IN (r_prep) injections/NNS (r_dobj) following/VBG (r_acl) min/NN (l_conj) physostigmine/NN
6536292	T4_T6	NONE	ethanol/NN (r_appos) saline/NN (r_pobj) of/IN (r_prep) injections/NNS (r_dobj) following/VBG (r_acl) min/NN (l_conj) physostigmine/NN (l_conj) atropine/NN
6536292	T10_T11	EFFECT	Physostigmine/NNP (r_compound) pretreatment/NN (r_nsubj) augmented/VBD (l_dobj) effect/NN (l_prep) of/IN (l_pobj) alcohol/NN
6536292	T10_T12	EFFECT	Physostigmine/NNP (r_compound) pretreatment/NN (r_nsubj) augmented/VBD (l_advcl) attenuating/VBG (l_dobj) influence/NN (l_poss) alcohol/NN
6536292	T14_T15	NONE	Atropine/NNP (l_advmod) alone/RB (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) alcohol/NN
11199955	T1_T2	NONE	phenytoin/JJ (r_compound) administration/NN (r_pobj) of/IN (r_prep) effects/NNS (l_prep) on/IN (l_pobj) pharmacokinetics/NNS (l_prep) of/IN (l_pobj) quetiapine/NN
11199955	T3_T4	NONE	fumarate/NNP (l_npadvmod) Seroquel/NNP
11199955	T3_T5	NONE	fumarate/NNP (r_nsubj) is/VBZ (l_attr) antipsychotic/NN
11199955	T4_T5	NONE	Seroquel/NNP (r_npadvmod) fumarate/NNP (r_nsubj) is/VBZ (l_attr) antipsychotic/NN
11199955	T7_T8	MECHANISM	phenytoin/NN (r_nsubj) have/VB (l_dobj) effect/NN (l_prep) on/IN (l_pobj) metabolism/NN (l_prep) of/IN (l_pobj) quetiapine/NN
3918122	T5_T6	NONE	heroin/NN (r_pobj) in/IN (r_prep) cause/NN (r_appos) aureus/NNP (r_pobj) of/IN (r_prep) strains/NNS (l_conj) in/IN (l_pobj) pentazocine/NN
3918122	T5_T7	NONE	heroin/NN (r_pobj) in/IN (r_prep) cause/NN (r_appos) aureus/NNP (r_pobj) of/IN (r_prep) strains/NNS (l_conj) in/IN (l_pobj) pentazocine/NN (l_conj) tripelennamine/NN
3918122	T6_T7	EFFECT	pentazocine/NN (l_conj) tripelennamine/NN
3918122	T8_T9	EFFECT	tripelennamine/NN (r_nsubj) was/VBD (l_acomp) responsible/JJ (l_prep) for/IN (l_pobj) activity/NN (l_relcl) antagonized/VBN (l_agent) by/IN (l_pobj) pentazocine/NN
11134454	T1_T2	NONE	Carbamazepine/NNP (r_amod) overdose/NN (l_acl) recognized/VBN (l_agent) by/IN (l_pobj) assay/NN (l_compound) antidepressant/NN
11134454	T3_T4	EFFECT	carbamazepine/NN (r_compound) overdose/NN (l_prep) with/IN (l_pobj) level/NN (l_amod) antidepressant/JJ
11134454	T3_T6	NONE	carbamazepine/NN (r_compound) overdose/NN (r_pobj) by/IN (r_agent) caused/VBN (l_advcl) alert/JJ (l_prep) with/IN (l_pobj) screen/NN (l_prep) for/IN (l_pobj) antidepressants/NNS
11134454	T4_T5	NONE	antidepressant/JJ (r_amod) level/NN (r_pobj) with/IN (r_prep) overdose/NN (r_pobj) by/IN (r_agent) caused/VBN (l_advcl) alert/JJ (l_prep) to/IN (l_pobj) reactivity/NN (l_prep) of/IN (l_pobj) carbamazepine/NN
11134454	T5_T6	ADVISE	carbamazepine/NN (r_pobj) of/IN (r_prep) reactivity/NN (r_pobj) to/IN (r_prep) alert/JJ (l_prep) with/IN (l_pobj) screen/NN (l_prep) for/IN (l_pobj) antidepressants/NNS
7599505	T1_T2	MECHANISM	cobalt/NN (l_conj) iron/NN
7599505	T3_T5	NONE	cobalt/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) determined/VBN (l_prep) by/IN (l_pcomp) using/VBG (l_dobj) diets/NNS (l_acl) containing/VBG (l_dobj) kg/NNS (l_prep) of/IN (l_pobj) Co/NNP
7599505	T3_T6	NONE	cobalt/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) determined/VBN (l_prep) by/IN (l_pcomp) using/VBG (l_dobj) diets/NNS (l_acl) containing/VBG (l_dobj) kg/NNS (l_conj) mg/kg/NN (l_prep) of/IN (l_pobj) Fe/NNP
7599505	T4_T5	NONE	iron/NN (r_conj) cobalt/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) determined/VBN (l_prep) by/IN (l_pcomp) using/VBG (l_dobj) diets/NNS (l_acl) containing/VBG (l_dobj) kg/NNS (l_prep) of/IN (l_pobj) Co/NNP
7599505	T4_T6	NONE	iron/NN (r_conj) cobalt/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) determined/VBN (l_prep) by/IN (l_pcomp) using/VBG (l_dobj) diets/NNS (l_acl) containing/VBG (l_dobj) kg/NNS (l_conj) mg/kg/NN (l_prep) of/IN (l_pobj) Fe/NNP
7599505	T5_T6	NONE	Co/NNP (r_pobj) of/IN (r_prep) kg/NNS (l_conj) mg/kg/NN (l_prep) of/IN (l_pobj) Fe/NNP
7599505	T7_T9	NONE	Cobalt/NNP (r_compound) excretion/NN (r_nsubjpass) enhanced/VBN (r_ccomp) increased/VBN (l_agent) by/IN (l_pobj) iron/NN
7599505	T8_T9	NONE	cobalt/NN (r_pobj) by/IN (r_agent) enhanced/VBN (r_ccomp) increased/VBN (l_agent) by/IN (l_pobj) iron/NN
7599505	T10_T11	MECHANISM	iron/NN (r_nsubj) inhibited/VBD (l_dobj) absorption/NN (l_prep) of/IN (l_pobj) cobalt/NN
7599505	T10_T12	MECHANISM	iron/NN (r_nsubj) inhibited/VBD (l_dobj) absorption/NN (l_prep) in/IN (l_pobj) treatments/NNS (l_compound) cobalt/NN
7599505	T13_T15	MECHANISM	Fe/NNP (r_dobj) receiving/VBG (r_acl) groups/NNS (r_pobj) in/IN (r_prep) absorption/NN (r_pobj) of/IN (r_prep) rate/NN (r_nsubj) resulted/VBD (l_prep) in/IN (l_pobj) excretion/NN (l_prep) of/IN (l_pobj) cobalt/NN
7599505	T14_T15	NONE	Fe/NNP (r_pobj) of/IN (r_prep) mg/NN (r_dobj) receiving/VBG (r_acl) groups/NNS (r_pobj) in/IN (r_prep) absorption/NN (r_pobj) of/IN (r_prep) rate/NN (r_nsubj) resulted/VBD (l_prep) in/IN (l_pobj) excretion/NN (l_prep) of/IN (l_pobj) cobalt/NN
7599505	T16_T17	MECHANISM	iron/NN (r_pobj) of/IN (r_prep) effect/NN (l_prep) on/IN (l_pobj) retention/NN (l_prep) of/IN (l_pobj) cobalt/NN
7599505	T18_T19	NONE	cobalt/NN (r_compound) concentration/NN (l_prep) compared/VBN (l_prep) to/IN (l_pobj) contents/NNS (l_compound) iron/NN
7599505	T18_T21	NONE	cobalt/NN (r_compound) concentration/NN (r_pobj) Because/IN (r_prep) occurred/VBD (l_nsubj) effect/NN (l_prep) on/IN (l_pobj) absorption/NN (l_compound) iron/NN
7599505	T19_T20	NONE	iron/NN (r_compound) contents/NNS (r_pobj) to/IN (r_prep) compared/VBN (r_prep) concentration/NN (r_pobj) Because/IN (r_prep) occurred/VBD (l_nsubj) effect/NN (l_prep) of/IN (l_pobj) cobalt/NN
7599505	T20_T21	NONE	cobalt/NN (r_pobj) of/IN (r_prep) effect/NN (l_prep) on/IN (l_pobj) absorption/NN (l_compound) iron/NN
7599505	T22_T23	NONE	iron/NN (r_compound) balance/NN (r_pobj) in/IN (r_prep) Differences/NNS (r_nsubjpass) observed/VBN (l_advcl) showing/VBG (l_ccomp) fed/VBD (l_dobj) Fe/NNP
4038510	T1_T2	EFFECT	cisplatin/NN (l_prep) with/IN (l_pobj) protection/NN (l_compound) thiosulfate/NN
4038510	T4_T5	EFFECT	thiosulfate/NN (r_nsubj) is/VBZ (l_attr) agent/NN (l_prep) for/IN (l_pobj) cisplatin/NN
4038510	T6_T7	NONE	thiosulfate/NN (r_pobj) of/IN (r_prep) injection/NN (r_nsubj) permit/VB (l_dobj) doses/NNS (l_prep) of/IN (l_pobj) cisplatin/NN
4038510	T6_T9	NONE	thiosulfate/NN (r_pobj) of/IN (r_prep) injection/NN (r_nsubj) permit/VB (r_ccomp) determine/VB (r_advcl) given/VBN (l_prep) with/IN (l_pcomp) escalating/VBG (l_dobj) doses/NNS (l_prep) of/IN (l_pobj) cisplatin/NN
4038510	T7_T8	NONE	cisplatin/NN (r_pobj) of/IN (r_prep) doses/NNS (r_dobj) permit/VB (r_ccomp) determine/VB (r_advcl) given/VBN (l_nsubjpass) dose/NN (l_prep) of/IN (l_pobj) thiosulfate/NN
4038510	T8_T9	NONE	thiosulfate/NN (r_pobj) of/IN (r_prep) dose/NN (r_nsubjpass) given/VBN (l_prep) with/IN (l_pcomp) escalating/VBG (l_dobj) doses/NNS (l_prep) of/IN (l_pobj) cisplatin/NN
4038510	T10_T11	NONE	Cisplatin/NNP (r_nsubjpass) administered/VBN (l_prep) over/IN (l_pobj) hours/NNS (l_prep) of/IN (l_pobj) infusion/NN (l_compound) thiosulfate/NN
4038510	T13_T14	NONE	cisplatin/JJ (r_amod) pharmacokinetics/NNS (r_pobj) of/IN (r_prep) Comparison/NN (l_prep) in/IN (l_pobj) patients/NNS (l_acl) treated/VBN (l_prep) with/IN (l_pobj) m2/NN (l_conj) thiosulfate/NN
4038510	T13_T15	NONE	cisplatin/JJ (r_amod) pharmacokinetics/NNS (r_pobj) of/IN (r_prep) Comparison/NN (l_prep) in/IN (l_pobj) patients/NNS (l_acl) treated/VBN (l_prep) with/IN (l_pobj) m2/NN (l_conj) thiosulfate/NN (l_prep) to/IN (l_pobj) those/DT (l_prep) in/IN (l_pobj) patients/NNS (l_acl) treated/VBN (l_prep) without/IN (l_pobj) thiosulfate/NN
4038510	T14_T16	NONE	thiosulfate/NN (r_conj) m2/NN (r_pobj) with/IN (r_prep) treated/VBN (r_acl) patients/NNS (r_pobj) in/IN (r_prep) Comparison/NN (r_nsubj) indicated/VBD (l_ccomp) were/VBD (l_attr) changes/NNS (l_conj) volume/NN (l_conj) clearance/NN (l_prep) of/IN (l_pobj) cisplatin/NN
4038510	T15_T16	NONE	thiosulfate/NN (r_pobj) without/IN (r_prep) treated/VBN (r_acl) patients/NNS (r_pobj) in/IN (r_prep) those/DT (r_pobj) to/IN (r_prep) thiosulfate/NN (r_conj) m2/NN (r_pobj) with/IN (r_prep) treated/VBN (r_acl) patients/NNS (r_pobj) in/IN (r_prep) Comparison/NN (r_nsubj) indicated/VBD (l_ccomp) were/VBD (l_attr) changes/NNS (l_conj) volume/NN (l_conj) clearance/NN (l_prep) of/IN (l_pobj) cisplatin/NN
4038510	T18_T19	MECHANISM	thiosulfate/NN (r_pobj) of/IN (r_prep) administration/NN (r_nsubj) permits/VBZ (l_dobj) increase/NN (l_advcl) cisplatin/NN
2578597	T2_T3	NONE	antihistaminics/NNS (r_nsubj) are/VBP (l_attr) agents/NNS
2578597	T2_T4	NONE	antihistaminics/NNS (r_nsubj) are/VBP (l_conj) are/VBP (l_attr) adjuvants/NNS
2578597	T3_T4	NONE	agents/NNS (r_attr) are/VBP (l_conj) are/VBP (l_attr) adjuvants/NNS
2578597	T5_T6	NONE	diphenhydramine/NN (l_conj) orphenadrine/NN (l_nmod) hydroxyzine/NN
2578597	T6_T7	NONE	hydroxyzine/NN (r_nmod) orphenadrine/NN
2578597	T6_T8	NONE	hydroxyzine/NN (r_nmod) orphenadrine/NN (l_conj) pyrilamine/NN
2578597	T6_T9	NONE	hydroxyzine/NN (r_nmod) orphenadrine/NN (l_conj) pyrilamine/NN (l_conj) phenyltoloxamine/NN
2578597	T6_T10	NONE	hydroxyzine/NN (r_nmod) orphenadrine/NN (l_conj) pyrilamine/NN (l_conj) phenyltoloxamine/NN (l_conj) promethazine/NN
2578597	T6_T11	NONE	hydroxyzine/NN (r_nmod) orphenadrine/NN (l_conj) pyrilamine/NN (l_conj) phenyltoloxamine/NN (l_conj) promethazine/NN (l_conj) methdilazine/NN
2578597	T6_T12	NONE	hydroxyzine/NN (r_nmod) orphenadrine/NN (l_conj) pyrilamine/NN (l_conj) phenyltoloxamine/NN (l_conj) promethazine/NN (l_conj) methdilazine/NN (l_conj) tripelennamine/NN
3968644	T2_T3	NONE	allylnormetazocine/NN (l_appos) NANM/NNP
3968644	T2_T4	NONE	allylnormetazocine/NN (r_pobj) of/IN (r_prep) stereoisomers/NNS (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) compared/VBN (l_prep) with/IN (l_pobj) those/DT (l_prep) of/IN (l_pobj) phencyclidine/NN
3968644	T2_T5	NONE	allylnormetazocine/NN (r_pobj) of/IN (r_prep) stereoisomers/NNS (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) compared/VBN (l_prep) with/IN (l_pobj) those/DT (l_prep) of/IN (l_pobj) phencyclidine/NN (l_appos) PCP/NNP
3968644	T3_T4	NONE	NANM/NNP (r_appos) allylnormetazocine/NN (r_pobj) of/IN (r_prep) stereoisomers/NNS (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) compared/VBN (l_prep) with/IN (l_pobj) those/DT (l_prep) of/IN (l_pobj) phencyclidine/NN
3968644	T3_T5	NONE	NANM/NNP (r_appos) allylnormetazocine/NN (r_pobj) of/IN (r_prep) stereoisomers/NNS (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) compared/VBN (l_prep) with/IN (l_pobj) those/DT (l_prep) of/IN (l_pobj) phencyclidine/NN (l_appos) PCP/NNP
3968644	T4_T5	NONE	phencyclidine/NN (l_appos) PCP/NNP
3968644	T6_T7	NONE	-NANM/: (r_punct) doses/NNS (l_conj) PCP/NNP
3968644	T14_T16	EFFECT	-)-NANM/, (r_preconj) ,/, (r_punct) antagonized/VBD (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
3968644	T15_T16	NONE	-NANM/: (r_conj) -)-NANM/, (r_preconj) ,/, (r_punct) antagonized/VBD (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
3968644	T17_T19	NONE	-)-NANM/: (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) antagonized/VBN (l_punct) -NANM/: (l_conj) PCP/NNP
3968644	T17_T20	EFFECT	-)-NANM/: (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) antagonized/VBN (l_agent) by/IN (l_pobj) naloxone/NN
3968644	T17_T21	NONE	-)-NANM/: (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) antagonized/VBN (l_appos) doses/NNS (l_prep) of/IN (l_pobj) naloxone/NN
3968644	T17_T23	NONE	-)-NANM/: (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) antagonized/VBN (l_appos) doses/NNS (l_prep) of/IN (l_pobj) naloxone/NN (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pcomp) were/VBD (l_acomp) higher/JJR (l_prep) than/IN (l_pobj) those/DT (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
3968644	T18_T20	NONE	-NANM/: (r_punct) antagonized/VBN (l_agent) by/IN (l_pobj) naloxone/NN
3968644	T18_T21	NONE	-NANM/: (r_punct) antagonized/VBN (l_appos) doses/NNS (l_prep) of/IN (l_pobj) naloxone/NN
3968644	T18_T23	NONE	-NANM/: (r_punct) antagonized/VBN (l_appos) doses/NNS (l_prep) of/IN (l_pobj) naloxone/NN (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pcomp) were/VBD (l_acomp) higher/JJR (l_prep) than/IN (l_pobj) those/DT (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
3968644	T19_T20	NONE	PCP/NNP (r_conj) -NANM/: (r_punct) antagonized/VBN (l_agent) by/IN (l_pobj) naloxone/NN
3968644	T19_T21	NONE	PCP/NNP (r_conj) -NANM/: (r_punct) antagonized/VBN (l_appos) doses/NNS (l_prep) of/IN (l_pobj) naloxone/NN
3968644	T19_T22	NONE	PCP/NNP (r_conj) -NANM/: (r_punct) antagonized/VBN (l_appos) doses/NNS (l_prep) of/IN (l_pobj) naloxone/NN (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pcomp) were/VBD (l_nsubj) -)-NANM/,
3968644	T19_T23	NONE	PCP/NNP (r_conj) -NANM/: (r_punct) antagonized/VBN (l_appos) doses/NNS (l_prep) of/IN (l_pobj) naloxone/NN (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pcomp) were/VBD (l_acomp) higher/JJR (l_prep) than/IN (l_pobj) those/DT (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
3968644	T20_T22	NONE	naloxone/NN (r_pobj) by/IN (r_agent) antagonized/VBN (l_appos) doses/NNS (l_prep) of/IN (l_pobj) naloxone/NN (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pcomp) were/VBD (l_nsubj) -)-NANM/,
3968644	T20_T23	NONE	naloxone/NN (r_pobj) by/IN (r_agent) antagonized/VBN (l_appos) doses/NNS (l_prep) of/IN (l_pobj) naloxone/NN (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pcomp) were/VBD (l_acomp) higher/JJR (l_prep) than/IN (l_pobj) those/DT (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
3968644	T21_T22	EFFECT	naloxone/NN (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pcomp) were/VBD (l_nsubj) -)-NANM/,
3968644	T21_T23	EFFECT	naloxone/NN (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pcomp) were/VBD (l_acomp) higher/JJR (l_prep) than/IN (l_pobj) those/DT (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
3968644	T22_T23	NONE	-)-NANM/, (r_nsubj) were/VBD (l_acomp) higher/JJR (l_prep) than/IN (l_pobj) those/DT (l_acl) required/VBN (l_xcomp) antagonize/VB (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
3968644	T24_T25	NONE	naloxone/NN (r_nsubj) alter/VB (l_punct) -NANM/: (l_punct) -)-NANM/,
3968644	T24_T26	NONE	naloxone/NN (r_nsubj) alter/VB (l_punct) -NANM/:
3968644	T24_T27	NONE	naloxone/NN (r_nsubj) alter/VB (l_punct) -NANM/: (l_conj) PCP/NNP
3968644	T25_T27	NONE	-)-NANM/, (r_punct) -NANM/: (l_conj) PCP/NNP
3968644	T28_T29	EFFECT	Haloperidol/NN (r_nsubj) reduced/VBD (l_punct) -NANM/:
3968644	T28_T30	EFFECT	Haloperidol/NN (r_nsubj) reduced/VBD (l_conj) PCP/NNP
3968644	T28_T31	NONE	Haloperidol/NN (r_nsubj) reduced/VBD (l_conj) antagonize/VB (l_dobj) decreases/NNS (l_acl) produced/VBN (l_agent) by/IN (l_pobj) doses/NNS (l_conj) stereoisomer/NN (l_prep) of/IN (l_pobj) NANM/NNP
3968644	T29_T30	NONE	-NANM/: (r_punct) reduced/VBD (l_conj) PCP/NNP
3968644	T29_T31	NONE	-NANM/: (r_punct) reduced/VBD (l_conj) antagonize/VB (l_dobj) decreases/NNS (l_acl) produced/VBN (l_agent) by/IN (l_pobj) doses/NNS (l_conj) stereoisomer/NN (l_prep) of/IN (l_pobj) NANM/NNP
3968644	T30_T31	NONE	PCP/NNP (r_conj) reduced/VBD (l_conj) antagonize/VB (l_dobj) decreases/NNS (l_acl) produced/VBN (l_agent) by/IN (l_pobj) doses/NNS (l_conj) stereoisomer/NN (l_prep) of/IN (l_pobj) NANM/NNP
11197581	T1_T2	EFFECT	simvastatin/NN (l_conj) clarithromycin/NN
11197581	T3_T4	NONE	clarithromycin/NN (r_pobj) of/IN (r_prep) use/NN (r_pobj) from/IN (r_prep) resulting/VBG (l_conj) simvastatin/NN
11197581	T8_T9	MECHANISM	Clarithromycin/NNP (r_nsubj) is/VBZ (l_attr) inhibitor/NN (l_appos) enzyme/NN (l_amod) responsible/JJ (l_prep) for/IN (l_pobj) metabolism/NN (l_amod) simvastatin/NN
11197581	T10_T11	EFFECT	antibiotics/NNS (r_pobj) of/IN (r_prep) administration/NN (l_conj) inhibitors/NNS
11197581	T13_T14	NONE	antibiotics/NNS (r_nsubj) inhibit/VBP (l_dobj) metabolism/NN (l_prep) of/IN (l_pobj) inhibitors/NNS
11197581	T13_T15	MECHANISM	antibiotics/NNS (r_nsubj) inhibit/VBP (l_dobj) metabolism/NN (l_prep) of/IN (l_pobj) inhibitors/NNS (l_relcl) metabolized/VBN (l_agent) by/IN (l_pobj) simvastatin/NN (l_advmod) atorvastatin/NN
11197581	T13_T16	MECHANISM	antibiotics/NNS (r_nsubj) inhibit/VBP (l_dobj) metabolism/NN (l_prep) of/IN (l_pobj) inhibitors/NNS (l_relcl) metabolized/VBN (l_agent) by/IN (l_pobj) simvastatin/NN (l_punct) ,/, (l_preconj) cerivastatin/NN
11197581	T13_T17	MECHANISM	antibiotics/NNS (r_nsubj) inhibit/VBP (l_dobj) metabolism/NN (l_prep) of/IN (l_pobj) inhibitors/NNS (l_relcl) metabolized/VBN (l_agent) by/IN (l_pobj) simvastatin/NN (l_advmod) lovastatin/NN
11197581	T13_T18	MECHANISM	antibiotics/NNS (r_nsubj) inhibit/VBP (l_dobj) metabolism/NN (l_prep) of/IN (l_pobj) inhibitors/NNS (l_relcl) metabolized/VBN (l_agent) by/IN (l_pobj) simvastatin/NN
11197581	T14_T15	NONE	inhibitors/NNS (l_relcl) metabolized/VBN (l_agent) by/IN (l_pobj) simvastatin/NN (l_advmod) atorvastatin/NN
11197581	T14_T16	NONE	inhibitors/NNS (l_relcl) metabolized/VBN (l_agent) by/IN (l_pobj) simvastatin/NN (l_punct) ,/, (l_preconj) cerivastatin/NN
11197581	T14_T17	NONE	inhibitors/NNS (l_relcl) metabolized/VBN (l_agent) by/IN (l_pobj) simvastatin/NN (l_advmod) lovastatin/NN
11197581	T14_T18	NONE	inhibitors/NNS (l_relcl) metabolized/VBN (l_agent) by/IN (l_pobj) simvastatin/NN
11197581	T15_T16	NONE	atorvastatin/NN (r_advmod) simvastatin/NN (l_punct) ,/, (l_preconj) cerivastatin/NN
11197581	T15_T17	NONE	atorvastatin/NN (r_advmod) simvastatin/NN (l_advmod) lovastatin/NN
11197581	T15_T18	NONE	atorvastatin/NN (r_advmod) simvastatin/NN
11197581	T16_T17	NONE	cerivastatin/NN (r_preconj) ,/, (r_punct) simvastatin/NN (l_advmod) lovastatin/NN
11197581	T16_T18	NONE	cerivastatin/NN (r_preconj) ,/, (r_punct) simvastatin/NN
11197581	T17_T18	NONE	lovastatin/NN (r_advmod) simvastatin/NN
7496198	T3_T4	EFFECT	thiabendazole/NN (r_pobj) of/IN (r_prep) prescription/NN (l_relcl) treat/VB (l_prep) during/IN (l_pobj) cure/NN (l_compound) melarsoprol/NN
7496198	T5_T6	NONE	helminthic/JJ (r_amod) treatment/NN (r_pobj) of/IN (r_prep) administration/NN (r_dobj) avoid/VB (l_conj) improve/VB (l_prep) before/IN (l_pobj) cure/NN (l_prep) of/IN (l_pobj) melarsoprol/NN
11137703	T2_T3	NONE	red/NN (l_appos) RR/NN
11137703	T2_T4	NONE	red/NN (r_pobj) of/IN (r_prep) effects/NNS (l_prep) on/IN (l_pobj) 1,4,5-trisphosphate/CD
11137703	T2_T5	NONE	red/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) studied/VBN (l_nsubjpass) responses/NNS (l_amod) InsP(3))-induced/JJ
11137703	T3_T4	NONE	RR/NN (r_appos) red/NN (r_pobj) of/IN (r_prep) effects/NNS (l_prep) on/IN (l_pobj) 1,4,5-trisphosphate/CD
11137703	T3_T5	NONE	RR/NN (r_appos) red/NN (r_pobj) of/IN (r_prep) effects/NNS (r_nsubjpass) studied/VBN (l_nsubjpass) responses/NNS (l_amod) InsP(3))-induced/JJ
11137703	T4_T5	NONE	1,4,5-trisphosphate/CD (r_pobj) on/IN (r_prep) effects/NNS (r_nsubjpass) studied/VBN (l_nsubjpass) responses/NNS (l_amod) InsP(3))-induced/JJ
11137703	T7_T8	EFFECT	)/-RRB- (r_punct) Administering/VBG (l_prep) with/IN (l_pobj) microM/NNS (l_nmod) RR/NN
11137703	T9_T10	EFFECT	RR/NN (r_pobj) with/IN (r_prep) megakaryocytes/NNS (r_pobj) of/IN (r_prep) Pretreatment/NN (r_nsubj) inhibited/VBD (l_dobj) responses/NNS (l_compound) InsP(3)-induced/NNP
11137703	T12_T13	NONE	RR/NN (r_nsubj) had/VBD (l_dobj) effect/NN (l_prep) on/IN (l_pobj) responses/NNS (l_compound) InsP(3)-induced/NNP
11137703	T15_T16	NONE	RR/NN (r_nsubj) is/VBZ (l_attr) tool/NN (l_relcl) examine/VB (l_dobj) responses/NNS (l_amod) InsP(3)-mediated/VBN
19489169	T2_T3	NONE	Fluvastatin/NNP (r_nsubj) is/VBZ (l_attr) inhibitor/NN
19489169	T4_T5	NONE	inhibitors/NNS (l_advmod) lovastatin/NN
19489169	T4_T6	NONE	inhibitors/NNS (l_advmod) lovastatin/NN (l_conj) simvastatin/NN
19489169	T4_T7	NONE	inhibitors/NNS (l_advmod) lovastatin/NN (l_conj) simvastatin/NN (l_conj) pravastatin/NNP
19489169	T17_T18	MECHANISM	Cholestyramine/NN (r_nsubj) has/VBZ (l_dobj) effect/NN (l_prep) in/IN (l_pcomp) lowering/VBG (l_dobj) rate/NN (l_prep) of/IN (l_pobj) bioavailability/NN (l_amod) fluvastatin/NN
19489169	T19_T20	EFFECT	cholestyramine/NN (r_nsubjpass) given/VBN (l_advmod) prior/RB (l_prep) to/IN (l_pcomp) fluvastatin/NN
19489169	T21_T23	NONE	warfarin/JJ (r_compound) levels/NNS (r_pobj) on/IN (r_prep) effects/NNS (r_nsubjpass) observed/VBN (l_prep) in/IN (l_pobj) study/NN (l_acl) involving/VBG (l_dobj) administration/NN (l_prep) of/IN (l_pobj) warfarin/NN (l_conj) fluvastatin/NN
19489169	T24_T25	NONE	niacin/NN (r_pobj) with/IN (r_prep) studies/NNS (l_conj) propranolol/NN
19489169	T24_T26	NONE	niacin/NN (r_pobj) with/IN (r_prep) studies/NNS (r_nsubj) demonstrated/VBN (l_dobj) effect/NN (l_prep) on/IN (l_pobj) levels/NNS (l_compound) plasma/NN (l_amod) fluvastatin/NN
19489169	T24_T27	NONE	niacin/NN (r_pobj) with/IN (r_prep) studies/NNS (r_nsubj) demonstrated/VBN (l_conj) resulted/VBD (l_nsubj) administration/NN (l_prep) to/IN (l_pobj) population/NN (l_acl) receiving/VBG (l_dobj) digoxin/NN
19489169	T24_T28	NONE	niacin/NN (r_pobj) with/IN (r_prep) studies/NNS (r_nsubj) demonstrated/VBN (l_conj) resulted/VBD (l_prep) in/IN (l_pobj) difference/NN (l_prep) in/IN (l_pobj) extent/NN (l_prep) of/IN (l_pobj) bioavailability/NN (l_prep) of/IN (l_pobj) digoxin/JJ
19489169	T25_T26	NONE	propranolol/NN (r_conj) studies/NNS (r_nsubj) demonstrated/VBN (l_dobj) effect/NN (l_prep) on/IN (l_pobj) levels/NNS (l_compound) plasma/NN (l_amod) fluvastatin/NN
19489169	T25_T27	NONE	propranolol/NN (r_conj) studies/NNS (r_nsubj) demonstrated/VBN (l_conj) resulted/VBD (l_nsubj) administration/NN (l_prep) to/IN (l_pobj) population/NN (l_acl) receiving/VBG (l_dobj) digoxin/NN
19489169	T25_T28	NONE	propranolol/NN (r_conj) studies/NNS (r_nsubj) demonstrated/VBN (l_conj) resulted/VBD (l_prep) in/IN (l_pobj) difference/NN (l_prep) in/IN (l_pobj) extent/NN (l_prep) of/IN (l_pobj) bioavailability/NN (l_prep) of/IN (l_pobj) digoxin/JJ
19489169	T26_T27	NONE	fluvastatin/NN (r_amod) plasma/NN (r_compound) levels/NNS (r_pobj) on/IN (r_prep) effect/NN (r_dobj) demonstrated/VBN (l_conj) resulted/VBD (l_nsubj) administration/NN (l_prep) to/IN (l_pobj) population/NN (l_acl) receiving/VBG (l_dobj) digoxin/NN
19489169	T26_T28	NONE	fluvastatin/NN (r_amod) plasma/NN (r_compound) levels/NNS (r_pobj) on/IN (r_prep) effect/NN (r_dobj) demonstrated/VBN (l_conj) resulted/VBD (l_prep) in/IN (l_pobj) difference/NN (l_prep) in/IN (l_pobj) extent/NN (l_prep) of/IN (l_pobj) bioavailability/NN (l_prep) of/IN (l_pobj) digoxin/JJ
3969689	T1_T2	EFFECT	acetaminophen/NN (r_pobj) of/IN (r_prep) hepatotoxicity/NN (l_prep) by/IN (l_pobj) administration/NN (l_prep) of/IN (l_pobj) caffeine/NN
3969689	T3_T4	NONE	caffeine/NN (r_nsubj) is/VBZ (l_prep) with/IN (l_pobj) acetaminophen/NN
3969689	T3_T6	NONE	caffeine/NN (r_nsubj) is/VBZ (r_advcl) is/VBZ (l_xcomp) study/VB (l_dobj) effect/NN (l_prep) on/IN (l_pobj) hepatotoxicity/NN (l_prep) of/IN (l_pobj) acetaminophen/NN
3969689	T4_T5	NONE	acetaminophen/NN (r_pobj) with/IN (r_prep) is/VBZ (r_advcl) is/VBZ (l_xcomp) study/VB (l_dobj) effect/NN (l_prep) of/IN (l_pobj) caffeine/NN
3969689	T5_T6	NONE	caffeine/NN (r_pobj) of/IN (r_prep) effect/NN (l_prep) on/IN (l_pobj) hepatotoxicity/NN (l_prep) of/IN (l_pobj) acetaminophen/NN
3969689	T8_T9	EFFECT	acetaminophen/NN (r_nsubjpass) prescribed/VBN (l_prep) with/IN (l_pobj) caffeine/NN
8521984	T2_T4	NONE	1/CD (r_nummod) angiotensin/NN (l_conj) angiotensin/NN (l_prep) on/IN (l_pobj) pentagastrin-/NN
8521984	T2_T5	NONE	1/CD (r_nummod) angiotensin/NN (r_pobj) of/IN (r_prep) influence/NN (l_conj) induced/VBN (l_npadvmod) histamine/NN
8521984	T3_T4	NONE	2/CD (r_nummod) angiotensin/NN (l_prep) on/IN (l_pobj) pentagastrin-/NN
8521984	T3_T5	NONE	2/CD (r_nummod) angiotensin/NN (r_conj) angiotensin/NN (r_pobj) of/IN (r_prep) influence/NN (l_conj) induced/VBN (l_npadvmod) histamine/NN
8521984	T4_T5	NONE	pentagastrin-/NN (r_pobj) on/IN (r_prep) angiotensin/NN (r_conj) angiotensin/NN (r_pobj) of/IN (r_prep) influence/NN (l_conj) induced/VBN (l_npadvmod) histamine/NN
8521984	T6_T7	NONE	pentagastrin/NN (r_pobj) by/IN (r_agent) stimulated/VBN (r_acl) secretion/NN (r_dobj) inhibited/VBN (l_prep) by/IN (l_pobj) histamine/NN
8542840	T1_T2	INT	gentamycin/NN (l_conj) atracurium/NN
8542840	T3_T4	NONE	atracurium/NN (r_compound) infusion/NN (l_prep) in/IN (l_pobj) horses/NNS (l_acl) anaesthetised/VBN (l_prep) with/IN (l_pobj) halothane/NN
8542840	T6_T7	NONE	Atracurium/NN (r_nsubjpass) given/VBN (r_ccomp) given/VBN (l_nsubjpass) bwt/NNS (l_compound) kg/NNS (l_amod) gentamycin/NNP
8542840	T7_T8	NONE	gentamycin/NNP (r_amod) kg/NNS (r_compound) bwt/NNS (r_nsubjpass) given/VBN (l_ccomp) continued/VBN (l_nsubjpass) infusion/NN (l_compound) Atracurium/NNP
8542840	T11_T13	NONE	atracurium/NN (r_pobj) for/IN (r_prep) took/VBD (l_conj) min/NN (l_prep) for/IN (l_pobj) atracurium/NN (l_conj) gentamycin/NNP
8542840	T12_T13	EFFECT	atracurium/NN (l_conj) gentamycin/NNP
8542840	T14_T16	NONE	atracurium/NN (r_pobj) for/IN (r_prep) took/VBD (l_conj) min/NN (l_prep) for/IN (l_pobj) atracurium/NN (l_conj) gentamycin/NN
8542840	T15_T16	EFFECT	atracurium/NN (l_conj) gentamycin/NN
8542840	T17_T19	NONE	atracurium/NN (r_pobj) for/IN (r_prep) %/NN (l_conj) %/NN (l_prep) for/IN (l_pobj) atracurium/NN (l_conj) gentamycin/NN
8542840	T18_T19	EFFECT	atracurium/NN (l_conj) gentamycin/NN
8542840	T21_T22	EFFECT	gentamycin/NN (r_nsubj) augment/VB (l_dobj) blockade/NN (l_prep) of/IN (l_pobj) atracurium/NN
6100240	T1_T2	NONE	neomycin/NN (r_pobj) of/IN (r_prep) Failure/NN (l_acl) modify/VB (l_dobj) ACTH/NNP
6100240	T3_T4	NONE	neomycin/NN (r_compound) administration/NN (r_nsubj) attenuates/VBZ (l_dobj) types/NNS (l_prep) of/IN (l_pobj) hypertension/NN (l_nmod) steroid/NN
6100240	T3_T5	EFFECT	neomycin/NN (r_compound) administration/NN (r_nsubj) attenuates/VBZ (l_dobj) types/NNS (l_prep) including/VBG (l_pobj) hypertension/NN (l_compound) ACTH/NNP
6100240	T4_T5	NONE	steroid/NN (r_nmod) hypertension/NN (r_pobj) of/IN (r_prep) types/NNS (l_prep) including/VBG (l_pobj) hypertension/NN (l_compound) ACTH/NNP
6100240	T6_T7	NONE	neomycin/NNS (r_pobj) of/IN (r_prep) effects/NNS (l_prep) on/IN (l_pobj) ACTH/NNP
6100240	T8_T9	NONE	Neomycin/NNP (r_nsubj) has/VBZ (l_dobj) effect/NN (l_prep) on/IN (l_pobj) pressure/NN (l_conj) responses/NNS (l_prep) to/IN (l_pobj) ACTH/NNP
1109556	T4_T5	NONE	diuretics/NNS (r_dobj) given/VBN (r_csubj) interfere/VB (l_prep) with/IN (l_pobj) absorption/NN (l_prep) of/IN (l_pobj) tablet/NN (l_prep) of/IN (l_pobj) digoxin/NN
7635041	T3_T4	NONE	drugs/NNS (r_pobj) at/IN (r_prep) looks/VBZ (l_prep) in/IN (l_pobj) turn/NN (l_appos) corticosteroids/NNS
7635041	T3_T5	NONE	drugs/NNS (r_pobj) at/IN (r_prep) looks/VBZ (l_prep) in/IN (l_pobj) turn/NN (l_appos) corticosteroids/NNS (l_conj) cyclosporin/NN
7635041	T3_T6	NONE	drugs/NNS (r_pobj) at/IN (r_prep) looks/VBZ (l_prep) in/IN (l_pobj) turn/NN (l_appos) corticosteroids/NNS (l_conj) cyclosporin/NN (l_conj) azathioprine/RB
7635041	T3_T7	NONE	drugs/NNS (r_pobj) at/IN (r_prep) looks/VBZ (l_prep) in/IN (l_pobj) turn/NN (l_appos) corticosteroids/NNS (l_conj) cyclosporin/NN (l_conj) azathioprine/RB (l_conj) methotrexate/NNP
7635041	T3_T8	NONE	drugs/NNS (r_pobj) at/IN (r_prep) looks/VBZ (l_prep) in/IN (l_pobj) turn/NN (l_appos) corticosteroids/NNS (l_conj) cyclosporin/NN (l_conj) azathioprine/RB (l_conj) methotrexate/NNP (l_conj) cyclophosphamide/NN
11217867	T2_T3	NONE	Olanzapine/NNP (l_appos) derivative/NN
11217867	T2_T4	NONE	Olanzapine/NNP (r_nsubj) is/VBZ (l_attr) agent/NN
11217867	T3_T4	NONE	derivative/NN (r_appos) Olanzapine/NNP (r_nsubj) is/VBZ (l_attr) agent/NN
11217867	T6_T7	NONE	olanzapine/RB (r_nsubj) was/VBD (l_acomp) superior/JJ (l_prep) to/IN (l_pobj) haloperidol/NN
11217867	T8_T9	NONE	olanzapine/NN (r_pobj) with/IN (r_prep) lower/JJR (l_prep) than/IN (l_prep) with/IN (l_pobj) treatment/NN (l_amod) haloperidol/NN
11217867	T10_T13	NONE	olanzapine/NN (r_pobj) of/IN (r_prep) study/NN (r_pobj) In/IN (r_prep) proved/VBD (l_xcomp) be/VB (l_acomp) effective/JJ (l_prep) than/IN (l_pobj) risperidone/NN
11217867	T11_T12	NONE	risperidone/NN (r_conj) olanzapine/NN (r_pobj) of/IN (r_prep) study/NN (r_pobj) In/IN (r_prep) proved/VBD (l_nsubj) olanzapine/RB
11217867	T12_T13	NONE	olanzapine/RB (r_nsubj) proved/VBD (l_xcomp) be/VB (l_acomp) effective/JJ (l_prep) than/IN (l_pobj) risperidone/NN
11217867	T14_T15	NONE	risperidone/NN (r_nsubj) was/VBD (l_acomp) superior/JJ (l_xcomp) olanzapine/NN
11217867	T16_T17	NONE	olanzapine/JJ (r_amod) treatment/NN (r_pobj) with/IN (r_prep) seen/VBN (r_acl) function/NN (r_pobj) in/IN (r_prep) Improvements/NNS (r_nsubj) were/VBD (l_acomp) greater/JJR (l_prep) than/IN (l_pobj) changes/NNS (l_acl) seen/VBN (l_prep) with/IN (l_pobj) risperidone/NN
11217867	T16_T18	NONE	olanzapine/JJ (r_amod) treatment/NN (r_pobj) with/IN (r_prep) seen/VBN (r_acl) function/NN (r_pobj) in/IN (r_prep) Improvements/NNS (r_nsubj) were/VBD (l_acomp) greater/JJR (l_prep) than/IN (l_pobj) changes/NNS (l_acl) seen/VBN (l_prep) with/IN (l_pobj) risperidone/NN (l_conj) haloperidol/NN
11217867	T23_T24	NONE	Olanzapine/NNP (r_nsubjpass) associated/VBN (l_prep) with/IN (l_pobj) symptoms/NNS (l_prep) than/IN (l_pobj) haloperidol/NN
11217867	T23_T25	NONE	Olanzapine/NNP (r_nsubjpass) associated/VBN (l_prep) with/IN (l_pobj) symptoms/NNS (l_prep) than/IN (l_pobj) haloperidol/NN (l_conj) risperidone/NN
11217867	T26_T27	NONE	olanzapine/NN (r_nsubjpass) associated/VBN (l_advcl) seen/VBN (l_prep) with/IN (l_pobj) hyperprolactinaemia/NN (l_amod) clozapine/NN
11217867	T26_T28	NONE	olanzapine/NN (r_nsubjpass) associated/VBN (l_advcl) seen/VBN (l_advcl) seen/VBN (l_prep) with/IN (l_pobj) risperidone/NN
11217867	T27_T28	NONE	clozapine/NN (r_amod) hyperprolactinaemia/NN (r_pobj) with/IN (r_prep) seen/VBN (l_advcl) seen/VBN (l_prep) with/IN (l_pobj) risperidone/NN
11217867	T30_T31	NONE	haloperidol/NN (r_pobj) with/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) reported/VBD (l_prep) with/IN (l_pobj) olanzapine/NN
11217867	T30_T32	NONE	haloperidol/NN (r_pobj) with/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) reported/VBD (l_ccomp) were/VBD (l_attr) mouth/NN (l_conj) gain/NN (l_conj) compared/VBN (l_prep) with/IN (l_pobj) risperidone/NN
11217867	T30_T33	NONE	haloperidol/NN (r_pobj) with/IN (r_prep) comparison/NN (r_pobj) In/IN (r_prep) reported/VBD (r_ccomp) occurred/VBD (l_prep) with/IN (l_pobj) olanzapine/NN
11217867	T31_T32	NONE	olanzapine/NN (r_pobj) with/IN (r_prep) reported/VBD (l_ccomp) were/VBD (l_attr) mouth/NN (l_conj) gain/NN (l_conj) compared/VBN (l_prep) with/IN (l_pobj) risperidone/NN
11217867	T32_T33	NONE	risperidone/NN (r_pobj) with/IN (r_prep) compared/VBN (r_conj) gain/NN (r_conj) mouth/NN (r_attr) were/VBD (r_ccomp) reported/VBD (r_ccomp) occurred/VBD (l_prep) with/IN (l_pobj) olanzapine/NN
11217867	T35_T36	NONE	olanzapine/NN (r_nsubj) increase/VB (r_ccomp) indicate/VBP (l_conj) decrease/VB (l_prep) compared/VBN (l_prep) with/IN (l_pobj) haloperidol/NN
11217867	T37_T38	NONE	risperidone/NN (r_pobj) with/IN (r_prep) Compared/VBN (r_prep) reported/VBN (l_nsubjpass) olanzapine/NN
11217867	T39_T40	NONE	Olanzapine/NNP (r_compound) treatment/NN (r_nsubj) improves/VBZ (l_prep) to/IN (l_pobj) extent/NN (l_prep) than/IN (l_pobj) haloperidol/NN
11217867	T39_T41	NONE	Olanzapine/NNP (r_compound) treatment/NN (r_nsubj) improves/VBZ (l_prep) to/IN (l_conj) to/IN (l_pobj) extent/NN (l_prep) as/IN (l_pobj) risperidone/NN
11217867	T40_T41	NONE	haloperidol/NN (r_pobj) than/IN (r_prep) extent/NN (r_pobj) to/IN (l_conj) to/IN (l_pobj) extent/NN (l_prep) as/IN (l_pobj) risperidone/NN
11217867	T42_T43	NONE	Olanzapine/NNP (r_nsubj) demonstrated/VBD (l_prep) compared/VBN (l_prep) with/IN (l_pobj) haloperidol/NN
11217867	T44_T46	NONE	haloperidol/NN (r_pobj) with/IN (r_prep) compared/VBN (r_prep) risk/NN (r_nsubj) support/VBP (l_dobj) choice/NN (l_prep) of/IN (l_pobj) olanzapine/NN
11217867	T45_T46	NONE	risperidone/NN (r_conj) haloperidol/NN (r_pobj) with/IN (r_prep) compared/VBN (r_prep) risk/NN (r_nsubj) support/VBP (l_dobj) choice/NN (l_prep) of/IN (l_pobj) olanzapine/NN
11178969	T1_T2	NONE	polyphenols/NNS (l_prep) as/IN (l_pobj) enhancers/NNS
11178969	T4_T5	NONE	gallate/NN (r_nsubj) showed/VBD (l_dobj) inhibition/NN (l_relcl) was/VBD (l_acomp) potent/JJ (l_prep) than/IN (l_pobj) that/DT (l_prep) of/IN (l_pobj) acid/NN
11206187	T1_T2	NONE	galangin/NN (l_conj) 3,7-dihydroxyflavone/CD (l_prep) with/IN (l_pobj) vancomycin/NNP
11206187	T3_T4	NONE	vancomycin/NNP (r_pobj) of/IN (r_prep) MICs/NNS (r_nsubjpass) lowered/VBN (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) galangin/NN
7786695	T17_T18	NONE	magnesium/NN (r_compound) supplementation/NN (r_nsubj) is/VBZ (l_conj) carried/VBN (l_prep) in/IN (l_conj) with/IN (l_pobj) salts/NNS
7786695	T19_T20	NONE	magnesium/NN (r_compound) depletion/NN (r_pobj) of/IN (r_prep) treatments/NNS (r_nsubj) are/VBP (l_acomp) tricky/JJ (l_xcomp) using/VBG (l_dobj) magnesium/NN (l_acl) sparing/VBG (l_dobj) diuretics/NNS
7786695	T19_T21	NONE	magnesium/NN (r_compound) depletion/NN (r_pobj) of/IN (r_prep) treatments/NNS (r_nsubj) are/VBP (l_acomp) tricky/JJ (l_xcomp) using/VBG (l_dobj) magnesium/NN (l_acl) sparing/VBG (l_dobj) diuretics/NNS (l_appos) doses/NNS (l_prep) of/IN (l_pobj) B6/NNP
7786695	T19_T22	NONE	magnesium/NN (r_compound) depletion/NN (r_pobj) of/IN (r_prep) treatments/NNS (l_appos) doses/NNS (l_prep) of/IN (l_pobj) D/NN
7786695	T19_T23	NONE	magnesium/NN (r_compound) depletion/NN (r_pobj) of/IN (r_prep) treatments/NNS (l_appos) doses/NNS (l_prep) of/IN (l_conj) of/IN (l_pobj) selenium/NN
7786695	T20_T21	NONE	diuretics/NNS (l_appos) doses/NNS (l_prep) of/IN (l_pobj) B6/NNP
7786695	T20_T22	NONE	diuretics/NNS (r_dobj) sparing/VBG (r_acl) magnesium/NN (r_dobj) using/VBG (r_xcomp) tricky/JJ (r_acomp) are/VBP (l_nsubj) treatments/NNS (l_appos) doses/NNS (l_prep) of/IN (l_pobj) D/NN
7786695	T20_T23	NONE	diuretics/NNS (r_dobj) sparing/VBG (r_acl) magnesium/NN (r_dobj) using/VBG (r_xcomp) tricky/JJ (r_acomp) are/VBP (l_nsubj) treatments/NNS (l_appos) doses/NNS (l_prep) of/IN (l_conj) of/IN (l_pobj) selenium/NN
7786695	T21_T23	NONE	B6/NNP (r_pobj) of/IN (r_prep) doses/NNS (r_appos) diuretics/NNS (r_dobj) sparing/VBG (r_acl) magnesium/NN (r_dobj) using/VBG (r_xcomp) tricky/JJ (r_acomp) are/VBP (l_nsubj) treatments/NNS (l_appos) doses/NNS (l_prep) of/IN (l_conj) of/IN (l_pobj) selenium/NN
7786695	T22_T23	NONE	D/NN (r_pobj) of/IN (l_conj) of/IN (l_pobj) selenium/NN
7786695	T32_T33	NONE	magnesium/NN (r_pobj) of/IN (r_prep) properties/NNS (r_pobj) of/IN (r_prep) use/NN (r_nsubj) is/VBZ (l_prep) in/IN (l_pobj) solutions/NNS
6443625	T2_T1	NONE	progestogen/NN (r_compound) administration/NN (r_conj) estrogen/NN
6443625	T5_T6	NONE	levonorgestrel/NN (r_npadvmod) treated/VBN (r_amod) rats/NNS (r_conj) control/NN (r_pobj) of/IN (r_prep) urine/NN (r_pobj) in/IN (r_prep) levels/NNS (l_conj) levels/NNS (l_acl) shown/VBN (l_agent) by/IN (l_pobj) rats/NNS (l_acl) treated/VBN (l_prep) with/IN (l_pobj) estradiol/NN
3964797	T1_T2	NONE	digoxin/JJ (r_compound) amiodarone/NN
3964797	T3_T4	MECHANISM	Amiodarone/NNP (r_nsubjpass) known/VBN (l_xcomp) raise/VB (l_dobj) levels/NNS (l_compound) digoxin/JJ
3964797	T5_T7	NONE	digoxin/NN (r_pobj) for/IN (r_prep) variables/NNS (r_nsubjpass) determined/VBN (l_prep) before/RB (l_conj) after/IN (l_pobj) amiodarone/NN
3964797	T6_T7	NONE	digoxin/NN (r_pobj) of/IN (r_prep) dose/NN (r_pobj) after/IN (r_prep) determined/VBN (l_prep) before/RB (l_conj) after/IN (l_pobj) amiodarone/NN
3964797	T8_T9	MECHANISM	amiodarone/NN (r_compound) administration/NN (r_pobj) During/IN (r_prep) reduced/VBN (l_nsubjpass) clearance/NN (l_prep) of/IN (l_pobj) digoxin/NN
3964797	T12_T13	NONE	Amiodarone/NNP (r_nsubj) caused/VBD (l_conj) were/VBD (l_acomp) related/VBN (l_prep) to/IN (l_pobj) changes/NNS (l_prep) in/IN (l_pobj) pharmacokinetics/NNS (l_compound) digoxin/JJ
3964797	T14_T15	MECHANISM	digoxin/JJ (r_compound) pharmacokinetics/NNS (l_acl) produced/VBN (l_agent) by/IN (l_pobj) amiodarone/NN
3964797	T15_T16	NONE	amiodarone/NN (r_pobj) by/IN (r_agent) produced/VBN (r_acl) pharmacokinetics/NNS (r_pobj) in/IN (r_prep) alterations/NNS (r_nsubj) explain/VBP (l_dobj) increase/NN (l_prep) in/IN (l_pobj) level/NN (l_compound) digoxin/JJ
11064383	T1_T2	NONE	budesonide/NN (l_prep) in/IN (l_pobj) Survanta/NNP
11064383	T1_T3	NONE	budesonide/NN (l_prep) in/IN (l_pobj) Survanta/NNP (l_appos) surfactant/NN
11064383	T2_T3	NONE	Survanta/NNP (l_appos) surfactant/NN
11064383	T4_T5	NONE	surfactant/NN (r_compound) extract/NN (l_prep) from/IN (l_pobj) lung/NN (l_appos) Survanta/NNP
11064383	T4_T6	NONE	surfactant/NN (r_compound) extract/NN (r_pobj) of/IN (r_prep) effect/NN (r_nsubjpass) determined/VBN (l_prep) on/IN (l_pobj) rate/NN (l_prep) of/IN (l_pobj) particles/NNS (l_prep) of/IN (l_pobj) budesonide/NN
11064383	T5_T6	NONE	Survanta/NNP (r_appos) lung/NN (r_pobj) from/IN (r_prep) extract/NN (r_pobj) of/IN (r_prep) effect/NN (r_nsubjpass) determined/VBN (l_prep) on/IN (l_pobj) rate/NN (l_prep) of/IN (l_pobj) particles/NNS (l_prep) of/IN (l_pobj) budesonide/NN
11064383	T7_T8	NONE	budesonide/NN (r_pobj) of/IN (r_prep) particles/NNS (r_nsubjpass) generated/VBN (l_prep) from/IN (l_pobj) solution/NN (l_compound) ethanol/NN
11064383	T10_T11	NONE	Survanta/NNP (r_nsubj) increased/VBD (l_dobj) extent/NN (l_prep) of/IN (l_pobj) dissolution/NN (l_prep) of/IN (l_pobj) budesonide/NN
11064383	T12_T13	NONE	Survanta/NNP (r_nsubj) increased/VBD (l_prep) in/IN (l_pobj) manner/NN (l_amod) similar/JJ (l_prep) to/IN (l_pobj) sulfate/NN
11064383	T14_T16	NONE	budesonide/JJ (r_pobj) of/IN (r_prep) concentration/NN (r_pobj) of/IN (r_prep) Analysis/NN (r_nsubj) indicated/VBD (l_ccomp) is/VBZ (l_attr) equilibration/NN (l_prep) of/IN (l_pobj) budesonide/NN (l_prep) between/IN (l_pobj) phase/NN (l_nmod) Survanta/NNP
11064383	T15_T16	NONE	budesonide/NN (l_prep) between/IN (l_pobj) phase/NN (l_nmod) Survanta/NNP
1115340	T1_T2	NONE	agents/NNS (l_prep) as/IN (l_pobj) phenobarbitone/NN
1115340	T1_T3	NONE	agents/NNS (l_prep) as/IN (l_pobj) phenobarbitone/NN (l_conj) phenytoin/NN
6545985	T1_T2	EFFECT	neurotensin/NN (l_conj) enkephalins/NNS
6545985	T1_T3	EFFECT	neurotensin/NN (l_conj) enkephalins/NNS (l_conj) tuftsin/NN
6545985	T4_T6	NONE	neurotensin/NN (l_conj) enkephalins/NNS (l_conj) analogue/NN (l_appos) Ala2-metenkephalinamide/NN
6545985	T5_T6	NONE	enkephalins/NNS (l_conj) analogue/NN (l_appos) Ala2-metenkephalinamide/NN
6545985	T6_T7	NONE	Ala2-metenkephalinamide/NN (r_appos) analogue/NN (r_conj) enkephalins/NNS (l_conj) tuftsin/NN
6545985	T8_T9	EFFECT	neurotensin/NN (r_nsubj) antagonized/VBD (l_dobj) effect/NN (l_prep) of/IN (l_pobj) enkephalins/NNS
6545985	T10_T11	EFFECT	neurotensin/NN (l_conj) tuftsin/NN
6545985	T12_T13	EFFECT	neurotensin/NN (r_nsubj) modulates/VBZ (l_dobj) function/NN (l_prep) of/IN (l_pobj) neurons/NNS (l_conj) action/NN (l_prep) of/IN (l_pobj) tuftsin/NN
10319155	T1_T2	NONE	extract/NN (r_pobj) of/IN (r_prep) activity/NN (l_conj) in/IN (l_pobj) combination/NN (l_prep) with/IN (l_pobj) antibiotics/NNS
10319155	T5_T6	NONE	GL/NNP (r_pobj) of/IN (r_prep) combinations/NNS (r_pobj) of/IN (r_prep) effects/NNS (l_prep) with/IN (l_pobj) kinds/NNS (l_prep) of/IN (l_pobj) antibiotics/NNS
10319155	T5_T7	NONE	GL/NNP (r_pobj) of/IN (r_prep) combinations/NNS (r_pobj) of/IN (r_prep) effects/NNS (l_prep) with/IN (l_pobj) kinds/NNS (l_appos) ampicillin/UH
10319155	T5_T8	NONE	GL/NNP (r_pobj) of/IN (r_prep) combinations/NNS (r_pobj) of/IN (r_prep) effects/NNS (l_prep) with/IN (l_pobj) kinds/NNS (l_appos) ampicillin/UH (l_conj) cefazolin/NN
10319155	T5_T9	NONE	GL/NNP (r_pobj) of/IN (r_prep) combinations/NNS (r_pobj) of/IN (r_prep) effects/NNS (l_prep) with/IN (l_pobj) kinds/NNS (l_appos) ampicillin/UH (l_conj) cefazolin/NN (l_conj) oxytetracycline/JJ
10319155	T5_T10	NONE	GL/NNP (r_pobj) of/IN (r_prep) combinations/NNS (r_pobj) of/IN (r_prep) effects/NNS (l_prep) with/IN (l_pobj) kinds/NNS (l_appos) ampicillin/UH (l_conj) cefazolin/NN (l_conj) oxytetracycline/JJ (l_conj) chloramphenicol/NN
10319155	T6_T7	NONE	antibiotics/NNS (r_pobj) of/IN (r_prep) kinds/NNS (l_appos) ampicillin/UH
10319155	T6_T8	NONE	antibiotics/NNS (r_pobj) of/IN (r_prep) kinds/NNS (l_appos) ampicillin/UH (l_conj) cefazolin/NN
10319155	T6_T9	NONE	antibiotics/NNS (r_pobj) of/IN (r_prep) kinds/NNS (l_appos) ampicillin/UH (l_conj) cefazolin/NN (l_conj) oxytetracycline/JJ
10319155	T6_T10	NONE	antibiotics/NNS (r_pobj) of/IN (r_prep) kinds/NNS (l_appos) ampicillin/UH (l_conj) cefazolin/NN (l_conj) oxytetracycline/JJ (l_conj) chloramphenicol/NN
10319155	T11_T12	EFFECT	GL/NNP (r_pobj) of/IN (r_prep) combinations/NNS (l_prep) with/IN (l_pobj) antibiotics/NNS
10319155	T13_T14	EFFECT	GL/NNP (r_nsubjpass) combined/VBN (l_prep) with/IN (l_pobj) cefazolin/NN
3155550	T1_T2	NONE	naloxone/NN (l_prep) on/IN (l_pcomp) blocking/VBG (l_dobj) inhibition/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) endorphin/NN
3155550	T1_T3	NONE	naloxone/NN (l_prep) on/IN (l_pcomp) blocking/VBG (l_dobj) inhibition/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) endorphin/NN (l_conj) morphine/NN
3155550	T5_T6	NONE	naloxone/NN (l_prep) on/IN (l_pobj) production/NN (l_prep) of/IN (l_pobj) inhibition/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) endorphin/NN
3155550	T5_T7	NONE	naloxone/NN (l_prep) on/IN (l_pobj) production/NN (l_prep) of/IN (l_pobj) inhibition/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) endorphin/NN (l_conj) morphine/NN
3155550	T10_T11	EFFECT	naloxone/NN (r_pobj) of/IN (r_prep) injection/NN (r_nsubj) caused/VBD (l_dobj) blockade/NN (l_prep) of/IN (l_pobj) inhibition/NN (l_prep) of/IN (l_pobj) response/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) injection/NN (l_prep) of/IN (l_pobj) endorphin/NN
3155550	T10_T13	NONE	naloxone/NN (r_pobj) of/IN (r_prep) injection/NN (r_nsubj) caused/VBD (l_conj) blocked/VBD (l_dobj) inhibition/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) endorphin/NN
3155550	T11_T12	NONE	endorphin/NN (r_pobj) of/IN (r_prep) injection/NN (r_pobj) by/IN (r_agent) induced/VBN (r_acl) response/NN (r_pobj) of/IN (r_prep) inhibition/NN (r_pobj) of/IN (r_prep) blockade/NN (r_dobj) caused/VBD (l_conj) blocked/VBD (l_nsubj) dose/NN (l_prep) of/IN (l_pobj) naloxone/NN
3155550	T12_T13	EFFECT	naloxone/NN (r_pobj) of/IN (r_prep) dose/NN (r_nsubj) blocked/VBD (l_dobj) inhibition/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) endorphin/NN
3155550	T14_T15	EFFECT	naloxone/NN (r_nsubj) had/VBD (l_dobj) effect/NN (l_prep) on/IN (l_pobj) inhibition/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) morphine/NN
3155550	T16_T17	EFFECT	naloxone/NN (l_prep) at/IN (l_pobj) doses/NNS (l_acl) antagonized/VBN (l_dobj) inhibition/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) endorphin/NN
3155550	T16_T18	EFFECT	naloxone/NN (l_prep) at/IN (l_pobj) doses/NNS (l_acl) antagonized/VBN (l_dobj) inhibition/NN (l_acl) induced/VBN (l_agent) by/IN (l_pobj) endorphin/NN (l_conj) morphine/NN
3155550	T19_T20	NONE	naloxone/NN (r_npadvmod) sensitive/JJ (r_amod) system/NN (r_nsubjpass) involved/VBN (l_prep) in/IN (l_pobj) production/NN (l_prep) of/IN (l_pobj) inhibition/NN (l_nmod) endorphin/NN
3155550	T19_T21	NONE	naloxone/NN (r_npadvmod) sensitive/JJ (r_amod) system/NN (r_nsubjpass) involved/VBN (l_prep) in/IN (l_pobj) production/NN (l_prep) of/IN (l_pobj) inhibition/NN (l_nmod) endorphin/NN (l_conj) induced/VBN (l_npadvmod) morphine/NN
3155550	T19_T22	NONE	naloxone/NN (r_npadvmod) sensitive/JJ (r_amod) system/NN (r_nsubjpass) involved/VBN (r_ccomp) indicate/VBP (l_conj) suggest/VBP (l_ccomp) elicit/VBP (l_nsubj) endorphin/NN
3155550	T19_T23	NONE	naloxone/NN (r_npadvmod) sensitive/JJ (r_amod) system/NN (r_nsubjpass) involved/VBN (r_ccomp) indicate/VBP (l_conj) suggest/VBP (l_ccomp) elicit/VBP (l_nsubj) endorphin/NN (l_conj) morphine/NN
3155550	T19_T24	NONE	naloxone/NN (r_npadvmod) sensitive/JJ (r_amod) system/NN (r_nsubjpass) involved/VBN (r_ccomp) indicate/VBP (l_conj) suggest/VBP (l_ccomp) elicit/VBP (l_conj) descending/VBG (l_dobj) systems/NNS (l_prep) for/IN (l_pobj) endorphin/NN
3155550	T19_T25	NONE	naloxone/NN (r_npadvmod) sensitive/JJ (r_amod) system/NN (r_nsubjpass) involved/VBN (r_ccomp) indicate/VBP (l_conj) suggest/VBP (l_ccomp) elicit/VBP (l_conj) descending/VBG (l_dobj) systems/NNS (l_prep) for/IN (l_pobj) endorphin/NN (l_conj) morphine/NN
3155550	T20_T21	NONE	endorphin/NN (l_conj) induced/VBN (l_npadvmod) morphine/NN
3155550	T20_T23	NONE	endorphin/NN (r_nmod) inhibition/NN (r_pobj) of/IN (r_prep) production/NN (r_pobj) in/IN (r_prep) involved/VBN (r_ccomp) indicate/VBP (l_conj) suggest/VBP (l_ccomp) elicit/VBP (l_nsubj) endorphin/NN (l_conj) morphine/NN
3155550	T20_T25	NONE	endorphin/NN (r_nmod) inhibition/NN (r_pobj) of/IN (r_prep) production/NN (r_pobj) in/IN (r_prep) involved/VBN (r_ccomp) indicate/VBP (l_conj) suggest/VBP (l_ccomp) elicit/VBP (l_conj) descending/VBG (l_dobj) systems/NNS (l_prep) for/IN (l_pobj) endorphin/NN (l_conj) morphine/NN
3155550	T21_T22	NONE	morphine/NN (r_npadvmod) induced/VBN (r_conj) endorphin/NN (r_nmod) inhibition/NN (r_pobj) of/IN (r_prep) production/NN (r_pobj) in/IN (r_prep) involved/VBN (r_ccomp) indicate/VBP (l_conj) suggest/VBP (l_ccomp) elicit/VBP (l_nsubj) endorphin/NN
3155550	T21_T24	NONE	morphine/NN (r_npadvmod) induced/VBN (r_conj) endorphin/NN (r_nmod) inhibition/NN (r_pobj) of/IN (r_prep) production/NN (r_pobj) in/IN (r_prep) involved/VBN (r_ccomp) indicate/VBP (l_conj) suggest/VBP (l_ccomp) elicit/VBP (l_conj) descending/VBG (l_dobj) systems/NNS (l_prep) for/IN (l_pobj) endorphin/NN
3155550	T22_T25	NONE	endorphin/NN (r_nsubj) elicit/VBP (l_conj) descending/VBG (l_dobj) systems/NNS (l_prep) for/IN (l_pobj) endorphin/NN (l_conj) morphine/NN
3155550	T23_T24	NONE	morphine/NN (r_conj) endorphin/NN (r_nsubj) elicit/VBP (l_conj) descending/VBG (l_dobj) systems/NNS (l_prep) for/IN (l_pobj) endorphin/NN
7632757	T1_T2	EFFECT	diphosphonate/NN (l_appos) interaction/NN (l_compound) MDP)-gentamicin/NNP
7632757	T3_T4	NONE	Gentamicin/NNP (r_nsubj) is/VBZ (l_attr) antibiotic/NN
7632757	T5_T6	MECHANISM	gentamicin/NN (r_nsubj) cause/VB (l_ccomp) seen/VBN (l_prep) on/IN (l_pobj) scintigraphy/NN (l_compound) MDP/NNP
7632757	T9_T10	NONE	gentamicin/NN (r_compound) therapy/NN (r_pobj) of/IN (r_prep) monitoring/NN (l_conj) scintigraphy/NN (l_acl) employing/VBG (l_dobj) MDP/NNP
7632757	T9_T11	NONE	gentamicin/NN (r_compound) therapy/NN (r_pobj) of/IN (r_prep) monitoring/NN (l_conj) scintigraphy/NN (l_acl) employing/VBG (l_advcl) carried/VBN (l_nsubjpass) radiopharmaceutical/NN
7632757	T10_T11	NONE	MDP/NNP (r_dobj) employing/VBG (l_advcl) carried/VBN (l_nsubjpass) radiopharmaceutical/NN
7756960	T2_T3	NONE	immunodepressant/NN (l_appos) sandimmune/NN
6537219	T1_T2	NONE	disulfiram/NN (r_compound) ethanol/NN
6537219	T3_T4	NONE	disulfiram/NN (r_compound) ethanol/NN
6537219	T5_T6	EFFECT	ethanol/NN (r_nsubjpass) administered/VBN (l_prep) to/IN (l_pobj) rats/NNS (l_acl) treated/VBN (l_prep) with/IN (l_pobj) disulfiram/NN
6537219	T6_T7	NONE	disulfiram/NN (r_pobj) with/IN (r_prep) treated/VBN (l_prep) before/IN (l_pobj) challenge/NN (l_compound) ethanol/NN
11085336	T1_T2	NONE	18-Methoxycoronaridine/CD (l_appos) 18-MC/CD
11085336	T2_T3	NONE	18-MC/CD (r_appos) 18-Methoxycoronaridine/CD (l_conj) ibogaine/NN
11085336	T5_T6	NONE	ibogaine/NN (r_pobj) Like/IN (r_prep) decreases/VBZ (l_nsubj) mg/kg/NNS (l_nummod) 18-MC/CD
11085336	T5_T7	NONE	ibogaine/NN (r_pobj) Like/IN (r_prep) decreases/VBZ (l_dobj) administration/NN (l_prep) of/IN (l_pobj) morphine/NN
11085336	T5_T8	NONE	ibogaine/NN (r_pobj) Like/IN (r_prep) decreases/VBZ (l_dobj) administration/NN (l_prep) of/IN (l_pobj) morphine/NN (l_conj) cocaine/NN
11085336	T5_T9	NONE	ibogaine/NN (r_pobj) Like/IN (r_prep) decreases/VBZ (l_dobj) administration/NN (l_conj) administration/NN (l_prep) of/IN (l_pobj) ethanol/NN
11085336	T5_T10	NONE	ibogaine/NN (r_pobj) Like/IN (r_prep) decreases/VBZ (l_dobj) administration/NN (l_conj) administration/NN (l_prep) of/IN (l_pobj) ethanol/NN (l_conj) nicotine/NN
11085336	T5_T12	NONE	ibogaine/NN (r_pobj) Like/IN (r_prep) decreases/VBZ (l_conj) affect/VB (l_nsubj) 18-MC/NN
11085336	T6_T7	NONE	18-MC/CD (r_nummod) mg/kg/NNS (r_nsubj) decreases/VBZ (l_dobj) administration/NN (l_prep) of/IN (l_pobj) morphine/NN
11085336	T6_T8	NONE	18-MC/CD (r_nummod) mg/kg/NNS (r_nsubj) decreases/VBZ (l_dobj) administration/NN (l_prep) of/IN (l_pobj) morphine/NN (l_conj) cocaine/NN
11085336	T6_T9	NONE	18-MC/CD (r_nummod) mg/kg/NNS (r_nsubj) decreases/VBZ (l_dobj) administration/NN (l_conj) administration/NN (l_prep) of/IN (l_pobj) ethanol/NN
11085336	T6_T10	NONE	18-MC/CD (r_nummod) mg/kg/NNS (r_nsubj) decreases/VBZ (l_dobj) administration/NN (l_conj) administration/NN (l_prep) of/IN (l_pobj) ethanol/NN (l_conj) nicotine/NN
11085336	T6_T11	NONE	18-MC/CD (r_nummod) mg/kg/NNS (r_nsubj) decreases/VBZ (l_conj) affect/VB (l_prep) unlike/IN (l_pobj) ibogaine/NN
11085336	T7_T9	NONE	morphine/NN (r_pobj) of/IN (r_prep) administration/NN (l_conj) administration/NN (l_prep) of/IN (l_pobj) ethanol/NN
11085336	T7_T10	NONE	morphine/NN (r_pobj) of/IN (r_prep) administration/NN (l_conj) administration/NN (l_prep) of/IN (l_pobj) ethanol/NN (l_conj) nicotine/NN
11085336	T7_T11	NONE	morphine/NN (r_pobj) of/IN (r_prep) administration/NN (r_dobj) decreases/VBZ (l_conj) affect/VB (l_prep) unlike/IN (l_pobj) ibogaine/NN
11085336	T7_T12	NONE	morphine/NN (r_pobj) of/IN (r_prep) administration/NN (r_dobj) decreases/VBZ (l_conj) affect/VB (l_nsubj) 18-MC/NN
11085336	T8_T9	NONE	cocaine/NN (r_conj) morphine/NN (r_pobj) of/IN (r_prep) administration/NN (l_conj) administration/NN (l_prep) of/IN (l_pobj) ethanol/NN
11085336	T8_T10	NONE	cocaine/NN (r_conj) morphine/NN (r_pobj) of/IN (r_prep) administration/NN (l_conj) administration/NN (l_prep) of/IN (l_pobj) ethanol/NN (l_conj) nicotine/NN
11085336	T8_T11	NONE	cocaine/NN (r_conj) morphine/NN (r_pobj) of/IN (r_prep) administration/NN (r_dobj) decreases/VBZ (l_conj) affect/VB (l_prep) unlike/IN (l_pobj) ibogaine/NN
11085336	T8_T12	NONE	cocaine/NN (r_conj) morphine/NN (r_pobj) of/IN (r_prep) administration/NN (r_dobj) decreases/VBZ (l_conj) affect/VB (l_nsubj) 18-MC/NN
11085336	T9_T11	NONE	ethanol/NN (r_pobj) of/IN (r_prep) administration/NN (r_conj) administration/NN (r_dobj) decreases/VBZ (l_conj) affect/VB (l_prep) unlike/IN (l_pobj) ibogaine/NN
11085336	T9_T12	NONE	ethanol/NN (r_pobj) of/IN (r_prep) administration/NN (r_conj) administration/NN (r_dobj) decreases/VBZ (l_conj) affect/VB (l_nsubj) 18-MC/NN
11085336	T10_T11	NONE	nicotine/NN (r_conj) ethanol/NN (r_pobj) of/IN (r_prep) administration/NN (r_conj) administration/NN (r_dobj) decreases/VBZ (l_conj) affect/VB (l_prep) unlike/IN (l_pobj) ibogaine/NN
11085336	T10_T12	NONE	nicotine/NN (r_conj) ethanol/NN (r_pobj) of/IN (r_prep) administration/NN (r_conj) administration/NN (r_dobj) decreases/VBZ (l_conj) affect/VB (l_nsubj) 18-MC/NN
11085336	T11_T12	NONE	ibogaine/NN (r_pobj) unlike/IN (r_prep) affect/VB (l_nsubj) 18-MC/NN
11085336	T13_T15	NONE	ibogaine/NN (r_nsubj) ameliorate/VB (l_dobj) signs/NNS (l_amod) opioid/JJ
11085336	T14_T15	NONE	18-MC/CD (r_conj) ibogaine/NN (r_nsubj) ameliorate/VB (l_dobj) signs/NNS (l_amod) opioid/JJ
11085336	T17_T18	NONE	18-MC/CD (r_conj) ibogaine/NN (r_nsubj) decrease/NN (l_conj) increases/VBZ (l_nsubj) ibogaine/NN
11085336	T19_T21	EFFECT	ibogaine/NN (r_nsubj) induced/VBN (l_npadvmod) morphine/NN
11085336	T19_T22	EFFECT	ibogaine/NN (r_nsubj) induced/VBN (l_conj) induced/VBN (l_npadvmod) nicotine/NN
11085336	T19_T24	NONE	ibogaine/NN (r_nsubj) induced/VBN (r_nmod) release/NN (r_advcl) enhances/VBZ (l_dobj) increases/NNS (l_amod) induced/VBN (l_npadvmod) cocaine/NN
11085336	T20_T21	EFFECT	18-MC/CD (r_conj) ibogaine/NN (r_nsubj) induced/VBN (l_npadvmod) morphine/NN
11085336	T20_T22	EFFECT	18-MC/CD (r_conj) ibogaine/NN (r_nsubj) induced/VBN (l_conj) induced/VBN (l_npadvmod) nicotine/NN
11085336	T20_T23	NONE	18-MC/CD (r_conj) ibogaine/NN (r_nsubj) induced/VBN (r_nmod) release/NN (r_advcl) enhances/VBZ (l_nsubj) ibogaine/NN
11085336	T20_T24	NONE	18-MC/CD (r_conj) ibogaine/NN (r_nsubj) induced/VBN (r_nmod) release/NN (r_advcl) enhances/VBZ (l_dobj) increases/NNS (l_amod) induced/VBN (l_npadvmod) cocaine/NN
11085336	T21_T22	NONE	morphine/NN (r_npadvmod) induced/VBN (l_conj) induced/VBN (l_npadvmod) nicotine/NN
11085336	T21_T23	NONE	morphine/NN (r_npadvmod) induced/VBN (r_nmod) release/NN (r_advcl) enhances/VBZ (l_nsubj) ibogaine/NN
11085336	T21_T24	NONE	morphine/NN (r_npadvmod) induced/VBN (r_nmod) release/NN (r_advcl) enhances/VBZ (l_dobj) increases/NNS (l_amod) induced/VBN (l_npadvmod) cocaine/NN
11085336	T22_T23	NONE	nicotine/NN (r_npadvmod) induced/VBN (r_conj) induced/VBN (r_nmod) release/NN (r_advcl) enhances/VBZ (l_nsubj) ibogaine/NN
11085336	T22_T24	NONE	nicotine/NN (r_npadvmod) induced/VBN (r_conj) induced/VBN (r_nmod) release/NN (r_advcl) enhances/VBZ (l_dobj) increases/NNS (l_amod) induced/VBN (l_npadvmod) cocaine/NN
11085336	T23_T24	EFFECT	ibogaine/NN (r_nsubj) enhances/VBZ (l_dobj) increases/NNS (l_amod) induced/VBN (l_npadvmod) cocaine/NN
11085336	T27_T28	NONE	Ibogaine/NNP (r_nsubj) attenuates/VBZ (l_conj) potentiates/VBZ (l_nsubj) 18-MC/CD
11085336	T27_T29	EFFECT	Ibogaine/NNP (r_nsubj) attenuates/VBZ (l_conj) potentiates/VBZ (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
11085336	T27_T30	NONE	Ibogaine/NNP (r_nsubj) attenuates/VBZ (l_conj) potentiates/VBZ (l_conj) attenuate/VBP (l_dobj) locomotion/NN (l_amod) induced/VBN (l_npadvmod) morphine/NN
11085336	T27_T31	NONE	Ibogaine/NNP (r_nsubj) attenuates/VBZ (l_conj) potentiates/VBZ (l_conj) attenuate/VBP (l_dobj) locomotion/NN (l_prep) in/IN (l_pobj) rats/NNS (l_amod) experienced/VBN (l_npadvmod) morphine/NN
11085336	T28_T29	EFFECT	18-MC/CD (r_nsubj) potentiates/VBZ (l_dobj) effects/NNS (l_prep) of/IN (l_pobj) morphine/NN
11085336	T28_T30	NONE	18-MC/CD (r_nsubj) potentiates/VBZ (l_conj) attenuate/VBP (l_dobj) locomotion/NN (l_amod) induced/VBN (l_npadvmod) morphine/NN
11085336	T28_T31	NONE	18-MC/CD (r_nsubj) potentiates/VBZ (l_conj) attenuate/VBP (l_dobj) locomotion/NN (l_prep) in/IN (l_pobj) rats/NNS (l_amod) experienced/VBN (l_npadvmod) morphine/NN
11085336	T32_T33	NONE	Ibogaine/NNP (r_nsubj) produces/VBZ (r_ccomp) produce/VB (l_nsubj) 18-MC/LS
11085336	T36_T39	NONE	18-MC/CD (r_nsubj) have/VBP (r_advcl) has/VBZ (l_dobj) affinities/NNS (l_prep) than/IN (l_pobj) ibogaine/NN
11085336	T37_T38	NONE	ibogaine/NN (r_conj) 18-MC/CD (r_nsubj) have/VBP (r_advcl) has/VBZ (l_nsubj) 18-MC/CD
11085336	T38_T39	NONE	18-MC/CD (r_nsubj) has/VBZ (l_dobj) affinities/NNS (l_prep) than/IN (l_pobj) ibogaine/NN
11085336	T40_T42	NONE	18-MC/CD (r_nsubjpass) sequestered/VBN (l_prep) like/IN (l_pobj) ibogaine/NN
11085336	T44_T45	NONE	18-MC/NN (r_nsubj) has/VBZ (l_conj) have/VB (l_dobj) index/NN (l_prep) than/IN (l_pobj) ibogaine/NN
2981704	T3_T4	NONE	spermidine/NN (l_appos) mM/NNP (l_conj) putrescine/NN
2981704	T5_T6	NONE	Spermine/NN (l_conj) enhanced/VBD (l_punct) ,/, (l_preconj) spermidine/NN
1115367	T1_T2	INT	ketamine/NN (l_conj) halothane/NN
1115367	T3_T4	NONE	ketamine/NN (r_pobj) of/IN (r_prep) interaction/NN (l_conj) metabolite/NN (l_prep) with/IN (l_pobj) halothane/NN
1115367	T6_T7	MECHANISM	halothane/NN (r_amod) requirement/NN (r_nsubjpass) depressed/VBN (l_npadvmod) hours/NNS (l_prep) after/IN (l_pobj) injection/NN (l_prep) of/IN (l_pobj) ketamine/NN
1115367	T10_T11	MECHANISM	ketamine/NN (r_pobj) of/IN (r_prep) life/NN (r_nsubj) was/VBD (l_prep) in/IN (l_pobj) presence/NN (l_prep) of/IN (l_pobj) halothane/NN
1115367	T11_T12	NONE	halothane/NN (r_pobj) of/IN (r_prep) presence/NN (l_prep) than/IN (l_pcomp) given/VBN (l_nsubjpass) ketamine/NN
1115367	T13_T14	EFFECT	ketamine/NN (r_nsubj) is/VBZ (l_conj) expected/VBN (l_nsubjpass) use/NN (l_prep) with/IN (l_pobj) halothane/NN
9120829	T1_T2	MECHANISM	temazepam/NN (r_pobj) of/IN (r_prep) ethanolysis/NN (l_prep) in/IN (l_pobj) solutions/NNS (l_compound) ethanol/NN
9120829	T3_T4	NONE	benzodiazepines/NNS (r_nsubj) are/VBP (l_attr) family/NN (l_prep) of/IN (l_pobj) drugs/NNS (l_amod) anxiolytic/JJ
9120829	T3_T5	NONE	benzodiazepines/NNS (r_nsubj) are/VBP (l_attr) family/NN (l_prep) of/IN (l_pobj) drugs/NNS
9120829	T4_T5	NONE	anxiolytic/JJ (r_amod) drugs/NNS
9120829	T7_T8	NONE	temazepam/NN (l_appos) benzodiazepine/NN
9120829	T7_T9	MECHANISM	temazepam/NN (l_appos) benzodiazepine/NN (l_conj) ethanol/NN
9120829	T10_T11	MECHANISM	alcohol/NN (l_conj) 3-hydroxy-1,4-benzodiazepine/CD
